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CHAPTER I. INTRODUCTION 
1.1. Overview 
Capillary electrophoresis (CE) and high-performance liquid chromatography 
(HPLC) are widely used analytical separation techniques with many applications in 
chemical, biochemical, and biomedical sciences [1-4]. Conventional analyte 
identification in these techniques is based on retention/migration times of standards; 
requiring a high degree of reproducibility, availability of reliable standards, and absence 
of coelution. From this, several new "information-rich" detection methods (also known 
as hyphenated techniques)1 are being explored that would be capable of providing 
unambiguous on-line identification of separating analytes in CE and HPLC [5]. As 
further discussed in Section 1.2 of this chapter, a number of such on-line detection 
methods have shown considerable success, including Raman [6-12], nuclear magnetic 
resonance (NMR) [13-19], mass spectrometry (MS) [20-25], and fluorescence line-
narrowing spectroscopy (FLNS) [26-32]. In this thesis, the feasibility and potential of 
combining the highly sensitive and selective laser-based detection method of FLNS with 
analytical separation techniques are discussed and presented. A summary of previously 
demonstrated FLNS detection interfaced with chromatography and electrophoresis is 
given, and recent results from on-line FLNS detection in CE (CE-FLNS), and the new 
combination of HPLC-FLNS, are shown. It is believed that the continued development 
of on-line FLNS detection with modern separation techniques (e.g., CE and HPLC) will 
further expand this detection approach in environmental and bioanalytical sciences. 
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FLNS has proven to be a powerful, high-resolution detection method that can be 
used for identification and characterization of structurally similar molecular analytes. Its 
physical principles and attributes are only briefly mentioned here, and more thoroughly 
discussed in Chapter 2 of this thesis, and in several books [33-39] and reviews [40-44], 
FLNS is a low temperature (typically 4.2 K) technique in which a tunable laser is used to 
selectively excite a narrow region within the inhomogeneously broadened absorption 
band of an analyte imbedded in an amorphous host [33]. Since only excited analytes 
fluoresce, the inhomogeneous broadening contribution to the fluorescence vibronic bands 
is largely eliminated at low temperature, i.e., the fluorescence spectrum is line-narrowed. 
Typically, the inhomogeneous broadening is in the range of 100-300 cm"1. The line-
narrowed widths of vibronic transitions are usually lifetime limited («5 cm"1) due to 
vibrational relaxation [41,43]. 
FLNS has been used for identification and spectroscopic characterization of a 
large number of organic [33,43,45] and inorganic [46] molecules as well as a wide 
variety of biomolecules including photosynthetic pigments [47-52], antenna protein-
pigment complexes [53], hemoglobin [54], and antibody-PAH complexes [55]. FLNS 
has also been applied to nucleosides/nucleotides, oligonucleotides, macromolecular 
DNA, and proteins adducted to metabolites of polycyclic aromatic hydrocarbons (PAHs) 
[28-32,41,43,56]. In particular, FLNS has proven to be the most powerful optical 
spectroscopic technique for the detection and characterization of PAH-DNA adducts 
formed in vitro [43,56,57] and in vivo [58-62], where one is limited to picomole or sub-
picomole quantities of bound metabolite. For example, one adduct in 108 base pairs for 
100 ng of macromolecular DNA [56] can be detected, while at the nucleoside level 0.1 
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femtomole of a moderately strong fluorophore such as benzo[a]pyrene-6-N7-guanine can 
be detected with a spectral resolution of-5 cm*1 [43,56], The distinction between 
adduction of a given metabolite to different bases and to different nucleophilic centers of 
a given base such as guanine (Gua) and adenine (Ade) has been demonstrated [57,62], 
Moreover, FLNS has been used to differentiate between external, base-stacked, and 
intercalated conformations of PAH-DNA adducts and stereoisomeric PAH-DNA adducts 
[59,60,63-66], The success of FLNS is the result of a combination of high sensitivity, 
high selectivity, and versatility. It is with these attributes that we believe FLNS will be a 
valuable contributor as an information-rich detection method in chromatography and 
electrophoresis. 
1.2. Information-rich Detection in Chromatography and Electrophoresis 
There is a multitude of detection techniques available for electrophoresis and 
chromatography and a detailed comparison is beyond the scope of this thesis (for reviews 
see Refs. 5,67,68). The most common detection modes include optical absorption, 
fluorescence, and radioactivity, where analyte identification is based on retention times 
(or migration distances) that are determined using standards. Such identification requires 
the absence of co-elution from other separating species, a high degree of reproducibility, 
and the availability of reliable standards. To circumvent these problems a number of 
information-rich detection schemes have been developed to provide a higher level of 
confidence in the identification process. They include absorption and fluorescence 
spectroscopy at room temperature [5], MS [20-25], NMR [13-19], electrochemical (EC) 
detection [69,70], circular dichroism (CD) [71], Fourier transform-infrared (FTIR) 
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spectroscopy [72,73], Raman spectroscopy [6-12], and FLNS [26-32]. A direct 
comparison of their attributes is difficult due to the inherent differences between the 
identification processes; nonetheless, a brief summary of each technique is given below. 
On-line wavelength-resolved absorbance detection is the most frequently applied 
method for monitoring separations due to its low cost and universal applicability. 
Although this method offers a spectral signature of the separated components, the spectra 
of liquid solutions are often broad and quite structureless at room temperature. 
Moreover, the sensitivity of this approach is low due to shot-noise and the typically short 
optical path. In contrast to absorbance, wavelength-resolved fluorescence 
emission/excitation detection provides higher sensitivity; this is especially true for laser-
induced fluorescence (LIF), which can have picomolar detection limits [74,75], 
Unfortunately, as in the case of absorption room temperature fluorescence spectra are 
often featureless, preventing identification of closely related analytes. 
NMR detection in chromatography and electrophoresis can provide unequivocal 
structural and conformational information on separated species. However, due to field 
inhomogenities from limited residence times and technical difficulties of probe/coil 
design, the sensitivity of this technique is severely compromised for on-line analysis 
[76,77] with detection limits of about 0.1-1 M [5]. In addition, the current spectral 
resolution of on-line NMR detection is rather low, excluding the possibility to 
differentiate between stereoisomers [5,78]. Furthermore, the need for solvent 
suppression methodologies or deuterated solvents imposes additional constraints for 
practical applications of on-line NMR analysis. 
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FTIR spectroscopy can also provide spectral information from which analyte 
identity may be obtained in both off- and on-line [72,73]. However, since most solvents 
used in separation procedures absorb strongly in the mid-IR region, flow cells with a 
small pathlength have to be used, severely decreasing the limit of detection (LOD), which 
is in the sub-millimolar range for on-line CE-FTIR analysis. It has been shown that the 
LOD for liquid chromatography (LC) can be improved by using a novel semi-on-line 
approach, where the LC effluent is deposited on a zinc selenide substrate followed by 
evaporation of the mobile phase prior to analysis [79]. 
Raman spectroscopy has also been used to provide on-line detection for LC [8,9] 
and CE [6,7]. The main advantage of Raman detection over room temperature absorption 
and fluorescence spectroscopies is that Raman spectra are highly structured. Various 
forms of Raman spectroscopy have been employed for on-line detection [6-12]. As in the 
case of FTIR, on-line analysis by Raman spectroscopy suffers from inadequate sensitivity 
and limit of detection due to solvent interference. Sub-micromolar detection limits have 
been reported for CE-Raman [10]. 
In on-line electrochemical (EC) detection, specifically amperometric detection, 
compounds are selectively oxidized or reduced at the electrode surface within a potential 
window that is governed by the choice of electrode and mobile phase. In potentiometric 
detection, selectivity is attained with an ion-selective electrode. Both EC techniques are 
capable of selectively detecting components in complex biological fluids [80,81], 
Detection limits for electroactive analytes in CE/LC with EC detection are typically in 
the low nanomolar range [67,82]. 
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Fluorescence-detected circular dichroism (FDCD) is another information-rich 
detection method being used for on-line detection in electrophoresis and chromatography 
[71]. It is applicable to chiral molecules whose CD signature varies with molecular 
conformation, thereby providing the analyst with important structural information. Since 
many biomolecules are chiral, this type of detection has found applications to 
bioanalytical sciences [71,83]. As an example of sensitivity, CE-FDCD detection allows 
for optical activity measurements of riboflavin in picoliter volumes with a detection limit 
in the subfemtomole range [71]. 
Detection by MS in CE and chromatography provides a high degree of structural 
information and, thus, is becoming widely used. Both off- and on-line MS detection 
modes have been successfully employed [20-25]. With MS detection, separated analytes 
are identified based on mass-to-charge ratios of parent ions or fragment ions produced 
from collision-induced dissociation. MS has very good sensitivity and excellent 
selectivity [5,67]. However, in the case of structurally similar molecules (e.g., geometric 
isomers), the highly discretionary, multi-pass process used often results in a severe 
decrease in throughput. Nonetheless, MS has a LOD in the femtomole range, which is 
often adequate for many applications. 
Finally, FLNS has been coupled both off- and on-line with chromatography and 
electrophoresis [26-32,84-89] as will be discussed and presented in the remainder of this 
thesis. FLNS is very sensitive and highly selective in both frequency and time domains 
and can provide structural/conformational information that lead to unambiguous analyte 
identification. Low attomole LOD for on-line FLNS has been demonstrated [30], and it is 
important to note that the applicability of FLNS can be expanded to non-fluorescent 
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compounds derivatized with a fluorescent marker, which adopts specific interactions with 
the analyte of interest [90]. 
1.3. Dissertation Organization 
Chapter 1 begins by providing a general overview of FLNS detection. In 
addition, Section 1.2 gives a brief synopsis of other common forms of information-rich 
detection currently being developed. Chapter 2 describes the pertinent principles and 
concepts of fluorescence line-narrowing spectroscopy for its analytical application to 
detection in chromatography and electrophoresis. A general description of solid-state 
spectral broadening is given in Section 2.1 and traditional "off-line" detection with FLN 
and its experimental instrumentation used by this laboratory are given in Section 2.2. 
The remaining section of Chapter 2 discusses and presents previous reports of FLN 
detection with polyacrylamide gel electrophoresis and thin-layer chromatography. 
Chapter 3 provides a brief description of the principles of capillary electrophoresis (CE) 
(Section 3.1) and the instrumentation for the formerly developed on-line CE-FLNS 
system (Section 3.2). Preliminary tests previously published on the CE-FLNS are shown 
and discussed in Section 3.2.2. Chapter 4 presents published results by the candidate on 
applications of CE-FLN and non-line-narrowing (NLN) fluorescence spectroscopy to the 
identification of eight diastereomeric deoxyadenosine adducts of dibenzo[a,/]pyrene (the 
most potent chemical carcinogen). Likewise, Chapter 5 presents published results by the 
candidate of CE-FLNS for the first ever identification of depurinating benzo[a]pyrene-6-
N7-guanine adduct in humans. In Chapter 6 the prospect, design, and application of on­
line HPLC-FLNS for four structurally similar molecules, along with a real-world 
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application to chemical carcinogenesis, are presented. A general conclusion is presented 
in Chapter 7. In Appendix A, a previously published paper on FLN/NLN spectral and 
conformational off-line analysis of deoxyadenosine adducts derived from syn- and anti-
dibenzo[a,/]pyrene diolepoxides are presented. In Appendix B, the preliminary results of 
DNA adduction from the anti-estrogen drug tamoxifen are reported with NLN 
fluorescence studies of intact DNA. Finally, Appendix C shows preliminary CE-NLN 
fluorescence results for a photosynthetic protein complex, CP43. 
'introductory portions of this thesis were adapted, in part, from Jankowiak, R., Roberts, K.P., and Small, 
G.J., Electrophoresis 2000, 21, 1251. 
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CHAPTER 2. FLUORESCENCE LINE-NARROWING SPECTROSCOPY 
(FLNS) 
2.1. Homogeneous and Inhomogeneous Spectral Broadening 
In solid-state molecular systems, molecules are frozen and have no freedom of 
rotation and translation, and should therefore provide much simpler optical spectra 
compared to gaseous or liquid samples. In the solid state, there are two possible 
contributions to spectral broadening: homogeneous (Thom) and inhomogeneous (Finh) [I], 
which are illustrated in Frames A and B of Figure 2-1, respectively. Depicted on the left 
in Figure 2-1A are three identical chromophores (guests) embedded in a perfect crystal 
lattice (host). The local microenvironments of the guest chromophores are identical, 
which results in the guests having identical absorption frequencies, o>t = û)2 = ©3, and a 
Thom width. The Fhom absorption profile has a Lorentzian line shape and predominantly 
originates from interactions of the guest molecules with lattice vibrations (phonons) of 
the host matrix [1]. Upon electronic excitation of the guest molecule from the ground 
state to the excited state, periodic movement of host molecules can destroy the phase 
relationship (guest-host equilibrium geometry) between the ground and excited state as 
defined by the total optical dephasing time (7%), given by: 
( 2 I )  
where T\, so-called lifetime or natural broadening, originates from the excited-state 
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Figure 2-1. Schematic of the optical absorbance lines for three identical chromophores in 
a perfect crystal lattice (A) and in and amorphous host (B). 
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the zero-point level of the ground electronic state, and T{ is the pure dephasing time. T{ 
is the result of phonons that are excited by thermal motion and is therefore strongly 
temperature dependent. For this discussion, it suffices to say that T{ is attibuted to a 
modulation of the single-site transition frequency that results from the interaction of the 
excited state with the bath phonons at high temperatures (> 10 K.) and other low-energy 
excitation modes at low temperatures (< 10 K) of the host matrix. The contribution of T{ 
to F hom is much greater than that of T\. Therefore, since F hom ultimately dictates the 
achievable spectral resolution, low temperatures are required to minimize the number of 
thermally activated phonons responsible for 7Y- For example, in amorphous solids at 
room temperature rhom from Ti is ~ 200 cm*1 and is < 0.1 cm"1 at 4.2 K, where the 
dependence of T{ is proportional to T"13 at T < 10 K. Therefore, the temperature-
dependent homogeneous line width can be given (in cm"1) as: 
Thorn = (7t^2c) (2.2) 
where c is the speed of light in a vacuum (2.9979 x 1010 cm/s) and Ti is comprised of T, 
and 7V as described above. 
Shown on the left of Figure 2-IB is an illustration of three identical chromophores 
in an amorphous lattice at low temperature. If the guest chromophore is embedded in an 
amorphous host, such as glasses, polymers, proteins, and DNA [1-3], each guest 
chromophore experiences energetically inequivalent microenvironments, forming an r^h 
Gaussian distribution (~ 100-300 cm"1) of fhom transitions [1,4,5]. Even at low 
temperatures (< 10 K), to achieve high-resolution absorbance or fluorescence spectra 
under these conditions Tmh must be effectively eliminated or reduced. This can be 
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accomplished by either dissolving the guest in a uniform matrix of similar molecular 
dimensions to the guest (e.g., mixed crystal or Shpol'skii techniques) or by generally 
more applicable laser-based methods such as spectral hole burning or fluorescence line-
narrowing spectroscopy (FLNS). 
2.1.1. Zero-Phonon Lines and Phonon Sidebands 
The coupling between electronic transitions of guest chromophores and the matrix 
phonons have major effects on the general shape of absorbance and fluorescence spectral 
lines. In what follows, these shapes will be discussed in terms of fluorescence since this 
thesis focuses on fluorescence detection. However, it should be noted that the principles 
described below are readily applicable to absorbance as well. Shown in Figure 2-2A is 
an inhomogeneously broadened fluorescence origin band [(0,0) band] at low temperature. 
The three relatively sharp lines within the fluorescence origin band are zero-phonon lines 
(ZPL), which refer to an electronic transition of a guest chromophore with no net change 
in the number of phonons in the host matrix [I]. Each single-site ZPL carries a 
homogeneous width, Thorn, which was described above for absorbance spectra in Figure 
2-1. Building to the lower energy side of each ZPL is a broader (~ 30-40 cm"1) phonon 
wing, known as the phonon sideband (PSB), which is a superposition of all lattice phonon 
transitions. Taking into account that phonons contribute to the overall fluorescence (0,0) 
band, the full width at half maximum (fwhm) of the Gaussian shown in Figure 2.2A is 
approximated as: 





Figure 2-2. Frame A: Schematic representation of an inhomogeneously broadened (0,0) 
fluorescence origin band. The three sharp dashed lines are zero-phonon lines (ZPL), 
while the smaller, broader contribution to lower energy of the ZPLs are phonon sidebands 
(PSB). Inhomogeneous broadening is effectively eliminated by selective excitation with 
a tunable laser source at col. Frame B: Resonant fluorescence ZPL and PSB from 
selective excitation within the inhomogeneously broadened spectrum in Frame A. The 
ZPL and PSB widths are enlarged relative to the inhomogeneous band to show detail. 
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where S is the Huang-Rhys factor, and is the mean phonon frequency [5,7,8]. The 
physical significance of Sû)m, is most appreciated for fluorescence where 2Sam 
corresponds to the Stokes shift for relaxed fluorescence. An expression for the single-site 
fluorescence profile in the low-temperature limit (T-» 0 K) has previously been derived 
and is given by [6,7]: 
/(<y) = e s l0(û)-{2)+ E SR-—lR(0)-O +Rû)m) (2.4) /?=l /t! 
where /2is the frequency of the ZPL, and /o(<y-/7) describes the fh0m Lorentzian line 
shape of the ZPL. The second term describes the phonon sideband contribution, with R = 
1,2,... terms corresponding to the one-phonon and multi-phonon (R > 2) transitions with 
A, the one-phonon profile. Frame B of Figure 2-2 shows the result of selectively exciting 
a narrow region of the inhomogeneous (0,0)-band in Frame A with a narrow laser 
excitation frequency, such that Fl « Thorn « finh- The result is a [resonant] 
fluorescence line-narrowed (FLN) spectrum with a ZPL width of2Thom, and a broad PSB 
centered at com. By expanding Eq. (2.4) to include a distribution of phonons coupled to 
the electronic transition, the l^R > 2) profile can be obtained by convolution of the one-
phonon profile R times [6,7]. An expression for the FLN spectrum, F(<y), obtained by 
convolution of the single-site fluorescence profile with the site distribution function, N(0 
- £DC), and the absorption at the excitation frequency/^ -/2 + Pcom), can be given as: 
00 
F(w)= Z 
R.P=0 X R\ 
's'i? 
P\ 
fcU2V(£2-û)c)lR(û)-n + Rû)m)lp(a>L -Q-P(om) (2.5) 
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In this case, N{D- (ûc) is taken as a Gaussian inhomogeneous distribution centered at ojc 
with an excitation frequency <ol and the R and P terms describe PSB transitions that build 
on the lower energy side of the ZPL, which itself (the ZPL) is defined as R, P = 0. In the 
case of P = 0, R > 1, the phonon transition is called a real-PSB. In the opposite case, R = 
0, P > 1, the transition is a pseudo-PSB. Lastly, the multiphonon case of R,P * 0 results 
in a contribution building on the pseudo-PSB. However, each contribution cannot be 
determined experimentally by FLN, while it is possible with spectral hole burning. A 
complete physical description of the origins of the PSB contributions and ZPL line-width 
are beyond the scope of this discussion, but can be generalized here as the result of 
lifetime broadening, electron-phonon interactions, and spectral diffusion. For a complete 
discussion of ZPLs and PSBs, the reader is referred to Refs. 1,6, 7, and 10. 
Of analytical importance is the relative intensity ratio of the ZPL to the PSB, 
which is determined by the strength of electron-phonon coupling. In the low temperature 
limit, the Franck-Condon factors for the ZPL and PSB are given by exp(-S) and [l-exp(-
S)], respectively. Weak electron-phonon coupling can be simply stated as S < 1, and 
strong coupling as S > 1. In the limit of very strong electron-phonon coupling, such that 
S »1, the resulting fluorescence spectrum will be dominated by the PSB emission with 
very weak ZPLs and fluorescence line-narrowing will be impossible. In a practical sense, 
the ZPL to PSB ratio is most easily determined experimentally, and depends not only on 
the host matrix, but also on intrinsic guest-host interactions. In terms of chromatography 
and electrophoresis, the host is the mobile phase or buffer, while the guest is the analyte. 
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2.2. Principles of FLNS 
The key requirements for FLNS detection are: (/) low temperature to minimize 
homogeneous spectral broadening; (») selective excitation with a narrow laser source to 
effectively eliminate inhomogeneous broadening; (iiï) weak electron-phonon coupling; 
and (zv) sufficiently low analyte concentration (< 10"4 M) to prevent energy transfer. In 
conventional room-temperature fluorescence detection with a broadband excitation 
source, all mutually different sites within a (0.0) transition that overlap the excitation 
bandwidth fluoresce, resulting in a broad, featureless spectrum. However, as introduced 
above, in FLNS a narrow laser frequency excites only those sites whose (0,0) transitions 
overlap the laser profile (often referred to as selecting an "isochromat"), resulting in a 
fluorescence line-narrowed (FLN) spectrum as shown in Figure 2-2. At first glance, this 
would seem to make FLNS an insensitive technique, but the reduction in homogeneous 
broadening alone, in going from 300 to 4.2 K (from 200 to < 0.1 cm"'), more than 
compensates for the loss in being site selective. 
Two types of excitation can be employed in FLNS: the chromophore can be 
excited in its inhomogeneously broadened origin absorption band (origin band excitation) 
or vibronic absorption bands (vibronic excitation). Figure 2-3 illustrates origin band 
excitation for the low temperature limit where the narrow bandwidth laser, with 
frequency mL, selectively excites chromophores within the (0,0) origin band. The 
resulting FLNS spectrum at the bottom of the top frame of Figure 2-3 is comprised of the 
highest energy ZPL which corresponds to the transition between the zero-point 
vibrational levels of the fluorescent (S,) and ground electronic (S0) states, and a series of 
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Figure 2-3. Origin band excitation in FLNS. Top frame: Fjnh denotes the inhomogeneous 
broadening of the (0,0) band. S is the Huang-Rhys factor, and om corresponds to the 
mean phonon frequency. Laser frequency, cdl, excites only those chromophores whose 
(0,0) transition overlaps the laser profile. toa and top correspond to the ground-state 
vibrational frequencies, in cm*1. Bottom frame: (0,0) absorption band (left) and FLN 
spectrum (right) obtained for pyrene in ethanol glass at T = 4.2 K, X*x = 371.5 nm. The 
sharp peaks (ZPLs) in the fluorescence spectrum correspond to pyrene ground-state 
vibrational frequencies [12]. 
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type of FLN spectrum provides ground-state vibrational frequencies (ooa and ©p) which, 
when combined with the relative vibronic intensities, serve as a "fingerprint" of the 
chromophore. In the bottom frame of Figure 2-3, an example of an origin-band excited 
FLN spectrum (right) is shown, along with the inhomogeneously broadened absorption 
spectrum (left) for pyrene embedded in ethanol glass at 4.2 K [12]. For clarity, only part 
of the FLN spectrum is shown; the narrow peaks are ZPLs, and their frequencies (not 
shown) correspond to the ground-state vibrations. The prominence of the ZPLs indicates 
weak electron-phonon coupling, i.e., S < 1. As the laser is tuned across the origin band, 
the fluorescence spectrum tracks the laser while maintaining the same vibronic structure. 
Vibronically excited FLNS probes the S i-state vibronic levels as shown in the top 
frame of Figure 2-4. The laser (coL) excites only two overlapping vibronic transitions, 
(la,0) and (lp,0), which are not resolved in the absorption spectrum. The two selected 
isochromats undergo vibrational relaxation to two different points (A and B) in the zero-
point level of the St-state. This is followed by fluorescence from the energetically 
distinct isochromats, resulting in an FLN spectrum that consists of two strong ZPLs 
[(0,0)A and (0,0)B]. This is often referred to as a "multiplet origin structure." The 
displacements between ©L and the doublet components of the origin transition, [(0,0)A 
and (0,0)B], yield the excited-state vibrational frequencies coa' and cop'. The vibronic 
bands that build on (0,0)A and (0,0)B to lower energy are not shown for simplicity. In an 
actual experiment, it is common to observe 6-8 ZPLs that contribute to the multiplet 






Figure 2-4. Principles of vibronic excitation in FLNS. Top frame: selective laser 
excitation (cdl) of two subsets of molecules (A and B) within the vibronic region. 
Schematic of the resulting fluorescence spectrum with two (0,0)A and (0,0)G transitions is 
shown at the bottom of the top frame. <ûa' and op' are the vibrational frequencies in the 
excited-state. Bottom frame: an example of vibronically excited FLN spectrum is shown 
for the j}77-DB[tf,/]PDE-14-N7Gua adduct; X«% = 376.0 nm, T = 4.2 K. The sharp ZPLs 
at 749 and 772 cm'1 correspond to excited state vibrational frequencies [12]. 
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Vibronically-excited FLNS has been used almost exclusively for identification 
and conformational analysis of closely related analytes due to its superior ability (relative 
to origin-excited FLNS) to differentiate structurally similar molecules [3,11,12]. It has 
been established that the Si-state vibrational frequencies and intensities are the most 
sensitive to subtle changes in the structure of the chromophore and its environment [11-
13]. This sensitivity has a firm theoretical understanding based on the Duschinsky effect 
(a mixing of the normal coordinates in the excited state and vibronically induced 
anharmonicity) [14]. An example of a vibronically excited FLN spectrum obtained at 4.2 
K. for the jy«-dibenzo[a,/]pyrene diolepoxide-14-N7Gua adduct is shown in the lower 
frame of Figure 2-4. Laser excitation at 378 nm selectively excites several modes; with 
the two strongest bands corresponding to 749 and 772 cm'1 excited state vibrations. The 
prominence of the vibronic ZPLs indicates weak electron-phonon coupling. By tuning 
across the S, <- S0 absorption spectrum one can determine all active excited state 
vibrations [1,3,10,15]. For each excitation frequency mLi a distinct fingerprint of the 
analyte is obtained. Lastly, it is important to note that FLN is generally observed only 
with excitation frequencies located within the S, <- S0 absorption spectrum at or near 4.2 
K. Excitation of the higher-energy states (S„, n > 2), or at temperatures larger than ~ 20 
K results in S[ fluorescence spectra that exhibit, at best, only a slight degree of line 
narrowing. This is a consequence of the site excitation energies of different electronic 
states being largely uncorrected, and is often termed non-line-narrowed (NLN) 
fluorescence. 
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2.3. Off-Line Detection 
By tradition, FLN and NLN detection is often accomplished in an "off-line" 
mode. In using FLN and NLN as an analytical technique to spectroscopically identify 
and characterize analytes (as is often the case in this laboratory) the basic procedure is to 
generate a reference library of spectra from a well-characterized standard. With this 
reference material, future identifications are possible by comparing sample data to 
previously generated reference data. In this laboratory, off-line FLN and NLN spectra 
are obtained using a Lambda Physik FL-2002 dye laser pumped by a Lambda Physik 
Lextra 100 XeCl excimer laser as an excitation source, as shown in the block diagram of 
Figure 2-5. The excimer laser provides high-energy (~ 150 mJ/pulse) pulses with a 
repetition rate up to 50 Hz at 308 nm. For time-resolved spectroscopy, a Lambda Physik 
EMG-97 zero-drift controller is used to trigger a high-voltage Roper Scientific FG-100 
pulse generator, which controls both the adjustable delay time and the width of the 
temporal detection window. Detector delay times of 0-200 ns, with a gate width of 200 
ns, are commonly used. The dye laser uses a Littrow style grating which provides a 
spectral line-width of ~ 0.2 cm*1. For FLN spectra, several excitation wavelengths are 
used, each of which reveals a portion of the S i excited state vibrational frequencies of the 
analytes. NLN spectra are obtained using nonselective excitation at 308 nm from the 
excimer laser. Samples are cooled in a glass cryostat with quartz optical windows to 77 
or 4.2 K. Fluorescence is dispersed by a McPherson 2061 1-m focal-length 
monochromator and detected by a Roper Scientific IRY 1024-GRB intensified 
photodiode array. For FLN measurements, the monochromator is equipped with a 2400 
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Figure 2-5. Block diagram of FLN and NLN spectroscopy instrumentation: S, sample in 
a copper holder; L, lens; P, prism; BS, beam splitter. 
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NLN spectra are 0.03 and 0.5 nm, respectively. Samples (ca. 20 |iL) are transferred to 
quartz tubes (2 mm i.d.) and the tubes sealed with a rubber septum. Solvent matrices are 
of HPLC or spectrometric grade. 
However, in many real-world analyses, samples can often be complex, unstable, 
and the analyte of interest present in small amounts. This can severely limit the 
applicability of the off-line experimental design described above for biological samples 
due to spectral interference [11]. For example, in studying metabolic pathways of 
polycyclic aromatic hydrocarbons, several structurally similar analytes are commonly 
encountered which need to be individually identified and quantified. For FLN and NLN 
to be operative under these conditions, sample constituents must first be separated and 
purified by, for example, extraction methods and/or preparative chromatography. This 
process generally requires ample amounts of sample and standard, reproducibility, and 
sufficient detection sensitivity by the preparative chromatography system. Moreover, 
most biological studies from in vivo experiments result in sample amounts that cannot 
sustain the losses associated with multiple sample-handling steps, or the losses associated 
with analyte degradation. To remedy these limitations and concerns, FLNS has been 
combined with various forms of chromatography and electrophoresis. The comparative 
performance of each combination will be discussed, beginning with the least expensive 
choice, thin-layer chromatography, and ending with the presentation of recent results by 
the candidate on the on-line combinations of FLNS with capillary electrophoresis and 
high-performance liquid chromatography. Similar to the above methods in off-line FLNS 
detection, identification of the chromatographically and electrophoretically separated 
analytes is made by comparison of sample spectra with reference spectra obtained (once) 
29 
from well-characterized standards. Excluding the relatively new separation method 
capillary electrophoresis (see Chapter 3), all the separation techniques discussed below 
are well known and the theory of their separation processes will only be briefly 
mentioned in the context of their performance when combined with FLNS. 
2.4. Thin-Layer Chromatography (TLC) and FLNS 
TLC is a well-established and inexpensive separations technique where 
chromatographic media is adhered to a glass plate. Samples are "spotted" on the plate 
and the plate placed in a TLC chamber containing an appropriate mobile phase. By 
capillary action, the mobile phase traverses up the TLC plate, separating components of 
the sample based on a dynamic equilibrium of the analyte between the stationary and 
mobile phases. TLC has been used in the analysis of many compounds including PAHs 
and DNA adducts, where analyte identification is generally accomplished by 
visualization of separated components on the TLC plate [16-26]. However, this method 
of identification is often difficult and ambiguous due to band broadening and/or 
incomplete separation of sample constituents. With FLNS, however, this limitation can 
be overcome by spatially analyzing the separated analyte zones with a focused laser beam 
to attain selectivity. The first experiments of TLC-FLNS were performed with PAHs and 
PAH-DNA adducts deposited on filter paper [16] and silica gel TLC plates [17,18], For 
example, Cooper et al. [16] studied B[a]P derived deoxyguanosine (dG) adducts (B[a]P-
C8dG) deposited on an octadecylsilate TLC plate. A detection level of -10 femtomole 
was demonstrated. Shown in Figure 2-6 is a vibronically excited FLN spectrum obtained 
with an excitation wavelength (>*«) of 395.7 nm for B[a]P-C8dG on the TLC plate. The 
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Figure 2-6. FLN spectrum of the B[a]P-C8dG nucleoside adduct on a TLC plate. Xex = 
395.7 nm (vibronic excitation), T = 4.2 K. The numbers above the peaks correspond to 
excited state vibrations (in cm"1). With permission from Ref. 17. 
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numbers above the peaks reflect the displacement of the ZPLs from the laser frequency in 
cm'1 and correspond to excited-state vibrational frequencies. These frequencies and the 
relative intensities of the ZPLs allowed for positive identification of B[a]P-C8dG. 
Similarly, Velthorst and coworkers established that by coupling FLNS with 
HPLC-TLC in a semi-on-line arrangement (see below), pyrene and halogenated pyrene 
derivatives could be identified on the chromatographic media (e.g., silica gel, CI8, and 
cellulose) of a TLC plate. The estimated limit of detection was in the low picomole 
range [19-21]. The same group demonstrated that a second separation (perpendicular to 
the HPLC deposition trace) on a TLC plate, prior to FLNS analysis, further improved the 
quality of chromatographic resolution and the FLN spectra [22,23]. The semi-on-line 
HPLC-TLC system is shown in Figure 2-7. A fused silica capillary is connected to the 
outlet of the HPLC detector flow cell, which is coupled to a heated spray jet assembly. 
Heating the spray jet assembly with hot nitrogen gas up to 175°C allowed for the 
effluent to be gently deposited on the linearly translating TLC plate. Evaporation of the 
mobile phase limited the amount of diffusion of the deposited traces. Upon final drying, 
the TLC plate was placed in a closed-cycle refrigeration system (10-20 K) for FLNS 
analysis [22]. An example of FLN spectra from this methodology for stereoisomer^ 
B[a]P-tetrol standards is shown in Figure 2-8. Detection limits were at the femtomole 
level [24]. With selective excitation at 364 nm, the FLN spectra of the trans- and cis-
stereoisomers of the anti- and jyzi-BP-tetrols are clearly distinguishable at 12 K. The 
numbers in Figure 2-8 correspond to excited-state vibrational frequencies. These results 
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Figure 2-7. Schematic of the HPLC-TLC system and the coupling interface. The lower 
left corner shows an the spray jet assembly in more detail (see text). With permission 
from Ref. 22. 
33 
I I I I I I I 
372 374 376 378 380 382 384 
Emission wavelength (nm) 
Figure 2-8. FLN spectra of trans- (1) and cis- (2) stereoisomers derived from the anti- (I) 
and 5>?z-B[a]P-tetrols (II) obtained with the HPLC-TLC-FLNS. Xex = 364 nm; T = 12 K. 
The numbers correspond to excited state vibrational frequencies (in cm"1). With 
permission from Ref. 24. 
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identified using TLC in combination with FLNS. However, drying the LC effluent with 
hot gas can lead to analyte decomposition and application of this methodology to real 
world samples has yet to be demonstrated. 
TLC-FLNS was also utilized in combination with a 32P-postlabeling (Randerath) 
procedure [25,26]. It is well known that DNA adducts can be enzymatically digested, 
labeled with 32P, and separated on a polyethylenimine (PEI)-cellulose TLC plate. In 32P-
postlabeling identification is typically accomplished by measuring the relative positions 
of the separated components autoradiographically. The autoradiogram of BPDE 
adducted (1 adduct in 102 base pairs) and 32P-postlabeled DNA digest on a PEI plate is 
shown in Figure 2-9 A. Direct on-line FLNS analysis of spot A was not possible due to 
strong luminescence background of the PEI plates. The background was several orders 
of magnitude stronger than that observed for the octadecylsilate TLC plates discussed 
above [16,17]. Therefore, the analyte from spot A needed to be extracted from the TLC 
plate prior to off-line FLNS analysis [26]. An example of FLN spectrum obtained with 
an excitation wavelength of 361 nm is shown in Figure 2-9B (top). Since this FLN 
spectrum is similar to the FLN spectrum obtained for the a/z/z'-BPDE-dAMP standard 
(Figure 8B, bottom), it was concluded that the BPDE adduct formation was with -dAMP. 
However, the bottom FLN spectrum possesses additional weak ZPLs in the 377-381 nm 
region, which are not present in the top spectrum. 
Similar experiments were performed in this laboratory where the B[a]P-DNA 
digest at the adduction level of- 1:10* base-pairs was analyzed by on-line TLC-FLNS 
[unpublished results]. It was shown that extensively washing the plates with ethanol 
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Figure 2-9. Frame A: Autoradiogram of BPDE adducted (~ 1:102) and 32P-postlabeled 
DNA after two-dimensional development on a PEI cellulose plate. Frame B, top: FLN 
spectrum of spot A extracted from the PEI plate of frame A. The bottom spectrum 
corresponds to the an/z'-BPDE-dAMP standard. T= 12K; XeX = 361.0 nm. From Ref. 26 
with permission. 
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migration times/distances for the TLC separation of antf-BPDE-dGMP [27], the same 
major spot as shown in Figure 2-9A was observed (data not shown). The on-line TLC-
FLNS analysis revealed that the spot on the PEI-TLC plate corresponded to the anti-
/ram'-BPDE-dGMP adduct isomer. This indicates, in agreement with a large number of 
32P-postlabeling studies [28-30], that the top FLN spectrum of Figure 2-9B most probably 
does not correspond to an//-BPDE-dAMP but to <wi//-/ran.y-BPDE-dGMP. In fact, the 
presence of the -dGMP adduct was anticipated since 90-95% of total an/z'-BPDE derived 
DNA adducts are formed with guanine rather than adenine [30]. 
These results show that although FLNS can be combined with TLC, providing 
additional selectivity in the analysis of TLC spots associated with structurally similar 
analytes, its practical application is often confounded by the luminescence background of 
chromatographic media and glass support. Moreover, band broadening in TLC 
separations further limits the sensitivity of this approach. Nonetheless, in cases where 
extremely low detection levels are not required, these methodologies can be utilized. In 
particular, the semi-on-line combination of HPLC-TLC-FLNS, where the coupling 
strategies have been extensively developed and tested, could be applicable to the analysis 
of complex mixtures. 
2.5. Polyacrylamide Gel Electrophoresis (PAGE) and FLNS 
PAGE is a well-established technique for separating intact DNA in a highly cross-
linked acrylamide gel separation media under the influence of an applied electric field. 
In many instances PAH-DNA adducts are best studied in intact DNA as opposed to the 
procedures described above. This is made possible by combining PAGE with FLNS. 
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The performance of PAGE-FLNS was tested with stable anti-B[a]? diolepoxide (anti-
BPDE) adducts of various oligodeoxynucleotides [32,33]. As with TLC-FLNS, 
fluorescence analysis of PAGE-separated bands directly on the separation media 
(polyacrylamide gel) was impractical due to background luminescence. Therefore, the 
separated DNA band had to be extracted and redissolved in glycerol/water for FLNS 
analysis. For the sequences studied, it was shown that the spectral features of the N'-dG 
adducts of single-stranded (ss) and double-stranded (ds) oligomers were similar, limiting 
spectral differentiation between ss and ds oligomers. Nonetheless, conformational 
information could be obtained for both ss and ds oligomers, as shown in Figure 2-10. 
The autoradiogram (left) shows the modification of ss d(TTAAGGAATT) by OM/Z-BPDE 
enantiomers (see figure caption for details). Frame A shows FLN spectra (XeX= 356.9 
nm) of DNA ss oligomers adducted with (+)-AW//-BPDE that were extracted from the 
polyacrylamide gel (lane 2 of the autoradiogram), bands a, b, and d. The slowly-
migrating DNA oligomers (assigned as external type adducts, solid line of frame A) 
displayed prominent ZPLs, whereas the oligomers with the fastest electrophoretic 
mobilities exhibited weaker ZPLs (alternating dotted and dashed line) and the origin band 
shifted to -381.5 nm, characteristic of highly base-stacked adducts [31,32], Adducted 
oligomers with a fluorescence origin at 379.5 nm and intermediate electrophoretic 
mobilities possessed weaker ZPLs (dashed line) compared to the external adduct type, 
but stronger than those of highly base-stacked adducts. Therefore, this type of adduct 
was assigned as partially base-stacked [31], 
Frame B shows spectra from two different (-)-an/z-BPDE adducted oligomers 
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Figure 2-10. Left: autoradiogram of d(TTAAGGAATT) modified by (±)-an//-BPDE 
enantiomers. Lanes 1-3 correspond to (-)-dmtt'-BPDE, (+)-a«ri-BPDE, and unreacted 
DNA oligomer, respectively. The anode is at the bottom of the figure; unmodified 
oligomer corresponds to the highly intense band exhibiting the fastest electrophoretic 
mobility. Bands of modified oligomers are labeled by lower-case letters. Frame A shows 
FLN spectra of (+)-anti- adducts corresponding to bands d (solid line), b (dashed line), 
and a (alternating dotted and dashed line) of lane 2. Frame B shows FLN spectra of (-)-
anfz'-BPDE adducts corresponding to bands a (dotted-dashed line) and band c (solid line) 
of lane 1. FLN spectra from top to bottom correspond to external (top), partially base-
stacked, and highly base-stacked adducts. X<x = 365.9 nm; T = 4.2 K. From Ref. 32 with 
permission. 
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c), and the alternating dotted and dashed spectrum is of the extract from the 
fastest-migrating band (a). Based on FLN and NLN spectra (data not shown), the 
conformations were assigned as partially- and highly base-stacked, respectively. The 
FLN spectrum of the extract from band d (line 1, data not shown) was very similar to the 
FLN spectrum of adduct extracted from spot d (lane 2), and therefore it was assigned as 
an external (-)-aw/z-BPDE-dGMP adduct. 
PAGE-FLNS was also used to study the binding of (-)-anti- and (+)-anfi-BPDE 
to several sequence-defined ds oligomers [31]. Two of the oligomers contained central 
5 -RAGGAR-3 ' sequences (R = purine), which appear to be frequently mutated by 
racemic (±)-an//-BPDE [33-35], Two other oligomers contained a central 5'-CCGG-3 ' 
or 5 -TGGT-3' sequence, which are strongly preferred for covalent binding but are less 
frequently mutated. Binding of the two enantiomers to the latter two sequences (data not 
shown) yielded a distribution of BPDE-N2-dG adduct conformations similar to those 
formed in random sequence DNA in vitro, which means that the external conformation of 
the N2-dG adduct was dominant. PAGE-FLNS studies established that binding of (-)-
anti-B?DE to the 5 -RAGGAR-3 sequences yielded more of the partially base-stacked 
and less of the quasi-intercalated conformers than observed for random sequence DNA 
[31,32]. Importantly, the (+)-aw//'-BPDE bound to the more mutagenically inclined 5'-
RAGGAR-3 ' sequences yielded little external-type adduct in comparison to the other two 
sequences or random sequence DNA. However, the (+)-an//'-BPDE adducts formed with 
the 5 -RAGGAR-3' sequences yielded an unusually high proportion of partially base-
stacked adducts. Since the (+)-a«/z-BPDE appears to be more mutagenic, this result 
suggests a possible role of partially base-stacked adduct conformations in mutagenesis. 
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In both TLC- and PAGE-FLNS, sensitivity is of large concern. If only small 
amounts of sample are available, which is commonly the case in studying the systems 
these combinations were intended for, either the background luminescence of the 
separation media or sample losses associated with analyte extraction will likely prevent 
these combinations from ever being useable for low-level detection. Moreover, TLC and 
PAGE can suffer from low separation resolution and efficiency, inherent to the 
techniques. Therefore, for FLNS to be useful in studying analytes in complex biological 
systems, more efficient separation techniques were needed that could accommodate small 
sample amounts, provide the necessary separation efficiency and resolution, and have 
minimal background interference in on-line detection. This was accomplished with 
capillary electrophoresis as presented in Chapters 3,4, and 5 of this thesis, and then high-
performance liquid chromatography as presented in Chapter 6. 
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CHAPTER 3. CAPILLARY ELECTROPHORESIS WITH ON-LINE FLNS (CE-
FLNS) 
3.1. Principles of Capillary Electrophoresis 
Capillary electrophoresis (CE) is a modern separation technique that permits rapid 
and efficient separation of components under the influence of an applied electric field. 
The first highly efficient CE separations were demonstrated by Jorgenson and Lukas in 
the early 1980s [1,2], and the first commercial CE instruments arrived later that same 
decade. Since its inception, CE has established itself as a widely used analytical and 
bioanalytical separations technique for a variety of applications such as inorganic anions 
[3-7], metal cations [8-11], drugs [12-14], carbohydrates [15-19], polycyclic aromatic 
hydrocarbons [20,21], peptides [22,23], proteins [24,25], DNA [26,27], DNA adducts 
[28,29], bacteria [30,31], and single cells [32,33]. Much like traditional electrophoresis, 
separation by CE is achieved when an external field is applied to a solution of charged 
species. Each ion is attracted to the electrode of opposite charge, and, at a given electric 
field, charged species travel with different velocities depending upon their size, valent 
charge, and environment [34]. This rate is known as the electrophoretic mobility of an 
analyte and is expressed in cm2/V s [1]. However, a unique feature of CE is the 
phenomenon known as electroosmosis (see below). Briefly, the occurrence of 
electroosmosis, originating on the inner wall of the glass capillary, provides a force that 
drives the flow of all species in the same direction within the capillary; usually from the 
positive to the negative electrode [35]. 
Traditionally, electrophoretic separations have been performed on semisolid 
support media such as slab gel or non-gelatinous material such as paper or cellulose 
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acetate [36]. The support media provide a physical support for the electrolyte buffer that 
maintains electrical conductance between the electrodes (cathode and anode). In CE, the 
capillary itself provides this support for the electrolyte and its small size (typically 
between 20 to 150 |im inner diameter) ensures rapid heat dissipation. A basic CE 
instrument schematic is shown in Figure 3-1, which consists of a high-voltage power 
supply, electrolyte-filled capillary placed between two electrolyte reservoirs, sample 
reservoir, and a detection system. 
The most common way of classifying separation methods in CE is based on the 
background electrolyte (buffer) system. The two classification systems are either 
continuous or discontinuous [37]. Further sub-classifications are based on the constancy 
of the electrolyte. If the composition of a continuous background electrolyte is constant; 
as in capillary zone electrophoresis [1,2,38-41], micellar electrokinetic capillary 
chromatography [41-45], and capillary gel electrophoresis [46-49], the resulting 
separation is a kinetic process. If the buffer composition is not constant, as in capillary 
isoelectric focusing [50-52], the result is a steady-state process [37]. In a constant 
electrolyte system, a constant electric potential and effective mobility for an analyte in 
the capillary is observed. Sample components will migrate (and separate) in a constant 
electric field according to their effective mobilities. In the case where the background 
electrolyte composition is not constant, effective mobilities will vary in the electric field 
along the capillary, focusing sample components at certain points (e.g., the isoelectric 
point for proteins). In contrast, a discontinuous electrolyte system is one in which the 
sample migrates between two different electrolytes as a distinct individual zone. As 






Figure 3-1. Basic schematic of a capillary electrophoresis setup, consisting of a high-
voltage power supply, electrolyte-filled capillary placed between two electrolyte 
reservoirs, sample reservoir, and a detection system near the cathode. 
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sample ions in the analyte zone in a discontinuous system [53]. Capillary 
isotachophoresis is an example of a discontinuous system [54,55]. 
As stated above, movement of charged species in an applied electric field is 
characterized by the electrophoretic mobility, fap, of the species. In capillary 
electrophoresis, the apparent mobility of an analyte is the sum of the electrophoretic 
mobility and the mobility of the electroosmotic flow, /4„ [35,37]: 
fi — fJep + fJeo (3.1) 
In the absence of electroosmosis the migration velocity (v) of a charged species is given 
by: 
v = /MpE = ttj- (3.2) 
where is the electrophoretic mobility, E is the field strength, Fis the voltage applied 
across the capillary, and L is the length of the capillary. Under these conditions the time 









As mentioned above, electroosmotic flow (EOF) is a unique phenomenon in CE 
that provides flow of a solution in contact with a solid surface in an applied electric field, 
and drives the flow of all species in the same direction within the capillary. 
Electroosmotic flow originates on the inner walls of fused silica capillaries when the 
silanol groups (SiOH) on the capillaries inner surface dissociates when in contact with 
the electrolyte, creating the negatively charged SiO surface [56]. A model of the silica-
solution interface is shown in Figure 3-2. Hydrated cations in the electrolyte are attracted 
to the negatively charged silanol groups, creating a double layer. The first layer, the 
compact layer, is tightly bound to the negative capillary surface by electrostatic forces. A 
second layer, the more loosely bound diffuse layer, consists of mobile cations and is able 
to flow toward the cathode in an applied electric field at the plane of shear, dragging the 
bulk solution in the capillary. The potential formed across the double layer is called the 
zeta potential (<Q, which is given in the Helmholtz equation as [35]: 
Ç_4xryuo (3.6) 
where rj is the viscosity, sis the dielectric constant of the solution, and /40 is the 
coefficient for electroosmotic flow. Therefore, electroosmotic mobility can be defined 
as: 
"™=l| (17) 
Factors that can affect electroosmotic flow are electrolyte pH, ionic strength, 
organic solvent composition, choice of buffer anions/cations, and applied voltage [37]. 
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Figure 3-2. Scheme showing the formation of electroosmotic flow (EOF) within a glass 
capillary. The negatively charged SiO groups on the inner wall of the capillary attract 
cations, forming a tightly bound compact layer. Further into the capillary a loosely 
bound diffuse layer is formed, where hydrated cations drag the bulk solution toward the 
cathode. 
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drop results in a flat bulk flow profile of solvent toward the cathode. The resulting flat 
flow-profile creates an extremely efficient "pumping" mechanism when compared to the 
parabolic flow profile associated with pressure-driven separation techniques such as high-
performance liquid chromatography. Therefore, the zone variance (cr2) and number of 
theoretical plates (jV) can be expressed as [35]: 
< r 2 =  WL\ (3.8) 




where D is the diffusion coefficient of the solute. Factors that can influence separation 
efficiency are: the length of the injection plug, axial diffusion, electromigration 
dispersion, solute-wall interactions, and Joule heating, to name a few. Axial diffusion is 
minimized when operating at high voltages, however, band broadening from Joule 
heating can occur from the electric current generated in the electrophoresis buffer. 
Therefore, optimal conditions are achieved by operating at voltages that create minimal 
heat and minimal diffusion [37]. Moreover, the small dimensions of the capillary used in 
CE allow heat to efficiently dissipate to the surrounding environment. Therefore, the 
control of Joule heating, along with the flat plug-like flow profile in CE create a highly 
efficient separation mechanism with separation efficiencies as high as 105-106 theoretical 
plates. 
Resolution (#) of two zones in CE is a function of selectivity, column efficiency, 
and migration time [57] and is given by: 
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where /4p,i and /4P,2 are the electrophoretic mobilities for the two solute zones and /^p.ove 
is the average electrophoretic mobility. From this equation the highest resolution is 
obtained when jjeo - -Mep', however, the trade-off is analysis time. 
3.2. CE-FLNS System 
In interfacing CE with on-line FLNS detection, the primary challenges were to 
develop a cryostat that could easily be adapted to a commercial CE instrument, and 
quickly be cooled to cryogenic temperatures to not introduce significant band-broadening 
of the separated analyte zones. This was accomplished in 1996 by Jankowiak et al. [58] 
with the CE-FLNS design shown in Figure 3-3. The apparatus consists of a modular CE 
apparatus, FLNS instrumentation, and a capillary cryostat (CC) mounted to an automated 
translation stage. The modular CE apparatus is a fully automated, high-voltage ATI 
Unicam Model 310 instrument. The inlet of a UV-transparent capillary is placed in the 
CE instrument with the outlet threaded axially through the CC and affixed at either end of 
the CC with plastic tubing. The capillary terminates in an outlet CE-buffer vial. CE 
separations are monitored using a model Innova 90C (Coherent, Santa Clara, CA) CW 
argon-ion laser excitation source operating at 351.1 nm (100 mW output power). 
Fluorescence emission is collected at a 90-degree angle to the excitation beam 
with a reflecting objective (25-0506 X 15, Ealing, Holliston, MA), focused into a 0.3-m 
monochromator (McPherson, Acton, MA), and detected with an intensified charge-
51 
Translator 








Figure 3-3. Schematic diagram of the CE-FLNS system. The instrumentation consists of 
a CE apparatus, capillary cryostat, translation stage, laser excitation source, a 
monochromator, and either an intensified photodiode array or charge-coupled device for 
detection. Pulse generators are employed for time-resolved spectroscopy. From Ref. 58 
with permission. 
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coupled device (Roper Scientific, Trenton, New Jersey) that is triggered by a high-
voltage pulse generator (Roper Scientific Model PG200). When the analyte of interest 
enters the detection cell, the cryostat is quickly cooled (see below) to liquid helium 
temperature (4.2 K). Automated translation of the cryostat is accomplished with a 
micron step-size translation stage having a 10-cm travel distance (New England 
Affiliated Technologies, Lawrence, MA). The excitation source for FLNS studies is a 
Lambda Physik FL-2002 pulsed dye laser (line-width of ~ 0.2 cm"1), pumped by a 
Lambda Physik Lextra 100 XeCl excimer laser (Lambda Physik, Ft. Lauderdale, FL) at a 
repetition rate of 10 Hz. FLN spectra are obtained using various delay times with a gate 
width of 200 ns. The spectral resolution for FLN in this set-up is 0.09 nm. 
3.2.1. Capillary Cryostat 
The CC consists of a double-walled quartz cell with inlet and return lines for 
introducing liquid nitrogen or liquid helium (see Figure 3-3). The outer portion of the CC 
is evacuated. The capillary, positioned in the central region of the CC, is cooled by a 
continuous flow of liquid nitrogen (77 K) or helium (4.2 K). The low thermal capacity of 
the capillary along with the small dimensions of the CC (inner portion, 4 mm ID x 22-cm 
length) allow rapid cooling to 4.2 K. To discriminate against scattered and reflected laser 
light, the CC is tilted 20° with respect to the laser beam. An example of the cooling rate 
is shown in Figure 3-4, where fluorescence spectra of pyrene, acquired as a function of 
time after opening the helium transfer line valve, are shown [59]. Spectrum (a) was 
obtained at room temperature and spectra (b)-(e) were obtained 30,35,40, and 50 
seconds after opening the valve. The five spectra, plotted using the same y-axis scale 
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Figure 3-4. FLN spectra of pyrene as a function of time (temperature) after opening the 
valve of the helium transfer line to the capillary cryostat; >«,= 364.0 nm. Spectrum (a) 
was obtained at room temperature and spectra (b) - (e) were obtained 30, 35,40, and 50 
seconds, respectively. From Ref. 59 with permission. 
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expansion (offset for clarity), illustrate a fast cooling rate (minimizing analyte zone 
dispersion) and a significant increase in fluorescence with decreasing temperature. 
Spectrum (e), obtained at 50 seconds, is identical to the FLN spectrum of pyrene obtained 
in a regular helium immersion cryostat. 
In CE-FLNS, when the analytes enter the CC optical window, the capillary is 
rapidly frozen in the CC to 4.2 K with liquid helium. Once frozen, long 
residence/detection times (up to hours) are available to completely characterize the 
analyte zones via FLNS. A precision stage provides translation of the CC along the 
capillary axis by ± 4 cm allowing the separated analytes to be sequentially characterized 
by FLNS. With this setup, the LOD of the CE-FLNS system is at the low-attomole level 
for moderately fluorescent chromophores [29]. When the fluorescence analysis is 
complete, efficient warming of the CC and capillary can be achieved by closing the valve 
of the helium transfer line and introducing (warm) helium gas into the CC [58]. 
3.2.2. Preliminary Test 
The CE-FLNS system was first tested by Jankowiak and co-workers [58] with a 
mixture of five PAHs [benzo[a]pyrene (B[a]P), benzo[e]pyrene (B[e]f), pyrene, 
1-hydroxypyrene, and benz[a]- anthracene (BA)], as shown in Figure 3-5. The CE 
electropherogram is shown in frame 3-5A, while the on-line FLN spectra of the five 
separated PAHs are shown in frames 3-5B and 3-5C. Identification was based on 
comparison of the vibronically excited FLN spectra of the CE-separated peaks with those 
of off-line generated reference spectra of the five compounds. 
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Figure 3-5. Fluorescence based CE electropherogram of the PAH mixture (frame A) and 
FLN spectra of the CE-separated PAHs (frame B); see Ref. 58 for separation conditions. 
Based on FLNS analysis the labeled peaks correspond to 1 -hydroxypyrene (I), pyrene 
(II), BA (III), and B[e]P (IV), and B[a]P (V). Laser excitation wavelength 378.0 nm, 
365.2 nm, 378.0 nm, 369.0 nm, and 395.7 nm respectively; T = 4.2 K. Peaks are labeled 
with their excited-state vibrational frequencies, in cm"1; from Ref. 58 with permission. 
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More rigorous testing of the CE-FLNS by Zamzow et al. [59] was conducted, an 
example of which is shown in Figure 3-6 for a mixture of protonated and deuterated 
benzo[fl]pyrene (B[a]P-diz). Frame 3-6A shows a portion of the room-temperature 
fluorescence electropherogram for a B[û]P-di2/B[a]P mixture (10"s M each). The 4.2 K 
FLN spectra for CE-separated peaks (a) and (b) obtained using selective laser excitation 
at 395.7 nm are shown in frames 3-6B (spectrum a) and 3-6C (spectrum b), respectively. 
The FLN peaks are labeled with their Si vibrational frequencies in cm"1. Comparison of 
the CE-FLN spectra in Figure 3-6 shows that spectrum (a) is virtually indistinguishable 
from spectrum (c) of the B[a]P-d|2 standard and that spectrum (b) is identical to spectrum 
(d) of the B[a]P standard. Obvious differences in vibrational frequencies and intensities 
between spectra (a) and (b) are observed. For example, there are strong modes at 353, 
493, and 558 cm"1 for B[a]P-dt2, while B[a]P has strong modes at 510 and 580 cm"1. 
Therefore, peaks (a) and (b) of the electropherogram were definitively identified as 
deuterated and protonated B[a]P, respectively. 
A preliminary test of on-line FLNS detection system with capillary 
electrochromatography (CEC) was also conducted (data not shown). CEC is a hybrid 
separation technique where the same flat, electroosmotic flow profile is used as in CE; 
however, the capillary is filled with functionalized stationary phase particles (e.g., C8, 
C18, and phenol) as in HPLC. The result is a high performance separation technique that 
can improve resolution and reduce analysis time in comparison to standard CE. 
However, its drawbacks are that the packed capillaries are difficult to manufacture, 
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Figure 3-6. Frame A: room-temperature fluorescence electropherogram for a mixture of 
B[a]P-di2 (peak a) and B[a]P (peak b); see Ref. 59 for séparation conditions. Frame B 
shows FLN spectra obtained for the CE-separated peak a (spectrum (a)), and the FLN 
spectrum from the reference library (spectrum (c)). Analogously, frame C shows the 
identification of the CE-separated peak b (see text for details). From Ref. 59 with 
permission. 
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performance analytical technique, especially with MS detection. A preliminary 
unpublished result from a CEC-FLNS experiment revealed that FLN spectra could be 
generated for a B[a]P-filled CEC (CI 8) capillary. However, the fragility of these 
capillaries makes their practical use for FLNS cost prohibitive, especially when most 
separations are possible with other, less expensive separation modes of CE. 
The above tests of the CE-FLNS system indicated that in comparison to TLC- and 
PAGE-FLNS, on-line CE-FLNS is a more practical technique for real-world applications. 
CE-FLNS is fast, offers less background luminescence, and its nanoliter injection 
volumes are highly compatible for bioanalysis. In terms of separation performance, CE 
has very high separation efficiencies and resolving power. Moreover, with on-line CE-
FLNS there is no post-separation extraction that could lead to sample losses from sample 
handling. In Chapters 4 and 5 of this thesis, CE-FLNS is applied for studies in chemical 
carcinogenesis: the analysis of diasteromeric DNA adducts from the most potent 
chemical carcinogen, dibenzo[a,/]pyrene; and to study the most common depurinating 
adducts of benzo[a]pyrene in humans exposed to coal smoke. 
Furthermore, by interfacing FLNS with the well-established, versatile separation 
protocols of HPLC, it is anticipated that on-line HPLC-FLNS will significantly expand 
the bioanalytical applicability of FLNS and provide a complementary technique to CE-
FLNS. This feasibility and design of this first-ever on-line combination of FLNS 
detection in HPLC is shown in Chapter 6. Its practicality is demonstrated with co-eluting 
geometric isomers of benzo[a]pyrene diols and a dibenzo[a,/]pyrene-deoxyadenosine 
adduct found in the skin of mice. 
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CHAPTER 4. ON-LINE IDENTIFICATION OF DIASTEROMERIC 
DIBENZO[a,/]PYRENE DIOL EPOXIDE-DERTVED DEOXY ADENOSINE 
ADDUCTS BY CAPILLARY ELECTROPHOREIS - FLUORESCENCE 
LINE-NARROWING AND NON-LINE-NARROWING SPECTROSCOPY 
A paper published in the Journal of Chromatography A, 1999,853, 159. 
K. P. Roberts, C. -H. Lin, R. Jankowiak, and G. J. Small 
4.1. Abstract 
A capillary electrophoretic method for the separation and on-line identification of 
closely related analytes using low temperature fluorescence spectroscopy is reported for 
the eight diastereomeric deoxyadenosine (dA) adducts derived from dibenzo[a,/]pyrene 
diol epoxide (DB[a,/]PDE). Electrophoretic separation of stereoisomers was 
accomplished by application of a mixed surfactant buffer (dioctyl sulfosuccinate (DOSS) 
and Brij-S), which was below the critical micelle concentration (CMC) due to the high 
concentration (~25%) of organic solvent. Addition of multiple surfactant additives to the 
separation buffer provided electrophoretic resolution, which was unattainable under 
single surfactant conditions. It is shown that the CE-separated analyte zones could be 
identified on-line via low-temperature (4.2 K) fluorescence non-line narrowing and 
fluorescence line-narrowing (FLN) spectroscopy. In addition, it was determined that in 
CE buffer trans-syn-, cis-syn-, and cis-anti-QB [a, Z]PDE-14-N6dA diastereomeric adducts 
exist mostly with the -dA and DB[a,/]P moiety in an 'open'-type conformation while the 
trans-anti-DB [a, Z]PDE-14-N6dA adducts exist in two different conformations whose 
relative distribution depends on matrix composition. The above conformations have also 
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been revealed by selective laser excitation. Thus, the low-temperature methodology not 
only provides fingerprint structure via vibrationally resolved 4.2 K fluorescence spectra 
for adduct identification, but also provides conformational information on the spatial 
relationship of the carcinogen and dA moiety. These results, taken together with those 
for DB[a,/]P-DNA adducts formed in standard glasses and mouse epidermis exposed to 
DB[o,/]P, support our earlier findings that DB[a,/]P-derived adducts exist in different 
conformations [Jankowiak et al., Chem. Res. Toxicol., 1998, //, 674]. Therefore, the 
combination of the separation power of CE and spectral selectivity of low temperature 
fluorescence spectroscopy at NLN and FLN conditions provides a powerful methodology 
that should prove useful for identification of closely related DNA adducts formed at low 
levels in biological systems. 
4.2. Introduction 
The polycyclic aromatic hydrocarbons are an important class of carcinogen. They 
are activated by two main pathways: one-electron oxidation to yield radical cations [1-4] 
and monooxygenation to produce bay region diol epoxides [5-10] which react with the 
nucleophilic centers of DNA bases, particularly those associated with guanine and 
adenine. It is widely accepted that the formation of DNA-PAH adducts is the initial 
event that leads to mutations that result in cancer [11,12]. In this paper we present results 
on DNA adducts formed from dibenzo[a,Z] pyrene (DB[a,/]P), the most potent member of 
the PAH class of carcinogens [13,14]. It is found in river sediment [15] and 
indoor/outdoor air samples [16,17]. The technique used to obtain the results was 
capillary electrophoresis-fluorescence line narrowing spectroscopy (CE-FLNS) that has 
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recently been developed by our laboratory [18]. The technique allowed, for the first time, 
on-line structural characterization of DNA-carcinogen adducts. Capillary electrophoresis 
can also be interfaced with non-line narrowed fluorescence (NLNF) spectroscopy. 
Prior to our development of CE-FLNS we had employed HPLC with FLNS to 
characterize and quantify a wide variety of DNA-PAH adducts in an off-line mode. The 
results obtained, when combined with the results of computational chemistry had shown 
that DB[a,/]P leads to a diverse spectrum of stable DNA adducts formed by the 
diolepoxide metabolic pathway [19]. Conformational information has been obtained for 
DB[a, Z]PDE- 14-N7Ade, -N7Gua [20], DB[a,/]P tetrols [21], and various DB[a,/]PDE-
14-N6deoxyadenosine (dA) stereoisomers adducts [22,23]. It was shown that anti- and 
syn- derived DB[o, Z]PDE-14-N6dA adducts in ethanol and glycerol/water glasses can 
adopt various 'open'- and 'folded'-type conformations between the dA and carcinogen 
moiety; only the folded conformation allows significant interactions between the dA and 
aromatic portion of the carcinogen [23]. 
Off-line fluorescence studies, however, indicated that in some instances the purity 
of the DB[a, /]PDE-derived adducts being analyzed poses a problem, especially if the 
analytes are unstable and/or cannot be HPLC baseline resolved. To circumvent this 
problem we developed and applied the methodology, which interfaces CE with FLNS for 
on-line spectral characterization and identification of these closely related species. It has 
been shown that CE-separated fluorescent analytes can be identified on-line via 
fingerprint structure of vibrationally resolved FLN spectra at 4.2 K [18,24,25]. 
CE has also been coupled to MS and NMR for on-line analyte characterization. 
Both have yielded interesting results without the requirement of standards present for 
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analysis, although some difficulties exist [26-32]. In the case of CE-MS some of the 
issues have been circumvented with the introduction of capillary electrochromatography 
(CEC) [33-35]. CEC incorporates the packed stationary phase of LC (minimizing the 
need for surfactants) and the efficient electroosmotic flow mechanism of CE. 
In this respect, we note that FLNS can also be coupled with CEC [36], and 
emphasize that the CE-FLNS approach mentioned above does not require standards each 
time a qualitative determination is to be made, but relies on an established reference 
library of spectra. This attribute of CE-FLNS is particularly important in the 
biomedical/biochemical sciences, where many standards (e.g., DNA and protein 
adducts/metabolites) are difficult/expensive to synthesize, and/or possess poor stability 
over time. These features of CE-FLNS, along with arbitrary detection times, selective 
determination in the frequency and time space, as well as increased fluorescence signal 
and/or decreased photodegradation (due to the low temperatures used), indicate that CE-
FLNS is an appropriate methodology for identification, characterization, and quantitation 
of closely related analytes [18,24,25], 
To complement the CE-FLNS methodology, it is shown here that adduct 
identification can also be achieved via CE and low-temperature fluorescence spectra 
obtained under non-line-narrowing conditions. With this approach, expensive tunable 
lasers are not required, i.e., a single-frequency excitation source can be used, expanding 
the applicability of low-temperature wavelength-resolved laser-induced fluorescence 
(LIF) detection in capillary electrophoresis [37]. Utilization of low-temperature in 
obtaining LIF spectra provides spectral resolution that is not possible at room 
temperature. At room temperature, fluorescence signals are spectrally broad and often 
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featureless, rendering them useless for identification purposes due to the nearly identical 
emission spectra of structurally similar analytes. In CE-FNLN spectroscopy, reduction in 
sample temperature to 4.2 K. effectively eliminates thermal broadening contribution, 
which for a single vibronic transition is approximately equal to kT~ 200 cm"1 at room 
temperature. In the case of FLNS, a further reduction in line-width by a factor of 10-100 
is achieved by selective excitation of a uniform subset of molecules [3,38,39], The 
selective excitation eliminates inhomogeneous broadening which is typically about 100-
500 cm"1 in amorphous solids [39]. 
In this paper, we report on the separation of eight DB[a,/]PDE-14-N6dA 
diastereomeric adducts (see Figure 4-1), and their on-line identification via low 
temperature NLN fluorescence spectra. An example of analyte identification via FLN 
spectra is also shown for completeness. The main goal, however, is to establish a 
protocol for the separation and spectral characterization of closely related diastereomeric 
DB[a,/]PDE-derived dA adduct standards in CE buffer, and to provide a library of the 
NLN spectral fingerprints for future on-line in vivo and in vitro studies of -dA adducts 
derived from DB[a,/]P by CE-FNLN/FLN. 
4.3. Experimental 
Caution, anti- and syn-DB[a,l)P diolepoxides are extremely hazardous 
chemicals and should be handled carefully In accordance with NIH guidelines. 
4.3.1. Materials 
Sodium tetraborate (STB), sodium dioctyl sulfosuccinate (DOSS), and Brij 30 
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Figure 4-1. Molecular structures of the eight DB[a,/]PDE-14-N6dA adducts investigated: 
A) (+/-)-/ra/7J-jyn-DB[a,/]PDE-14-N6dA; B) (+/-)-c/j-jyAz-DB[o,/]PDE-14-N6dA; C): 
(+/-)-/ra/7j-anti-DB[a,/]PDE-14-N6dA; and D): (+l-)-cis-anti-DY$[a,l\ PDE-14-N6dA. 
dR corresponds to deoxyribose. 
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sodium hydroxide (NaOH) were obtained from Fisher Scientific (Fair Lawn, NJ). All 
buffrs were prepared with water purified with a NANOpure II (Barnstead, Dubuque, IA) 
purification system. Capillaries were 75 pm i.d., 375 |im o.d. UV-transparent bare silica 
purchased from Polymicro Technologies Inc. (Phoenix, AZ). Glycerol was obtained 
from Spectrum Chemical Mfg. Corp. (Gardena, CA). 
4.3.2. Sample Preparation and Buffers 
The DB[a,/]PDE derived stereometric adducts trans-anti-, cis-anti-, trans-syn-, 
and c/ixsyw-DB [a, Z] PDE-14-N6dA were synthesized by a reaction of anti- and syn-
DB[a,/]PDE with dA. The (+/-)-anf/-DB[a,/]PDE was reacted with optically-active dA 
in dimethylformamide at 100°C for 30 min to give four diastereomeric a/i/i-DB[a,Z]PDE-
14-N6dA adducts. Likewise, the (+/-)-jyn-DB[a,Z]PDE was reacted with optically-
active dA under the same conditions, to yield the four jyzz-DB[a,/]PDE-14-N6dA 
diastereomeric adducts. Further details on the synthesis and structural characterization 
are described elsewhere [22]. 
The CE buffer consisted of an ACN-water solution (25.5% v/v) containing 34 
mM DOSS, 7.5 mM Brij-S (sulfonated Brij 30 as described by Ding and Fritz [37]), and 
6.8 mM sodium tetraborate to form a mixed surfactant solution. Aqueous NaOH was 
used to adjust the pH to 9. Before injection, the separation buffer was filtered through a 
0.22 |im syringe filter (Costor) and then degassed for 5 minutes. 
Matrix dependent (off-line) studies of the dA standards at 77 and 4.2 K were 
performed in both 100% CE buffer and 20% CE buffer / 80% glycerol (v/v) to determine 
how the matrix affected the conformational distribution of the stereoisomers. Samples 
were diluted to equal concentrations in the appropriate matrix, placed in 2 mm i.d. quartz 
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tubes, and brought to 4.2 K for LIF measurements. Approximately 20 |aL sample 
volumes were sufficient for the off-line analysis. 
4.3.3. Instrumentation 
A schematic of the CE-FLN/FNLN system is shown in Figure 4-2. A modular 
capillary electrophoresis system (Crystal 300 series, Model 310, ATI Unicam, Boston, 
MA) was used for the electrokinetic separations. Capillaries were 85 cm in length with a 
75 cm effective length for LIF detection. Capillaries were conditioned with 100 mM 
NaOH for 15 minutes (30 minutes for new capillaries), water for 5 minutes, and 
separation buffer for 15 minutes. The sample was hydrodynamically injected with 20 
mbar pressure for 3 seconds resulting in approximately a 10 nL injection volume. 
Separations were carried out at 20 kV resulting in a 40 pA current. 
Room-temperature, LIF electropherograms were obtained with a CW excitation 
source (Model Innova 90C argon ion laser, Coherent, Santa Clara, CA) equipped with 
UV optics and an intracavity prism for single line selection. Pulsed excitation was 
accomplished with a Lambda Physik FL-2002 dye laser, pumped by a Lambda Physik 
Lextra 100 XeCl excimer laser (Lambda Physik, Ft. Lauderdale, FL). When the 
molecules of interest electrokinetically migrated into the observation window, the 
temperature of the capillary, housed in a specially designed capillary cryostat (CC) 
[18,24,25], was reduced to 4.2 K for low-temperature, on-line analysis. The cooling 
process took less than one minute. Individual analyte zones in the capillary were 
selectively probed by automated translation of the CC. Fluorescence was collected with a 
specially designed objective (Ealing, Holliston, MA), passed through a Model 218 0.3 
meter monochromator (McPherson Inc., Acton, MA), and detected with an intensified 
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Translator 







Figure 4-2. Schematic apparatus of the CE-FLNS system used for structural 
characterization of CE-separated analytes. 
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CCD camera (Princeton Instruments, Trenton, NJ) using gated and non-gated modes of 
detection. Spectral resolution for FLN and NLN were 0.09 and 0.8 nm, respectively. 
Further details of the experimental setup are given in Ref. [18]. 
4.4. Results and Discussion 
4.4.1. Off-line NLN fluorescence spectra in CE buffer 
In this section we present NLN fluorescence spectra obtained using a CE buffer in 
order to determine whether or not the spectra allow for distinction between the isomers of 
anti- and yfl-DB [a, /]PDE-14-N6dA. A reference library was established for the 
DB[a./]PDE-14-N6dA adducts in CE buffer, as shown in Figure 4-3. Spectra a-d, 
correspond to the (-)-trans-anti-, (-)-cis-anti-, (+)-trans-syn-, {+)-cis-syn-dA adducts, 
respectively. Identical spectra for the corresponding optical conjugates were obtained 
(not shown). However, the NLN spectra of the above four stereoisomers adducts are 
clearly distinguishable, and can therefore be used for on-line identification of 
DB[a,/]PDE-derived deoxyadenosine adducts. 
As shown in spectrum a, the {-)-trans-anti-àA adduct (in CE buffer) favors a 
conformation with a (0,0) origin band at 383.5 nm, in sharp contrast to the spectra 
obtained recently in ethanol and glycerol/water glasses where the major origin band of 
the same adduct was red-shifted to -388 nm [23]. This large shift cannot be accounted 
for by simple matrix-dependent spectral shifting. Rather, it is due to matrix-induced 
conformational changes [20,21]. This is supported by the fact that a minor conformation, 
with an origin band at -383 nm, was also observed in an ethanol matrix (see Table 1). 
The remaining adducts spectra (b, c, and d), though all in conformation I, still reveal 
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380 400 420 
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Wavelength (nm) 
Figure 4-3. NLN fluorescence spectra obtained off-line for (-)-/rany-a«rz-DB[a,/]PDE-
14-N6dA (spectrum a), (-)-cis-amt'-DB[a, /]PDE-N6dA (spectrum b), {+)~trans-syn-
DB[a,Z]PDE-14-N6dA (spectrum), and (+)-cz'5-syn-DB[a,/]PDE-N6dA (spectrum d) 
adducts in CE-buffer. T = 4.2 K, Xc* = 308 nm, delay time = 80 ns, and gate width = 200 
ns. The numbers correspond to the ground state (So) vibrational frequencies. 
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Table 4-1. Fluorescence origin band comparison observed for syn- and anti-












(+)-trans-syn- 382.0 Ie 382.0 I 381.9 I 
389.0 II 389.0 II 
— — 
(+)-cis-syn- 383.6 I 384.0 I 383.4 I 
388.0 II 388.0 II 
— — 
(-)-trans-anti- 383.0 I' 
— 
I' 383.5 I 
388.1 n 388.3 II 390.1e II' 
(-)-cis-anti- 385.0 i 385.0d I 383.5 I 
389.0 ii 389.0 II 
— — 
a) Observed at T = 77 K with an excitation wavelength of 308 nm3. 
b) Conf. = Conformation. 
c) The bold Roman numerals indicate the major conformations observed by low-temperature 
fluorescence. 
d) Minor conformation at the nucleoside level, but major conformation in single-stranded DNA 
[19]. 
e) This origin band corresponds to the unique conformation II' clearly revealed in CE buffer when 
selectively excited at 351.1 nm. The same conformation was also observed in an 80% glycerol / 
20% CE matrix (see Fig. 4-5 for details). 
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significant differences in their So vibronic intensity distribution. The origin bands of the 
adducts discussed above are summarized in Table 1. The observed variations in the 
vibronic intensity distribution are not surprising given that the parent fluorophore B[e]P 
has Civ symmetry, and the out of plane deformation, as well as the conformation of the 
cyclohexenyl ring depend on adduct stereochemistry [41,42]. Furthermore, the 
significant intensity of the 770,790, and 780 cm"1 bands in spectra b, c, and d, 
respectively, of Figure 4-3 are due to electronic-vibrational coupling between the St state 
and higher energy dipole-allowed states, and is a consequence of the S\<—So absorption 
transition being only weakly allowed [42,43]. With regard to spectrum c, we note that 
the trans-syn-dA adduct exists mostly in conformation I with its NLN spectra being 
weakly matrix and excitation-frequency dependent (data not shown). The conformation 
of the cyclohexenyl ring of the trans-syn- dA has been previously assigned as being a 
unique half-boat configuration with the dA moiety in a pseudoaxial position [23]. 
Finally, spectrum d of Figure 4-3 is the NLN spectrum of the (+) cis-syn- adduct with a 
(0,0)i origin band at 383.5 nm. This adduct, in agreement with data previously obtained 
in ethanol and glycerol/water glasses [23], has been assigned as an open-type 
conformation with the cyclohexenyl ring in half-chair configuration and dA in a 
pseudoaxial position. A weak shoulder revealed in spectrum d of Figure 4-3 for the (+)-
cis-syn-dA adduct, denoted with a dashed arrow, corresponds to a decomposition product 
(presumably DB[a,/]-tetrols) which is not observed in freshly synthesized samples. To 
generate a more accurate reference spectrum of the cis-syn-dA adduct, the decomposition 
product was electrokinetically separated from the adduct standard and an on-line 




380 400 420 
Wavelength (nm) 
Figure 4-4. On-line NLN fluorescence spectrum of "pure" (+)-ci's-5yn-DB[a,/]PDE-14-
N6dA. Inset, an electropherogram of the standard revealing the pure cis-syn-dA adduct 
(large peak) and a small contribution from a decomposition product (denoted with an 
asterisk). T = 4.2K, Xcx = 308 nm, delay time = 80 ns, and gate width = 200 ns. 
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4.4.2. Excitation and matrix dependent conformations 
The existence of the conformations discussed above for the trans-anti-
DB[o,/]PDE-14-N6dA adducts is further confirmed below. Figure 4-5 shows the NLN (T 
= 77 K) fluorescence dependence of this -dA adduct on excitation wavelength and matrix 
composition. Spectra a and c were obtained (off-line) in CE buffer with excitation 
wavelengths of 308 nm and 351.1 nm, respectively. An excitation wavelength of 308 nm 
preferentially excites adducts in conformation I', with a (0,0) origin band at 383.5 nm, 
revealing characteristic bands at 770, 1315, and 2085 cm"1. In contrast, an excitation 
wavelength of 351.1 nm preferentially excites adducts in conformation II' with a (0,0) 
origin band at 390.1 nm, and vibrational bands at 750, 1280, and 2030 cm'1. A small 
contribution of conformation II' in spectrum a is also observed as denoted by an asterisk. 
Thus, we conclude that trans-anti-dA adducts exist in two conformations (I' and II'), 
whose relative distribution is not only matrix dependent, but can also be revealed by 
selective laser excitation. The small difference in the intensity distribution between 
spectra a of Figure 4-5 and 4-3 is due to a slightly different distribution of conformers I' 
and II' trapped at 4.2 and 77 K, respectively, and is the result of differences in cooling 
rates. The relatively strong bands at -2085 cm"1 (curve a) and -2030 cm*1 (curve c) 
correspond to the -1315 and -1280 cm"1 modes, which build on the intense Herzberg-
Teller origin bands at 770 and 750 cm"1, respectively; for more details see Ref. [21]. 
Spectrum b of Figure 4-5 was obtained under conditions identical to those used to 
obtain spectrum a except that in a 20/80 % (v/v) CE buffer/glycerol matrix. Comparison 
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Figure 4-5. Excitation wavelength and matrix dependence of the NLN fluorescence 
spectra of (-)-/ra«s-aw//-DB[a,/]PDE-14-N6dA adducts at 77 K. Spectra a and c were 
obtained in CE buffer with an excitation wavelength of 308 nm and 351.1 nm, 
respectively. Spectrum b was obtained in the 80 % glycerol / 20 % CE-buffer (v/v) 
solution with and A*x = 308 nm. Spectra a and b were obtained with a 0 ns delay time and 
200 ns observation window (see text for details). 
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conformation I' in CE buffer and conformation II' ((0,0) origin band at 389.6 nm) in the 
predominantly (80 %) glycerol matrix. We emphasize that this conformation change is 
reversible (spectra not shown). Small differences in the vibronic intensity distribution 
observed in spectra b and c of Figure 4-5 are caused by solvent (matrix) dependent 
Herzberg-Teller coupling [41,42]. Therefore, based on data presented in Figure 4-5, we 
conclude that the trans-anti- DB[a, /]PDE-14-N6dA adducts formed in CE buffer are 
trapped as a mixture of two adduct conformations. This provides additional support for 
the earlier assignment of these conformations as open- and folded-type, respectively. We 
recall that the cyclohexenyl ring in the above conformations possess a half-chair 
configuration with the dA moiety in a pseudoaxial and pseudoequatorial position, 
respectively [23]. Preliminary, matrix dependent, circular dichroism results support this 
assignment (data not shown). 
4.4.3. CE separation 
Despite considerable efforts, an electrokinetic separation of the -dA adducts was 
not achieved with either of the single surfactants, DOSS or Brij-S (data not shown). 
Therefore, we turned to mixed surfactant buffers, which were reported to be able to 
resolve structurally similar components that were inseparable under single surfactant 
conditions [44-46]. The buffer, which allowed for separation, consisted of 34.4 mM 
DOSS, 7.4 mM Brij-S, 6.8 mM sodium tetraborate, and 25.5 % acetonitrile (v/v). 
Altering the ratio of the two surfactants optimized electrophoretic resolution of the 
diastereomers. Utilizing the methodology described in Refs. [46,47], it was confirmed 
(data not shown) that at 25.5 % acetonitrile, micelle formation was inhibited. This 
suggests that the CE-separation mechanism involves a solvophobic association of the 
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PAH portion of the DB[a, /]PDE- 14-N6dA adducts with the hydrophobic chains of the 
surfactants. 
Separation of a mixture of eight diastereomeric -dA adducts is shown in Figure 4-
6. Since eleven peaks are nearly baseline resolved, three peaks of this electropherogram 
must belong to decomposition products or impurities. 
4.4.4. On-line, low-temperature identification of CE-separated peaks 
Figure 4-7 shows the low-temperature (4.2 K) on-line spectral identification of 
peaks 7 (spectrum a) and 11 (spectrum b) of the electropherogram shown in Figure 4-6. 
Peak identification is made based on comparisons with the library of the standard spectra. 
Spectrum a is identical to the off-line trans-syn-dA reference standard (spectrum c of 
Figure 4-3), and spectrum b is indistinguishable from the spectrum in Figure 4-4, which 
corresponds to the cis-syn-dA reference standard. Therefore, we conclude that peaks 7 
and 11 of the electropherogram shown in Figure 4-7 can be unambiguously assigned as 
the trans-syn- and c/s-syn-DB [a, Z]PDE-14-N6dA adducts, respectively. 
Another example is shown in Fig. 4-8, where the identification of peaks 4 
(spectrum a) and 5 (spectrum b) are illustrated. Both peaks reveal identical NLN spectra 
which are compared with the standard spectrum obtained for the (-)-trans-anti-dA 
(spectrum c). Since spectra a and b are nearly identical to the {-)-trans-anti-dA reference 
standard, we conclude that they must correspond to either the (+) or (-)-trans-anti-
DB[a,/]PDE-14-N6dA diastereomers. The increased broadening observed in spectra a 
and b, as compared to the standard spectrum c, is a consequence of a slight reduction in 
spectral resolution obtained in the on-line measurements. As mentioned earlier, 
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Figure 4-6. Room-temperature fluorescence electropherogram acquired during CE-
separation of the eight HPLC purified DB[a,/]PDE-derived adduct standards. The peaks 
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Figure 4-7. On-line NLN spectra (a and b) for the CE-separated peaks 7 and 11 of Figure 
4-6. The bands are labeled with their ground-state vibrational frequencies, in cm'1; T = 
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Figure 4-8. Spectra a and b were obtained on-line in the CE-buffer matrix (at T = 4.2 K. 
/-ex = 308 nm) for peaks 4 and 5, respectively, of Figure 4-6. Spectrum c is from the 
library of NLN spectra and corresponds to the {-)-trans-syn-dA adduct. Spectra a and b 
were obtained with spectral resolution of 0.8 nm; spectrum c was 0.5 nm. The NLN 
bands are labeled with their ground-state vibrational frequencies, in cm"1. 
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and as discussed in Ref. [48], the (+)-trans-anti- and (r)-trans-anti-type adducts possess 
indistinguishable fluorescence spectra [22,23]. Their differentiation has been 
accomplished via spiking with optically pure standards whose stereochemistry has been 
established by *H NMR and circular dichroism [22]. The latter revealed that peaks 4 and 
5 correspond to (+)-trans-anti and (-)-trans-anti-dA adducts, respectively. The same 
methodology of differentiating the (+/-) diastereomers was utilized for the remaining 
(+/-) -dA adduct pairs. 
As a final example, Fig. 4-9 shows the on-line identification of the CE-separated 
peaks 7 and 11 of Fig. 4-6 via FLN spectroscopy. Frame A of Fig. 4-9 shows the 4.2 K. 
FLN spectra (XeX = 372.0 nm) of the CE-separated peak 7 (spectrum a) and the (+)-trans-
syn-dA adduct standard (spectrum b). The comparison reveals vibronic modes at 720, 
757, and 796 cm*1 in the on-line spectrum which are identical to those found in the (+)-
trans-syn-dA adduct standard spectrum. Frame B of Fig. 4-9 compares the 4.2 K on-line 
FLN spectra (XcX = 372.0 nm) of the CE separated peak 11 (spectrum c) with that of the 
off-line (+)-cz'5-jy/7-dA adduct standard (spectrum d). Again, identical vibrational modes 
at 736, 796, 848, and 930 cm"1 are observed, proving that peak 11 corresponds to the (+)-
cis-syn-dA adduct. Thus, Figures 4-7 and 4-9 demonstrate that trans and cis isomers of 
the .syM-DB [o, /] PDE-14-N6dA adducts are readily distinguishable and can be 
unambiguously assigned by both NLN and FLN spectra. The results obtained by 
combining CE with low-temperature fluorescence spectroscopy and spiking are 
summarized in Table 4-2. 
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Figure 4-9. Spectra a and c were obtained on-line in CE-buffer for peaks 7 and 11 of 
Figure 4-6, with an excitation wavelength of 372.0 nm at T = 4.2 K. Spectra b and d are 
shown for comparison, and corresponds to FLN spectra of the (+)-trans-syn- and (+)-cis-
5>?7-DB[a,/]PDE-l4-N6clA adduct standards, respectively. The detection delay time was 
40 ns with a 200 ns gate width. The FLN peaks are labeled with their excited-state 
vibrational frequencies, in cm"1. 
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Table 4-2. The identity of the peaks in the electropherogram shown in Figure 4-6. 
Peak Number 
Peak Assignment 
1 (-) cis-anti-Tfà[a, Z]PDE-14-N6dA 
2 (+) cw-anrt-DB[a,/]PDE-14-N6dA 
3 decomposition product 
4 (+) frans-an/i-DB[a, /]PDE-14-N6dA 
5 (-) /ra/w-azz//-DB[a,/]PDE-14-N6dA 
6 decomposition product 
7 (+) Zra/75-jyn-DB[a,/]PDE-14-N6dA 
8 (-) trans-syn-DR[a, /]PDE-14-N6dA 
9 (-) c/jr-jryn-DB[a,/]PDE-14-N6dA 
10 decomposition product 
11 (+) cis-syn-DB[a, /]PDE-14-N6dA 
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4.5. Conclusions 
The use of a capillary electrophoresis method for the separation and on-line 
spectral identification of closely related analytes, via low-temperature fluorescence 
spectroscopy, has been demonstrated for diastereomeric dA adducts derived from the 
DB[o,Z]PDE. Successful separation of the eight stereoisomers was accomplished using 
an appropriate mixture of DOSS and Brij-S surfactants. Since the separation conditions 
inhibit micelle formation, it is concluded that the separation mechanism is the result of a 
solvophobic association of the PAH-dA adducts with the hydrophobic chains of the 
surfactants. It has been demonstrated that low temperature CE-FNLN/FLN methodology 
not only allows for on-line identification via vibrationally resolved 4.2 K fluorescence 
spectra, but also provides conformational information on the -dA adducts. We believe 
that the marriage of CE to low-temperature fluorescence spectroscopy will be useful in 




CC, capillary cryostat 
CCD, charge-coupled device 
CE, capillary electrophoresis 




DB[a,/]PDE, dibenzo[o, /]pyrene diol epoxide 
DB [a, Z] PDE-14-N2dG, dibenzo[a,/]pyrene diol epoxide-N2-deoxyguanosine 
jy/7-DB[a,/]PDE-14-N6dA, jy/z-dibenzo[a,/]pyrene diol epoxide-14-N6deoxyadenosine 
<3Mfi-DB[a,/]PDE-N6dA, aMfi-dibenzo[a,/]pyrene diol epoxide-14-N6deoxyadenosine 
DB[a,/]PDE-14-N7Ade, 14-(adenin-7-yl)-l 1,12,13-trihydroxy-11,12,13,14 
tetrahydrodibenzo [a, /] -pyrene 
DB[a,/]PDE-14-N7Gua, 14-(guanin-7-yl)-l 1,12,13-trihydroxy-11,12,13,14-
tetrahy drodibenzo[a, /]pyrene 
DB[a,Z]P tetrol, 11.12,13,14-tetrahydroxy-l l,12,13,14-tetrahydrodibenzo[o,/]pyrene 
DE, diolepoxide 
DOSS, dioctylsulfosuccinate 
FLNS, fluorescence line-narrowing spectroscopy 
LIF, laser-induced fluorescence 
NLN, non-line-narrowing 
PAH, polycyclic aromatic hydrocarbon 
50 state, electronic ground state 
51 state, lowest excited singlet state 
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CHAPTER S. ON-LINE IDENTIFICATION OF DEPURINATING DNA 
ADDUCTS IN HUMAN URINE BY CAPILLARY ELECTROPHOREIS 
FLUORESCENCE - LINE-NARROWING SPECTROSCOPY 
A paper published in Electrophoresis, 2000,21,799. 
K. P. Roberts, C. -H. Lin, M. Singhal, G. P. Casale, G. J. Small, and R. Jankowiak 
5.1. Abstract 
The benzo[a]pyrene (BP) derived 7-(benzo[a]pyren-6-yl)guanine (BP-6-N7Gua) 
depurinating one-electron oxidation adduct was identified in the urine extracts of coal-
smoke-exposed humans for the first time. Urine samples were prepared by solid phase 
extraction and reverse-phase high-performance liquid chromatography. Subsequently, 
the BP-6-N7Gua adduct was identified on-line with capillary electrophoresis -
fluorescence line-narrowing spectroscopy (CE-FLNS) at 4.2 K. The daily excretion of 
BP-6-N7Gua in human urine of individuals exposed to coal-smoke was about -226 pmol 
per |amol of creatinine. Due to the high level of excretion we propose that BP-6-N7Gua 
adducts found in urine could serve as effective biomarkers for risk assessment of BP 
exposure. The results demonstrate that CE-FLNS allows for on-line separation and DNA 
adducts identification in complex fluid-extracts. 
5.2. Introduction 
Capillary electrophoresis (CE) is now a well established and widely used 
analytical and bioanalytical separation technique. Various protocols necessary for CE 
separation of molecular analytes have been established [1-4]. Using CE, polycyclic 
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aromatic hydrocarbon (PAH)-carcinogens were measured with a detection level of 0.1 
attomole [5]. CE has also been successfully applied to the analysis of DNA adducts [3,6-
9], nucleic acid bases, and DNA oligonucleotides [2]. Fluorescence line narrowing 
spectroscopy (FLNS) provides frequency selection by exciting a homogeneous ensemble 
of molecules, providing a means to overcome the inhomogeneous spectral broadening 
[10,11], FLNS is capable of distinguishing between a given PAH metabolite covalently 
bound to different DNA bases and to different nucleophilic centers of a given base [10-
14]. Furthermore, FLNS has been used to distinguish between a given metabolite bound 
in helix external, partially base-stacked, and intercalated conformations [10,11,15]. Sub-
femtomole detection limits have been obtained, i.e. ~1 adduct in 108 base-pairs can be 
measured in about 100 pg of DNA [16]. Although excellent selectivity and sensitivity of 
FLNS indicate that this methodology is a powerful tool for the study of both stable and 
depurinating DNA adducts [10-17], it should be pointed out that a complex mixture of 
closely related adducts/metabolites cannot be resolved by FLNS alone. 
Therefore, we recently demonstrated that CE can be interfaced with FLNS for 
on-line structural characterization. It was shown that detection by laser-induced 
fluorescence (LIF) under line-narrowing (FLN) conditions provided excellent spectral 
resolution, which allowed for structural characterization of various PAHs [4] and PAH-
derived DNA adducts [3,8,9]. We emphasize that CE-FLNS does not require standards 
each time the analytes identification is to be made. Rather, it relies on an established 
reference library of spectra. This attribute is particularly important when standards (e.g. 
DNA adducts/metabolites) are difficult/expensive to synthesize, and/or exhibit poor 
stability. We have also shown that adduct identification can be achieved with CE-NLN 
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fluorescence spectroscopy at 4.2 K [3] (or at 77 K; unpublished results). For NLN 
spectroscopy non-selective excitation into the S2 state with a single-frequency excitation 
source can be used, leading to excitation of all sites within the inhomogeneously 
broadened band. The resulting spectra are much more characteristic for analyte 
identification than room-temperature spectra. With this approach, expensive tunable 
lasers are not required, expanding the applicability of low-temperature LIF detection in 
CE [3], 
Benzo[a]pyrene (BP), the carcinogen of interest in this manuscript, can be 
activated by one-electron oxidation to yield reactive intermediate radical cations and by 
monooxygenation to produce bay-region diol epoxides [17-21]. The active intermediates 
formed by one-electron oxidation and monooxygenation readily bind to DNA and have 
been shown to form adducts in vitro and in vivo [18,22], Results obtained in recent years 
unequivocally demonstrated the importance of the one-electron oxidation pathway for the 
carcinogenic activation of PAHs [18]. For example, it was shown that the BP-radical 
cation (at the C6 position) binds in vitro to the N7 position of adenine or guanine to form 
unstable BP-6-N7Ade and BP-6-N7Gua adducts that are rapidly lost (depurinated) from 
DNA [21,23]. Mouse skin studies showed that the major BP-derived depurinating 
adducts formed are BP-6-N7Ade, BP-6-N7Gua, and BP-6-C8Gua; together, they account 
for 74% of all BP adducts formed [22,24-26]. The presence of the BP-6-N7Gua adduct 
was also demonstrated in urine and feces of rats exposed to BP, where the identification 
was made by off-line FLNS [21]. However, the question remains as to whether or not 
these adducts are formed in humans. 
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In this study, urine from coal smoke exposed individuals is analyzed by CE-FLNS 
for the presence of BP-DNA adducts, since BP is one of the major carcinogens found in 
coal smoke [27]. Previously, PAH-metabolites such as 1-hydroxypyrene-glucuronide 
and BP-tetraols were used as biomarkers of PAH exposure in urine assays of individuals 
exposed to coal tar [28]. However, identification of depurinated PAH-DNA adducts in 
human fluids, if formed at detectable levels, would be more relevant indicators of PAH 
exposure since they directly reflect PAH-induced DNA damage. 
5.3. Experimental Section 
Caution. BP is an extremely hazardous chemical and should be handled 
carefully in accordance with NIH guidelines. 
5.3.1. Materials 
Sodium tetraborate (STB), sodium dioctyl sulfosuccinate (DOSS), and 
dimethylsulfoxide (DMSO) were obtained from Aldrich Chemical Co. (Milwaukee, WI). 
Acetonitrile (ACN), methanol, and sodium hydroxide (NaOH) were obtained from Fisher 
Scientific (Fair Lawn, NJ). All buffers were prepared with water purified by a 
NANOpure II (Bamstead, Dubuque, IA) purification system. Capillaries were 75 pm 
i d., 375 |im o.d. UV-transparent bare silica purchased from Polymicro Technologies Inc. 
(Phoenix, AZ). BP-6-N7Gua and BP-6-N7Ade standards were prepared via iodine 
oxidation reaction of BP with the individual DNA bases as described in detail elsewhere 
[18]. 
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5.3.2. CE-FLNS instrumentation 
The CE-FLNS instrumentation is described in Refs [3,5,6]. Briefly, the system 
consists of a modular CE (Crystal 300 series, Model 310, ATI Unicam, Boston, MA) 
system, FLNS apparatus, and a capillary cryostat (CC). A schematic of the CE-
FLN/FNLN system is shown in Figure 5-1. The CC consists of a double-walled quartz 
cell with inlet and return lines for introducing liquid nitrogen or liquid helium. The outer 
portion of the CC is evacuated. The capillary, positioned in the central region of the CC, 
is cooled by a continuous flow of liquid nitrogen (77 K) or liquid helium (4.2 K). The 
low thermal capacity of the capillary and the small dimensions of the CC (inner portion, 4 
mm ID x 22-cm length) allow rapid cooling to 4.2 K. (in less than 1 min.) and the ability 
to form disordered matrices for FLN to be operative in typical CE buffers. A precision 
stage provides translation of the CC along the capillary axis by +/- 4 cm allowing the 
separated analytes to be sequentially characterized by LIF spectroscopy. 
Room temperature, LIF electropherograms were obtained with a CW excitation 
source (Model Innova 90C argon ion laser, Coherent, Santa Clara, CA) equipped with 
UV optics and an intracavity prism for single line selection. The excitation wavelength 
was 351.1 nm with an output power of 100 mW. Fluorescence was collected with a 
reflecting objective (25-0506 x 15, Ealing, Holliston, MA; numerical aperture of 0.28), 
passed through a Model 218 0.3-m monochromator (McPherson Inc., Acton, MA), and 
detected with an intensified charge-coupled device (ICCD) (Roper Scientific, Trenton, 
NJ). The FLN spectra were obtained with a Lambda Physik FL-2002 pulsed dye laser, 
pumped by a Lambda Physik Lextra 100 XeCl excimer laser (Lambda Physik, Ft. 
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Translator 







Figure 5-1. Schematic apparatus of the CE-FLNS system used for low temperature 
structural identification of CE-separated analytes. 
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Lauderdale, FL). Low-temperature spectra were obtained using gated and non-gated 
modes of detection. A gate width of 200 ns and various delay times, as specified in figure 
captions, were used. Spectral resolution for NLN fluorescence and FLN spectra was 0.8 
and 0.09 nm, respectively. 
5.3.3. Solid phase extraction (SPE) and reverse-phase high-
performance liquid chromatography (RP-HPLC) 
The (dominantly) hydrophobic BP derived adducts/metabolites from human urine 
was done by a multi-staged process (Casale et al., in preparation). Urine samples were 
standardized to 100 mg creatinine as an internal standard. Extraction and 
preconcentration methods were employed with urine to minimize a large number of the 
(unwanted) endogenous species, which can chemically and spectrally interfere with the 
analytes of interest. The procedure was established with the extraction of adduct 
standards (BP-6-N7Gua and BP-6-N7Ade) added to human urine. The C-18 chains of 
the SPE cartridge efficiently retained the hydrophobic species, while a majority of 
unwanted components (e.g. salts) present in the urine samples eluted without retention. 
Adducts were released from the Sep-Pak columns when the 60/40 (v/v%) point was 
reached on the elution gradient. The standards were further isolated with a chloroform 
extraction, followed by evaporation to a volume of 10 |iL. Then DMSO (200 |iL) was 
added and evaporation continued until the chloroform was removed. 
Based on the RP-HPLC (C-18) retention times established by BP-6-N7Gua/-
N7Ade standards, maximum sample clean-up was achieved when 10-minute (70-80 
minute retention window) eluate fractions were collected from the first HPLC separation 
(methanol/water gradient). After concentrating the effluent to 200 pL in DMSO, urine 
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samples were further purified with the second RP-HPLC (ACN/water gradient) 
separation. With this separation, optimal adduct isolation (i.e., maximum adduct 
recovery with minimal background components) was achieved by collecting a 10-minute 
fraction (30-40 minute retention window) established by the adduct standards. Finally, 
effluent collected from the second separation was concentrated to 30 |iL in DMSO for 
CE-FLNS analysis. 
5.3.4. CE-separation conditions 
The CE buffer consisted of a 15% acetonitrile (ACN) solution (v/v) containing 20 
mM DOSS, and 4 mM sodium tetraborate. Aqueous NaOH was used to adjust the pH to 
9. Before injection, the separation buffer was filtered through a 0.22 ^m syringe filter 
(Costor) and then degassed for 5 minutes. All CE experiments were carried out in the 
micellar electrokinetic chromatography (MEKC) mode [29]. Introduction of the organic 
modifier ACN to the separation buffer provided adduct solubility within the mobile phase 
and thus established the dynamic equilibrium needed for differential partitioning 
(resolution) of the analytes by the pseudo-stationary phase. Capillaries (85 cm in length 
with a 75 cm effective length) were conditioned with 100 mM NaOH for 15 minutes (30 
minutes for new capillaries), water for 5 minutes, and separation buffer for 15 minutes. 
The samples were hydrodynamically injected with 20 mbar pressure for 3 seconds 
resulting in approximately a 10 nL injection volume. Electrokinetic separations were 
carried out at 22 kV resulting in a current of ~ 19 pA. To eliminate the possibility of 
contamination of adduct standards, room-temperature CE-LIF was used to confirm the 
purity of BP-6-N7Gua and B-6-N7Ade adduct. 
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5.3.5. Off-line FLNS experiments 
Reference spectra of BP-derived adduct standards were performed in 100% CE 
buffer. The samples were placed in 2 mm i d. quartz tubes, and brought to 4.2 K in a 
double nested liquid helium dewar for LIF measurements under NLN and FLN 
conditions. Approximately 20 p.L sample volumes were sufficient for off-line analyses. 
The delay times and gate widths are specified in figure captions. 
5.3.6. Molecular modeling 
Molecular structures of BP-6-N7Gua and BP-6-N7Ade are shown in Figure 5-2. 
Structural optimization of one of these adducts (-N7Gua) was performed with 
HyperChem's molecular modeling program. The MM+ force field parameters developed 
for organic molecules and the Polak-Ribiere method for molecular mechanics 
optimization were employed. A quenched dynamics (i.e. simulated annealing) was used 
to explore the conformational space. Ten structures were minimized and then subjected 
to 100 ps of molecular dynamics at T = 400 K. 
The dihedral angle a, defining the relative orientation of guanine in respect to the 
BP-moiety (see Figure 5-2), was used as a variable during the exploration of the 
conformational space. A Monte Carlo method was employed to determine the average 
value of a. Ten simulations were performed with 2000 steps at T = 400 K with a 
maximum allowed atomic displacement of 0.05 À. Fifteen randomly selected structures 
were again subjected to a 100 ps run (at 400 K) and cooled to 0 K. in 2 ps. The (0,0) 
transitions were calculated for the resulting fifteen structures using the ZINDO/S semi-
empirical quantum mechanical method. 
BP-6-N7Gua BP-6-N7Ade 
Figure 5-2. Molecular structures of one-electron oxidation BP-6-N7Gua and BP-6-
N7Ade adducts. The dihedral angle a corresponds to rotation around the single bond that 
connects the two moieties. 
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5.4. Results and Discussion 
5.4.1. Separation of BP-6-N7Gua and BP-6-N7Ade: limit of detection The 
room-temperature fluorescence electropherogram of the expected depurinated adducts 
standards (10 * M) is shown in Figure 5-3. Peaks a and b correspond to BP-6-N7Gua and 
BP-6-N7Ade, respectively, as established by CE migration times. The small-unidentified 
peaks observed in the electropherogram of Figure 5-3, most probably correspond to 
adduct decomposition products, and/or impurities present in solvents used in purification 
and/or CE separation. The inset of Fig. 5-3 shows the CE electropherogram obtained for 
the BP-6-N7Ade standard at much lower concentration. Fluorescence was integrated in 
the 385-500 nm range. This result establishes an absolute limit of detection for the BP-6-
N7Ade adduct (at room temperature) of approximately 2 attomole (~2 x 10"'° M; S/N 
~3); the detection limit for BP-6-N7Gua was similar. 
5.4.2. Identification and relative abundance of BP-6-N7Gua in human 
urine 
Curve a of Figure 5-4 shows the CE separation of the 10-minute HPLC urine 
fraction (see section II.3) of an individual chronically exposed to coal smoke (i.e., ~30 pg 
of BP per day). Electropherograms b and c are those of the BP-6-N7Gua standard and a 
urine fraction from non-exposed individual, respectively. The data, based on migration 
times and standard additions, indicates that the intense peak (-23 minutes) in the 
electropherogram of the coal smoke-exposed individual (curve a) corresponds to BP-6-
N7Gua at a level of ~0.9 finol. No detectable amounts of the BP-6-N7Gua or BP-6-
N7Ade were observed in the electropherogram of the urine extract from the non-exposed 
individual (curve c). 
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Figure 5-3. CE electropherogram of the BP adduct standards. Peak a corresponds to BP-
6-N7Gua and peak b corresponds to BP-6-N7Ade. The small (unidentified) peaks in the 
electropherogram are presumed to be impurities and/or adduct decomposition products. 
Inset, a detection limit of 10*'° M is shown for the BP-6-N7Ade standard. Laser 
excitation wavelength = 351.1 nm with the power output set to 100 mW. The 
fluorescence intensity of the electropherogram was obtained by integration of the spectral 
region from 385-500 nm. 




10 20 30 
Time (min) 
Figure 5-4. CE separations of urine extract of an individual exposed to coal smoke (a), 
BP-6-N7Gua standard (b), and the urine extract of a non-exposed individual (c). The 
arrow marks the location of the depurinated adduct, BP-6-N7Gua. The fluorescence 
intensity of the electropherogram was obtained by integration of the spectral region from 
385-500 nm. Spectra were obtained with an excitation wavelength of 351.1 nm (output 
power of 100 mW). 
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Figure 5-5. CE electropherogram, with fluorescence spectra corresponding to the CE-
separated peaks obtained for urine-extract from an individual exposed to coal smoke (X«x 
= 351.1 nm). Fluorescence intensity of the electropherogram (left) was obtained by 
integration of the spectral region from 385-500 nm. The peak labeled with an asterisk 
correspond to the BP-6-N7Gua adduct (see text for details). 
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Figure 5-5 shows another example of an electropherogram (left) of a urine 
fraction from a second coal smoke-exposed individual. In addition to the 
electropherogram, NLN fluorescence spectra of the CE separated peaks were monitored 
in real-time. An intense peak at -23 min (labeled with an asterisk) is also observed for 
this individual. The 4.2 K NLN spectrum of this peak is indistinguishable from that of 
the BP-N7Gua standard (not shown), suggesting again that BP-6-N7Gua is formed in 
vivo. The same quantitation procedure as described above revealed that the level of BP-
6-N7Gua is -0.6 fmol. It is worth pointing out that the peaks at-13 and 16 minutes, 
with emission maxima at ~ 475 and - 430 nm, would likely prevent spectral 
characterization of the -23 min peak had the analysis been performed using off-line NLN 
fluorescence. No attempts were made to identify the peaks whose spectra do not 
resemble BP-type fluorescence. 
5.4.3. CE-FLNS analysis 
The results in Figure 5-5 indicate that the one-electron oxidation BP-6-N7Gua 
adduct is probably formed in humans. Nevertheless, a more definitive identification is 
required. The 4.2 K NLN spectrum of the CE-separated peak (- 23 minutes), obtained 
with an excitation wavelength of 351.1 nm, is shown in frame A of Figure 5-6. The 
spectrum is indistinguishable from that of the BP-6-N7Gua adduct standard (spectrum 
not shown). We note that at 4.2 K the fluorescence intensity increases by a factor of 10 
due to the higher fluorescence quantum yield. The latter along with longer detection 
times for the frozen and stationary analyte zone provides sub-attomole detection limit. 
Figure 5-6 (Frame B) shows the 4.2 K high-resolution on-line FLN spectrum (Xe* = 386.5 
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Figure 5-6. On-line, 4.2 K analysis of the CE-separated peak at ~ 23 minutes in the 
electropherogram of Figure 5-5. Frame A: NLN fluorescence spectrum of the CE-
separated peak obtained with a CW Ar-ion laser; 351.1 nm. The origin, or (0,0) band, is 
at 406 nm. Frame B: Comparison the on-line FLN spectrum (solid line) for the CE 
separated peak to the FLN spectrum of BP-6-N7Gua standard. The FLN peaks are 
labeled with their excited-state vibrational frequencies, in cm"1. T = 4.2 K, Xex = 386.5 
nm, gate-width = 200 ns with a 40 ns delay. 
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nm) for the CE-separated peak (solid line) and the off-line FLN spectrum (dashed line) of 
the BP-6-N7Gua standard. The FLN spectra are nearly indistinguishable as revealed by 
the identical frequencies (and intensities) of the excited state vibronic modes at 1128, 
1164, 1218,1250, and 1316 cm"1. This result provides conclusive proof that the DNA 
adduct is BP-6-N7Gua and, as well, underscores the high selectivity and sensitivity of 
CE-FLNS. 
Quantitative studies revealed that the daily excretion of BP-6-N7Gua by the two 
individuals studied in this work was about 200 pmol per day. From spiking experiments, 
it was determined that adduct recovery was 65-85%, therefore, the daily excretion could 
be ~18-53 % higher. In terms of the creatinine level (an internal standard), the two coal 
smoke exposed individuals excreted about 226 pmol of BP-6-N7Gua per gmolof 
creatinine. By way of comparison, it was recently shown that psoriasis patients treated 
with coal tar medication excreted (in urine) 5-250 pmol of 1-hydroxypyrene [30] and 
15.0 ± 29.5 pmol of BP-tetraols per nmol of creatinine [28]. The BP-tetraols were 
claimed to be relevant for PAH-cancer risk assessment because formation of BP-
diolepoxide (which is known to form stable DNA adducts) precedes formation of BP-
tetraols [31]. 1 -hydroxypyrene (the metabolite most often used to assess PAH exposure) 
was measured in the urine of garbage incineration workers at the level of 0.05-0.41 pmol 
per pmol of creatinine [32]. However, we believe, due to the relatively high abundance 
of the BP-6-N7Gua adduct formed in coal smoke-exposed humans, that it is a more 
biologically relevant marker for PAH exposure since it reports directly on DNA damage. 
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5.4.4. Spectral characterization of the BP-6-N7Gua standard 
The 4.2 K fluorescence origin bands of BP-6-N7Gua in CE-separation buffer 
obtained under NLN conditions are shown in Figure 5-7, frame A. The origin band 
maximum for 0 ns delay is at 407.1 nm shifting to 406.1,405.6,404.5 nm for 20, 40 and 
80 ns delay times, respectively. The gate width was kept constant at 20 ns. Such a blue 
shift with increasing delay time has been observed for the BP-6-N7Ade adduct and was 
attributed to a distribution of BP-6-N7Ade adduct conformers [33]. 
Vibronically excited FLN spectra (Figure 5-7A, curves a-c), obtained with = 
386.5 nm and delay times of 0,40, and 80 ns are shown in Fig. 5-7B. The observed 
narrowing of the FLN spectra and decreasing intensity of the zero-phonon lines in the 
long wavelength region with increasing delay time indicates that fluorescence originates 
only from BP-6-N7Gua adducts absorbing at the high-energy wing of the 
inhomogeneously broadened vibronic absorption band. The latter is in agreement with 
the observed distribution of fluorescence lifetimes (data not shown). Such narrowing 
correlates well with the NLN spectra shown Fig. 5-7A. From an analytical standpoint, 
the importance of the results is that adducts formed in vivo and corresponding adduct 
standards should be measured with identical delay times. 
5.4.5. Modeling studies of BP-6-N7Gua 
To provide some insight on the blue-shift of the fluorescence origin bands, a 
molecular modeling study was initiated. A typical structure obtained from molecular 
dynamics simulations (T = 0 K), and subsequent optimization, is shown in Figure 5-8. 
The dihedral angle a (defined in Figure 5-2) of the optimized BP-6-N7Gua structure at T 
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Figure 5-7. (A) NLN fluorescence spectra (curves a-d) of BP-6-N7Gua in CE buffer 
obtained at delay times of 0,20,40, and 80 ns, respectively; XcX = 308 nm. Spectra b, c, 
and d were multiplied by a factor of 2,8, and 40, respectively. (B) FLN spectra obtained 
for BP-6-N7Gua in CE buffer with an excitation wavelength of 386.5 nm for 0 (spectrum 
a), 40 (spectrum b), and 80 ns (spectrum c) delay times. The numbers correspond to 
excited-state vibrational frequencies in cm*1. T = 4.2 K; gate width = 200 ns. 
I l l  
Figure 5-8. 
90.2° at T = 
Optimized structure of the BP-6-N7Gua adducts. The average value of a is 
O K .  
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value of a over the whole simulation period was -91° with a root-mean-square (RMS) 
deviation of ~ 6°. This suggests that, upon cooling to 4.2 K, a distribution of 
conformations with slightly different a values is possible. As a check on this, fifteen 
randomly selected and thermally equilibrated (at 400 K) structures of BP-6-N7Gua were 
subjected to additional quenched dynamics to see whether or not a distribution of a exists 
at 0 K. The calculations revealed a narrow distribution of dihedral angles with a equal to 
91.5° ± 1.4°. 
Results of the ZINDO/S calculations on the fifteen structures showed that the 
mean (0,0)-transition was at 397.0 nm with a RMS of ± 0.5 nm. The experimentally 
observed (0,0)-band for BP-6-N7Gua in ethanol and CE-buffer glasses was red-shifted by 
~ 8 nm and -9 nm, respectively; this discrepancy is primarily due to the fact that the 
calculations were performed in vacuo. Since we are interested in the relative energy shift 
rather then absolute values, the calculated RMS deviation of ± 0.5 nm for the selected 
conformers can be compared with experimental results. The results show that the RMS 
deviation of the (0,0)-bands is in reasonable agreement with the experimental data where 
the relative band shifts are ~1.6 nm for the CE buffer (see Fig. 5-7A) and 1.2 nm for an 
ethanol glass (results not shown), respectively. However, this agreement might be 
fortuitous since the blue shift could also originate from a matrix-induced change in the 
relative orientation between the two moieties and/or frequency-dependent permanent 
dipole moment changes across the inhomogeneously broadened absorption band. 
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5.5. Conclusions 
CE-FLNS was used to prove that the depurinating adduct BP-6-N7Gua is formed 
in humans. The urine fractions analyzed were isolated by SPE and RP-HPLC. Attomole 
detection limits with CE-FLNS were demonstrated and quantitative studies revealed that 
the level of BP-6-N7Gua formed in humans exposed to coal smoke was -200 pmol per 
day (-226 pmol per pmol of creatinine). The identification of BP-6-N7Gua in humans 
provides further support for the hypothesis that the one-electron oxidation metabolic 
pathway plays an important role in PAH-induced carcinogenesis. It is possible that the 
formation of apurinic sites and stable BP-diolepoxide type adducts work in concert to 
prevent error-free repair of DNA. Be that as it may, it is reasonable to assume that there 
is considerable positive correlation between the levels of apurinic sites and stable adducts 
formed. Thus, the characterization and determination of depurinating PAH-DNA adducts 
in urine provides a basis for risk assessment monitoring. This approach is more reliable 
than one based on the monitoring of PAH metabolites produced by detoxification 
pathways since it reports DNA damage directly. 
5.6. Abbreviations: Ade, adenine; BP, benzo[a]pyrene; BP-6-N7Ade, 7-
(benzo[a]pyren-6-yl)adenine; BP-6-N7Gua, 7-(benzo[a]pyren-6-yl)guanine; CE, 
capillary electrophoresis; CW, continuous wave; DB[a,/]PDE, dibenzo[a,/]pyrene diol 
epoxide; FLNS, fluorescence line-narrowing spectroscopy; ICCD, intensified charge-
coupled device; LIF, laser-induced fluorescence; NLN, non-line-narrowing; PAH, 
polycyclic aromatic hydrocarbon; RP-HPLC, reverse-phase high-performance liquid 
chromatography; SPE, solid phase extraction. 
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CHAPTER 6. HIGH-PERFORMANCE LIQUID CHROMATOGRAPY 
INTERFACED WITH FLUORESCENCE LINE-NARROWING 
SPECTROSCOPY FOR ON-LINE ANALYSIS 
A paper published in Analytical Chemistry, 2001, 75,951. 
K. P. Roberts, R. Jankowiak, and G. J. Small 
6.1. Abstract 
We have demonstrated, for the first time, that high-performance liquid 
chromatography (HPLC) can be interfaced with fluorescence line-narrowing 
spectroscopy (FLNS) for on-line identification and characterization of analytes. 
Interfacing centered primarily on the design and construction of a novel liquid helium 
cryostat that accommodates variable-sized quartz tubes/capillaries suitable for HPLC as 
well as capillary electrophoresis/electrochromatography. In addition to the high spectral 
resolution afforded by FLNS, analyzing the separated components at 4.2 K minimizes 
photodegradation from the excitation source and provides indefinite detection times for 
signal averaging. The proof-of-principle for the HPLC-FLNS system is first 
demonstrated with a mixture of four structurally similar polycyclic aromatic 
hydrocarbons, then applied to the analysis of DNA adducts from mouse skin exposed to 
the carcinogen dibenzo[o,/]pyrene. With femtomole detection limits, HPLC-FLNS can 
be used for real-world analyses of complex mixtures. 
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6.2. Introduction 
High-performance liquid chromatography (HPLC) is a powerful, practical, and, 
hence, common separation technique used for analysis of chemical and biochemical 
mixtures. The success of HPLC is due to the attention given to developing column 
technology, establishing rigorous separation protocols, and improving detection methods. 
Traditionally, analyte identification in HPLC has been based on chromatographic 
retention times determined with standards that, however, can be expensive to obtain. 
Such identification, together with quantification, requires the absence of coelution and a 
high degree of reproducibility. Consequently, there is a need for high-resolution 
detection/identification methods that can provide unambiguous characterization of 
separated analytes without depending on standards. Moreover, on-line analysis avoids 
any post-column degradation associated with off-line analysis of separated fractions. 
Several on-line methods have shown success either by providing selective information, 
such as m/z ratios when interfacing HPLC with MS [1-3], or by providing structural 
information when combined with HPLC-NMR [4,5], -FTIR [6,7], and -Raman [8-10]. 
In this paper, we report the first on-line interfacing of HPLC with fluorescence 
line-narrowing spectroscopy (FLNS), which utilizes narrow-line excitation at low 
temperatures (typically 4.2 K.) [11-14]. Identification in FLNS is based on comparison of 
an analyte's vibronically resolved fluorescence spectra to a library of reference spectra 
generated once from standards, alleviating the need for standards for every identification. 
The average widths of vibronic bands in FLNS are - 5 cm*1. At this temperature 
photodegradation is minimized and the sensitivity of the laser-induced fluorescence (LIF) 
increases by a factor of -10 for many molecules. FLNS can also be used for 
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conformational analysis [15], and for non-fluorescent molecules upon derealization with 
a fluorescent label [16]. 
Originally, identification of constituents in chemical mixtures by FLNS required 
separation and isolation of the individual components with preparative chromatography 
to avoid spectral interference. This off-line approach, however, necessitates ample 
amounts of material and sample stability. Therefore, to overcome these detriments, 
FLNS was interfaced semi-on-line with thin-layer chromatography (TLC) [17-21] and 
polyacrylamide gel electrophoresis (PAGE) [22,23]. It was shown, for example, that by 
directly depositing (and drying) effuent from an LC column onto a linearly translating 
TLC plate by a novel spray-jet assembly, FLNS could be performed on the deposited 
trace, or after an additional TLC separation perpendicular to the trace. This approach was 
used to identify structurally similar molecules such as tetrols derived from polycyclic 
aromatic hydrocarbons (PAH) and PAH-DNA adducts [20,21]. Although only minor 
losses in chromatographic resolution were encountered, spectral interference from the 
separation media in both TLC- and PAGE-FLNS limit the sensitivity of these 
approaches. Recently, FLNS was coupled on-line with capillary 
electrophoresis/electrochromatography (CE/CEC) [24-28]. In comparison to TLC- and 
PAGE-FLNS, the CE-FLNS methodology provided: z) reduced background 
luminescence, ii) elimination of the post-separation extraction step often needed in TLC 
and PAGE; Hi) high separation efficiency of CE; and iv) small sample volume 
compatibility of CE with bioanalysis. It was shown with the CE-FLN system that 
complex mixtures of PAHs, stable PAH-DNA adducts, and depurinating PAH-DNA 
adducts can be unambiguously identified on-line [24]. With low attomole detection 
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limits, CE-FLNS showed, for the first time, that depurinating benzo[a]pyrene-guanine 
adducts are formed in humans and excreted into urine [28]. 
In this study, the construction and feasibility of an on-line HPLC-FLNS system 
are demonstrated with a mixture of four structurally similar PAHs. In addition, the first 
real-world application of the system is shown for the analysis of a PAH-DNA adduct 
formed from dibenzo[a, fjpyrene (DB[a,/]P) treated mouse-skin. We believe that 
interfacing FLNS with HPLC will further expand the applicability of FLNS and provide a 
complementary technique to CE-FLNS. 
6.3. Experimental Section 
Caution. Benzo[a|pyrene, fra/K-7,8-dihydrodiol-benzo[a]pyrene, and 
/ra/fs-9,10-dihydrodiol-benzo[a)pyrene are extremely 
hazardous chemicals and should be handled carefully in 
accordance with NIH guidelines. 
6.3.1. Reagents and Chemicals 
Ethanol (EtOH) and water were of HPLC grade and purchased from Aldrich 
(Milwaukee, WI). Both solvents were filtered through 0.22 |im filters (Costar, Coming, 
NY), sonicated, and purged with dry helium gas prior to use. Benzo[a]pyrene (B[a]P), 
benzo[e]pyrene (B[e]P), fraro-7,8-dihydrodiol-benzo[a]pyrene (/rans-7,8-B[a]P-diol), 
and trans-9,10-dihydrodiol-benzo[a]pyrene (trans-9,10-B[a]P-diol) were purchased from 
Midwest Research Institute (Kansas City, MO), stored at -70°C, and kept from contact 
with water and light during handling. Stock solutions (1 x 10"5 M) were prepared in 
EtOH and subsequent dilutions were made with the HPLC mobile phase. 
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6.3.2. Mouse Skin Treated with DB[o,/]P 
Female Swiss mice were treated with 200 nmol of DB[a,/]P in 50 mL of acetone. 
Four hours later, the mouse skin was excised, minced, and grounded in liquid nitrogen. 
The ground mouse skin was soxilated with a solvent mixture (CHCb : MeOH (1:1 v/v)) 
for 48 hours to extract any depurinating DNA adducts. After evaporating the soxilate 
extract to dryness, the residue was dissolved in DMSO/MeOH for preparative HPLC 
fractionation. The sample was first ran through an acetonitrile (ACN)/HzO gradient 
using a YMC ODS-AQ 6.0 x 250 mm column (YMC, Wilmington, NC), a Waters 600E 
solvent delivery system and 996 PDA UV absorbance (254 nm) detector. An 80-min 
linear gradient from 20 to 100% ACN, at a constant flow rate of 1.0 mL/min was 
performed followed by re-fractionation with a MeOH/HiO gradient over 70-min from 30-
100% MeOH. This HPLC separation used a Jasco FP-920 (Jasco Inc., Easton, MD) 
fluorescence detector. Broad fractions were collected according to retention times 
established by standards of DB[a,/]P adducts, dried, and then immediately stored in the 
freezer to prevent decomposition prior to HPLC-FLNS analysis. 
6.3.3. FLN Chromatographic System 
Micro-HPLC separations of the mixture of the four PAHs were performed by 
interfacing a standard quaternary Hewlett-Packard (HP) series 1050 (Hewlett-Packard 
Co., Palo Alto, CA) HPLC system with a microflow processor (Acurate, LC Packings, 
San Francisco, CA). Separations were achieved by setting the HPLC pump to a flow rate 
of 250 piL per minute and reducing the flow through a 1-mm calibrator (CAL-400-1.0) of 
the microflow processor. The microflow processor split the mobile phase to give a 
column flow rate of 30 pL per minute. An HP-1050 autosampler was used to inject 2 -
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50 (iL sample volumes onto an Advantage 100,1.0 x 250 mm CIS 5-(im column 
(Thomson Instrument Co., Clear Brooke, VA). The column was directly connected to a 
0.460 mm i.d. x 2 mm o.d. x 30 cm quartz tube (InnovaQuartz Inc., Phoenix, AZ). The 
quartz tube was positioned in the center of the on-line FLN cryostat and served as the 
detection cell for all LIF experiments discussed in the Results and Discussion Section, 
excluding Section 6.5.4, which utilized a smaller i.d. tube. Effluent flow rate was 
measured at the end of the quartz tube. Separations were carried out in an isocratic mode 
with an 85% EtOH and 15% H%0 (v/v) mobile phase composition. 
HPLC-FLNS analyses of the mouse-skin preparative HPLC fractions utilized a 
narrow-bore (2.1 x 150 mm) Waters Symmetry-C8 column connected to the 0.360 mm 
1.d. detection tube. A 30-min linear Et0H/H%0 gradient, starting at 30% EtOH and 
ending at 100% EtOH at a constant flow rate of 0.20 mL/min was utilized. Elution of 
DB[a,/]P-N3Ade was monitored by room-temperature fluorescence emission spectra of 
the standard (see below). The same HPLC system was used as described above; 
excluding the micro-flow processor since the HP-1050 pumping system could adequately 
operate at this flow rate. Injection volumes of 5 |iL were used in the mouse-skin 
experiments. Each day the separation column was equilibrated for 30 minutes or until the 
baseline was stabilized prior to sample injection. When the analytes of interest were 
detected in the quartz detection cell, liquid helium was introduced into the cryostat to 
freeze the separation and the HPLC pump was turned off. 
6.3.4. Laser Systems and Fluorescence Instrumentation 
The excitation source used for room-temperature HPLC separations was a model 
Innova 90C (Coherent, Santa Clara, CA) CW argon-ion laser excitation source operating 
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at 351.1 nm ( 100 mW output power). The excitation source for FLNS studies was a 
Lambda Physik FL-2002 pulsed dye laser (line-width of ~ 0.2 cm"1), pumped by a 
Lambda Physik Lextra 100 XeCl excimer laser (Lambda Physik, Ft. Lauderdale, FL) at a 
repetition rate of 10-30 Hz. Fluorescence emission for on-line HPLC-FLNS was 
collected at a 90-degree angle to the excitation beam with a reflecting objective (25-0506 
X 15, Ealing, Holliston, MA), focused into a 0.3-m monochromator (Model 218, 
McPherson, Acton, MA), and detected with an intensified charge-coupled device (Model 
ICCD-1024MLG-E/1, Roper Scientific, Trenton, NJ). 
Off-line FLN reference spectra for the studied analytes were acquired to serve as 
a library for spectral identification in the on-line analyses. Samples of the four PAH 
standards were diluted to 1 X 10"6 M in the HPLC mobile phase (85/15 : EtOH/HaO 
v/v%), while the mouse-skin sample and DB[a,/]P-N3Ade standard were dissolved in a 
50/50 (v/v%) solution of the EtOH and H%0 mobile phase constituents with a drop of 
DMSO to enhance solubility. Standard solutions were placed in 2 mm i.d. quartz tubes 
and submerged in a double-nested glass liquid helium dewar equipped with quartz 
windows (H.S. Martin Inc., Vineland, NJ). Approximately 30 |j.L sample volumes were 
sufficient for off-line FLN analyses. Fluorescence emission was collected with a 2-inch 
lens at a 90-degree angle to the excitation beam, focused into a 1-m monochromator 
(McPherson Model 2061, Acton, MA), and detected with an intensified linear photodiode 
array (Model IRY-1024/GRB, Roper Scientific, Trenton, NJ). A series of reference 
spectra were taken for each standard with various delay times and excitation 
wavelengths. Gate widths and delay times are specified in the figure captions. The 
spectral resolution for this FLN setup was 0.03 nm. 
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6.5. Results and Discussion 
6.5.1. On-line Cryostat 
The first step in developing an HPLC system with low temperature FLN detection 
was the design of a cryostat that would be compact, robust, and amendable to either large 
diameter (0.5-3 mm o.d.) quartz tubing or capillaries (< 0.5 mm o.d.). As shown in 
Figure 6-1, the cryostat consists of a double-walled quartz observation window (15 cm in 
length) and inlet/return lines for introducing a continuous flow of liquid nitrogen or liquid 
helium; the outer portion of the cryostat is evacuated. In some cases, liquid nitrogen 
temperatures may provide sufficient spectral information for analyte identification [25]. 
The cryostat shown in Figure 6-1 is a modification of a previous capillary cryostat, which 
had a shorter observation window and longer inlet/return lines [24-28]. Automated 
translation of the cryostat was accomplished by mounting the cryostat to a micron step-
size translation stage (Model 310-M, New England Affiliated Technologies, Lawrence, 
MA). Laser excitation was performed perpendicular to the length of the observation 
window and at a 90-degree angle to the fluorescence collection objective. This allowed 
FLNS to be performed along the entire length of the quartz observation window of the 
cryostat. To discriminate against scattered and reflected laser light, the cryostat was 
tilted 20° with respect to the laser beam. The cryostat is now commercially available 











Figure 6-1. Schematic diagram of the HPLC-FLNS system. The instrumentation 
consists of a micro-HPLC apparatus with a quartz tube connected to the outlet of a 
separation column, HPLC cryostat, translation stage, and FLNS detection system. The 
quartz tube is positioned axially in the cryostat (see text for details). 
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6.5.2. Cooling efficiency 
A fast cooling rate is desirable to lessen the diffusion of the separated analyte 
zone and to minimize analysis time. The performance of the cryostat was tested by 
measuring the cooling rate from 300 to 4.2 K as described in Ref. [26]. In brief, a 0.460 
mm i.d. quartz detection tube was placed in the cryostat and filled with a micromolar 
solution of B[a]P. With an excitation wavelength of 395.7 nm, the room-temperature 
fluorescence of B[a]P was broad and featureless, with an origin-band width of ~ 500 cm" 
However, less than 2 minutes after opening the helium inlet valve, 4.2 K. was achieved 
as revealed by a fluorescence intensity increase of ~ 10 and vibronic band-widths of - 5 
cm"1 (results not shown). Reaching 4.2 K can also be visualized by the presence of liquid 
helium in the cryostat observation window. However, it is worthy to note that the time 
needed to reach the freezing point of the mobile phase is all that is necessary to "trap" the 
separated components in the cryostat. By relieving the pressure on the HPLC prior to 
opening the liquid helium inlet valve diffusion of the analyte zone diffusion was not 
significant within the time needed to freeze the mobile phase. In most cases, the mobile 
phase was frozen in approximately 30 seconds. 
6.5.3. HPLC-FLNS analysis of four closely related analytes 
Four structurally similar test molecules (B[e]P, B[a]P, and two metabolite isomers 
of B[a]P, trans-1,8-B[a]P-diol and /rawj-9,10-B[a]P-diol) were used in this study to 
demonstrate the potential of on-line HPLC-FLNS. As a mixture, off-line FLNS could not 
be used to identify the four test components due to spectral overlap. This problem often 
rises when attempting to identify analytes susceptible to partial decomposition, or when 
attempting to identify geometric/positional isomers. Therefore, the mixture of the above 
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four test molecules provided a case in point of where on-line HPLC-FLNS could be used 
and off-line FLNS could not. The result of injecting 2 |iL of a mixture of the four 
components (1 x 10"6 M each) is shown in the fluorescence HPLC chromatogram in 
Figure 6-2. It can be seen in the chromatogram that, under isocratic separation conditions 
(see Experimental Section), all four components are not resolved. Specifically, the first 
major peak in the chromatogram shows a fronting shoulder (marked with an arrow), 
suggesting coelution of two of the four components. Standard-addition experiments 
indicated that the shouldering peak at 11 minutes was a mixture of trans-1,%- and trans-
9,10-B[a]P-diol and that the more clearly resolved peaks at 25 and 27 minutes were 
B[e]P and B[a]P, respectively. However, with the poor resolution exhibited in the 11-
minute peak, absolute identification of the peak's constituents based on retention time or 
spiking with standards creates a degree of uncertainty. This scenario provided a good 
example of how on-line FLNS detection could be employed to test peak purity and 
selectively identify coeluting components. 
On-line FLN analysis began by freezing the analyte zone corresponding to the 
unresolved peak at 11 minutes as it traversed into the detection window of the cryostat. 
The cryostat was then automatically translated to the lower portion of the observation 
window, which corresponded to the peak's shoulder. This process was monitored by 
non-selective excitation at 351.1 nm (data not shown). Selectively tuning the laser 
through the Si vibronic bands of the two suspected B[a]P-diol isomers was then 
performed to determine which isomer corresponds to the peak's shoulder. At an 
excitation wavelength of 394.2 nm (Figure 6-3), for example, the on-line FLN spectrum 
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Figure 6-2. Room-temperature fluorescence chromatogram acquired during the HPLC 
separation of the four components in the test mixture. B[e]P and B[a]P are fairly-well 
resolved, while the peak at ~ 11 minutes appears to be coelution of the B[a]P-diols, as 
suggested by the shoulder on the front of the peak. Column, 1 mm X 25 cm, CI 8; mobile 
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Figure 6-3. Comparison of an on-line HPLC-FLN spectrum for the front shoulder of the 
peak at - 11 minutes (solid line) in the chromatogram of Figure 6-2 with the off-line 
reference spectrum for the trans-9,10-B[a]P-diol standard (dashed line). Conditions: T = 
4.2 K, Xex = 394.2 nm, 200 ns gate-width with a 40 ns delay. Peaks are labeled with their 
excited state vibrational frequencies, in cm"1. Delaying the detection gate by 40 ns 
significantly reduced scattering incident laser light, providing a much cleaner FLN 
spectrum. 
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identical to that of the off-line reference spectrum obtained for /rans-9,10-B[a]P-diol 
(dashed line), thus identifying the 11-min peak's shoulder in Figure 6-2. 
Next, the cryostat was translated up to the portion of the observation window 
corresponding to the second half of the 11-minute peak for FLN analysis. Comparison of 
the on-line FLN spectrum to the off-line FLN reference spectrum (XeX = 381.9 nm) 
identified the second half of the 11-minute peak as /rons-7,8-B[o]P-diol (results not 
shown). A second level/method of FLNS identification was accomplished by mapping 
out all excited-state vibrational modes of the molecule; typically, 6-8 excitation 
wavelengths are used in this process. For simplicity, an example of FLN spectra obtained 
at two different excitation wavelengths is shown in Figure 6-4. Selective excitation into 
the vibrational levels of Si produce FLN spectra where the position of the peaks reflects 
the analyte's excited-state vibrational frequencies, as measured relative to the laser-
excitation frequency. Utilizing multiple excitation wavelengths ensures that the FLN 
spectra correspond to the molecule of interest and not to an impurity with similar 
vibrational frequencies. For example, distinctive modes at 743, 776,794, and 832 cm"1 
are revealed at the excitation wavelength of 381.9 nm as shown in spectrum a of Figure 
6-4. In spectrum b it can be seen that at excitation wavelength of 383.1 nm, in addition to 
the modes observed in spectrum a (e.g., 743, 776, 794, and 832 cm"1), new modes at 560 
and 651 cm*'are also revealed. The variations in intensity reflect the difference in 
selectivity for certain Si vibrational modes at the two excitation wavelengths. The 
concentration limit of detection was determined, from room-temperature HPLC-LIF 
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Figure 6-4. On-line FLN spectra obtained at two different excitation wavelengths for the 
second half of the 11-minute peak in the HPLC chromatogram of Figure 6-2. Spectra a 
and b were obtained with an excitation wavelength of 381.9 and 383.1 nm, respectively. 
Both spectra were taken with a 200 ns gate width and a 60 ns delay time. Peaks are 
labeled with their excited-state vibrational frequencies, in cm"1. 
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The peak at 25 minutes in Figure 6-2 was assumed, based on retention time, to be 
B[e]P. As shown in Figure 6-5A, on-line FLNS of this analyte zone by selectively 
exciting 500 cm"1 above the origin band of B[e]P at 368.9 nm revealed characteristic 
vibronic modes of B[e]P at 453,497, 534, and 563 cm"1. As expected, these modes 
perfectly match those in the off-line reference library (data not shown for simplicity). 
Likewise, with an excitation wavelength of 395.7 nm, the peak at 27 minutes in the 
chromatogram was confirmed by FLNS to be B[a]P, with distinct modes at 326,374, 
450,471, 512, and 580 cm"1 (see Figure 6-5B). 
6.5.4. HPLC-FLNS of mouse skin treated with DB|a,/)P 
Attempts to identify depurinating DB[a,/]P-derived DNA adducts in an HPLC 
fraction from mouse skin by off-line FLNS were impossible due to spectral interference 
from impurities, as shown in Figure 6-6 (solid line spectrum). Although a few partially-
resolved vibronic modes (300, 352, 385, and 446 cm'1) line up with those in the off-line 
FLNS reference standard spectrum for the expected DB[<7,/]P-10-N3Ade adduct (dashed 
line), impurities in the mouse-skin fractions prevent absolute identification of the DNA 
adduct. Identification of DB[a,/]P adducts by FLNS has been previously shown for 
synthetic DB[a,/]P-type standards, but not for real-world samples [26,29]. Frame A of 
Figure 6-7 shows the result of a narrow-bore HPLC-LIF separation of the mouse-skin 
fraction. Based upon retention times established with standards (data not shown) and 
monitoring the position of the room-temperature fluorescence spectra, the peak at ~ 23 
minutes in the chromatogram (marked with an asterisk) was tentatively assigned as the 
depurinating DB[a,/]P-10-N3Ade adduct. However, room-temperature spectral 
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Figure 6-5. Frame A; On-line FLN spectrum of the peak at ~ 25 minutes in the 
chromatogram of Figure 6-2. The vibrational frequencies (XeX = 368.9 nm) identify the 
peak at 25 minutes as B[e]P. The spectrum was taken at with a gate-width of 200 ns and 
a 0 ns delay time. Frame B; FLN spectrum of the peak at ~ 27 minutes in the 
chromatogram. The vibronic modes (XeX = 395.7 nm) identify the 27-min peak as B[o]P; 
200 ns gate-width, 20 ns delay. The vibronic modes are labeled with their excited-state 
frequencies, in cm"1. 
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Wavelength (nm) 
Figure 6-6. Comparison of off-line spectrum from a mouse-skin fraction (solid line) 
expected to contain the depurinating DB[a,/]P-10-N3Ade adduct, to the FLN reference 
spectrum of the adduct standard (dashed line). Spectral interference prevents certain 
identification of DB[a,/]P-10-N3Ade from mouse skin treated with DB[a,/]P. Both 
spectra were taken with an excitation wavelength of 416 nm, 200 ns gate width, and a 40 
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Figure 6-7. On-line identification of the depurinating DB[a,/]P-N3Ade adduct by HPLC-
FLNS. Frame A shows the room-temperature, narrow-bore HPLC-LIF chromatogram of 
the mouse-skin fraction; = 351.1 nm. The peak at ~ 23 minutes is suspected to 
correspond to the depurinated DB[a,/]P-10-N3Ade adduct, as established by retention 
time. The - 23-min peak of the chromatogram was trapped in the cryostat and frozen to 
4.2 K for on-line FLNS. Frame B shows the result of selective excitation of the 23-min 
peak with 416 nm and a 200 ns gate width, 40 ns delay. The spectrum is identical to the 
reference spectrum of the DB[a,/]P-10-N3 Ade adduct standard shown in Figure 6-6 
(dashed line). Peaks are labeled with their excited state vibrational frequencies, in cm"1. 
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adducts or decomposition products could show similar retention times and/or spectra. 
Therefore, absolute identification was accomplished by chromatographically displacing 
the spectrally interfering components and analyzing the 23-minute peak with on-line 
FLNS. 
As the 23-minute peak made its way into the cryostat observation window, the 
analyte zone was frozen to 4.2 K. As shown in Frame B of Figure 6-7, selective laser 
excitation of 416 nm revealed distinct vibronic modes at 300, 315, 352,373, 385,410, 
446,489, and 523 cm'1 in the spectrum of the separated analyte. When compared to the 
library of reference spectra of DB[o, /]P-derived DNA adducts, these modes match 
identically to those of the off-line spectra for DB[a,/]P-10-N3Ade (dashed line spectrum 
of Figure 6-6). By identifying the above adduct in mice, these results further substantiate 
the formation of depurinating DNA adducts from the most potent chemical carcinogen 
DB[a,/]P via the one-electron oxidation metabolic pathway [29]. Since the adduct of 
interest was identified, no attempt was made to characterize the other peaks in the 
chromatogram. The quantity of the -N3Ade adduct was determined with room-
temperature HPLC-LIF to be ~ 2 X 10*7 M, using DB[a,/]P as an external standard and 5 
|uL injection volumes. More detailed studies of DB[a,/]P-10-N3Ade and other DNA 
adducts possibly formed on mouse-skin treated with DB[o,Z]P are the subject of future 
investigations with on-line HPLC-FLNS. 
6.6. Conclusions and Future Prospects 
We have demonstrated that on-line HPLC-FLNS can be used for on-line 
identification of closely related molecular analytes. The HPLC/CE cryostat provides a 
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fast cooling rate, has a longer detection window, and accommodates variable-size quartz 
tubes and capillaries for HPLC and CE, respectively. The separation shown in Figure 6-2 
was obtained with a 1-mm i.d. column directly connected to 0.46 mm i.d. detection 
tubing, whereas the separation shown in Figure 6-7A utilized a new 2.1-mm i.d. column 
connected to 0.36 mm detection tubing. The former was available in the early stages of 
developing HPLC-FLNS. Although improvements were made in the latter 
chromatographic set-up, the separation shown in Figure 6-2 provided a demonstrative 
example of how HPLC-FLNS can be used to identify/resolve analytes not clearly 
resolved by HPLC alone, as shown with the coelution of the trans-1,%- and trans-9,10-
B[a]P-diols (see Figures 6-2, -3, and -4). 
It is anticipated that HPLC-FLNS will be a useful tool in the analysis of complex 
mixtures where structurally similar analytes are commonly encountered. Situations such 
as these often arise in analyzing biological mixtures (e.g., depurinating PAH-DNA 
adducts formed in vivo) where absolute, unambiguous identification is of vital 
importance, and identification based solely on retention time may not be sufficient. 
Moreover, with femtomole detection limits, this system should be adequate for many 
real-world applications. 
Future plans are to utilize the HPLC-FLNS system to study estrogen quinone 
derived DNA adducts, urinary porphyrins, and various intact (and/or partly denatured) 
photosynthetic protein-antenna complexes. In each case, the availability of standards and 
sample stability often compromises (or negates) identification. It is also anticipated that 
FLNS detection can be used in combination with nano- and capillary-HPLC (research in 
progress), which provide high separation efficiencies and detection sensitivities. 
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Moreover, detection of non-line-narrowed fluorescence spectra at liquid nitrogen 
temperatures may be adequate in many situations [26]. 
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CHAPTER 7. CONCLUDING REMARKS 
It has been shown in this thesis that combining the highly efficient separation 
processes of HPLC and CE with highly selective and sensitive FLNS detection can be 
powerful combinations used for real-world applications. By providing a detection 
method that can alleviate the dependence on highly expensive (and/or difficult to attain) 
working standards, many more application can be envisioned. Techniques such as these 
are clearly in high demand, and by combining information-rich detection with new and 
improving separation methodologies, many advances in characterizing complex 
biochemical and biomedical are anticipated. 
In comparison to off-line FLNS detection, operating in an on-line mode of 
detection is fast and reduces interferences from decomposition and losses associated with 
sample handling. In comparison to TLC- and PAGE-FLNS, CE- and HPLC-FLNS 
provided higher separation power, a reduction in background luminescence, eliminated 
the post-separation extraction step often needed in TLC and PAGE, and can easily 
accommodate the small sample volume often encountered in bioanalysis. The HPLC-
/CE-FLNS systems have proven useful in the analyses of structurally similar molecules 
such as PAHs and PAH-DNA adducts. In particular, a highly important bioanalytical 
application of CE-FLNS showed, for the first time, that depurinating adducts are formed 
in humans, leading to further understanding of the initial events in chemical 
carcinogeneis. With low detection limits, the ability to utilize well-established separation 
protocols, and the need in modern analytical sciences for detection methods that can 
provide unambiguous identification, CE- and HPLC-FLNS will be valuable contributors. 
Further expansion of these systems to applications in photosynthetic complexes (see 
142 
Appendix C), porphyrins, and DNA adducts formed from the anti-estrogen drug, 
tamoxifen (see Appendix B) are underway and preliminary results are encouraging. 
Finally, with the growing trend in miniaturized separation techniques such as nano-, 
capillary-HPLC, lab-on-a-chip, etc, the highly informative and sensitive fluorescence 
detection method of FLNS will continue to diversify to many more bioanalytical 
applications. 
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APPENDIX A. SPECTRAL AND CONFORMATIONAL ANALYSIS OF 
DEOXYADENOSINE ADDUCTS DERIVED FROM SYN- AND ANTI-
DIBENZO[fl,/]PYRENE DIOLEPOXIDES: FLUORESCENCE STUDIES 
A paper published in Chemical Research and Toxicology, 1999,12, 768. 
R. Jankowiak, C.-H. Lin, D. Zamzow, K. P. Roberts, K.-M. Li, and G. J. Small 
A.l. Abstract 
Low-temperature fluorescence spectra and results of conformational studies on 
trans-syn-, cis-syrt-, trans-anti-, and cis-anti-dibçnzo [a, Z]pyrene diol epoxide 
(DB[A,/]PDE) derived deoxyadenosine (dA) adducts are presented and compared with 
those previously obtained for the stereoisomers DB[a,/]P-tetrols (Jankowiak et al., 
Chem. Res. Toxicol. 1997,10,677-686). In contrast to DB[a,/]P-tetrols, for which only 
/rawj-isomers showed two conformers, all stereoisomeric dA adducts adopt two different 
conformations with either half-chair or half-boat structures for the cyclohexenyl ring, and 
an 'open'- or 'folded'-type configuration between dA and the DB[o,/]P moiety. The major 
conformations observed for trans-syn-, cis-syn-, and cis-anti-DB[a,/]PDE-14-N6dA could 
be assigned based on the previous calculations for the DB[a,/]P-tetrols. The major 
conformers of the trans-syn- and c/s-syn-DB[a, /]PDE-14-N6dA adducts exist in 
conformations I and II, with their fluorescence origin bands at ~382 and ~389 nm, 
respectively. In conformation I the cyclohexenyl ring adopts a half-boat structure with 
dA in a pseudoaxial position (an open configuration), whereas the cyclohexenyl ring in 
conformation II adopts a half-chair structure with dA in pseudoequatorial position (a 
folded configuration). The major conformation of cis-anti-DE[a,/]PDE-14-N6dA, with 
144 
its origin band at -389 nm, was also assigned as a folded-type configuration with a half-
chair structure in the cyclohexenyl ring. Molecular mechanics and dynamical simulations 
were performed for interpretation of the low-temperature fluorescence spectra and *H 
NMR coupling constants observed for the trans-anti-DB[a,Z]PDE-14-N6dA adduct. The 
major conformer of this adduct has a half-chair structure in the cyclohexenyl ring, but 
different deviation from planarity in the fjord-region than conformer II of cis-anti-
DB[a,Z]PDE-N6dA. This new structure is labeled as conformer II'. Its (0,0)-
fluorescence band is at 388.1 and 388.3 nm in ethanol and glycerol/water glasses, 
respectively, consistent with the folded-type configuration revealed by the calculations. 
The fluorescence line narrowed spectra reveal that the trans-syn-, cis-syn-, trans-anti-, 
and cis-anft'-DB[a,/]PDE-l4-N6dA adducts can be distinguished. Thus, their spectra 
should prove useful for identification of DB[a,/]P-DNA adducts formed at low levels in 
biological samples. 
A.2. Introduction 
Dibenzo[o,/]pyrene (DB[a,/]P)' is the most potent carcinogen among the 
polycyclic aromatic hydrocarbons (PAHs) [1,2]. It has been found in river sediment [3] 
1 Abbreviations: CE, capillary electrophoresis; dAMP, deoxyadenosine monophosphate; DB[a,Z]P, 
dibenzo[a,/]pyrene; DB[a,/]PDE, dibenzo[a,/]pyrene diol epoxide; DB[o,/]PDE-14-Nz-dG, 
dibenzo[a,/]pyrene diol epoxide-N2-deoxyguanosine; jy«-DB[o,/]PDE-14-N6dA, yn-dibenzo[o,/]pyrene 
diol epoxide-14-N6deoxyadenosine; o«//-DB[a,/]PDE-N6dA, aw/-dibenzo[a,/jpyrene diol epoxide-14-
N6deoxyadenosine; DB[a,/]PDE-14-N7Ade, 14-(adenin-7-yl)-11,12,13-trihydroxy-l 1,12,13,14 
tetrahydrodibenzo[o, /]-pyrene; DB[a, /]PDE-14-N7Gua, 14-(guanin-7-y 1> 11,12,13-trihydroxy-11,12,13,14-
tetrahydrodibenzo[a,/]pyrene; DB[o,/]P tetrol, 11,12,13,14-tetrahydroxy-l 1,12,13,14-
tetrahydrodibenzo[a,/]pyrene; DE, diolepoxide; FLNS, fluorescence line-narrowing spectroscopy; g/w, 
glycerol/water, MD, molecular dynamics; Me2SO, dimethyl sulfoxide; MM, molecular mechanics; PAH, 
polycyclic aromatic hydrocarbon; S0 state, electronic ground state; S, state, lowest excited singlet state; 
ZPL, zero-phonon lines. 
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and indoor [4] and outdoor [5] samples, suggesting potential (eco)toxicological hazards. 
DB[a,/]P can be enzymatically activated by two main pathways: one-electron oxidation 
to yield radical cations [6-9] and monooxygenation to produce bay region diol epoxides 
[10-15]. Numerous DB[a,/]P-DNA adducts have been reported [6-16]. 
Low-temperature fluorescence spectroscopy has proven to be a valuable tool for 
DNA-adduct characterization. In particular, fluorescence line-narrowing spectroscopy 
(FLNS) [8,17] has been used for definitive identification [6,8-24] of adducts. 
Furthermore, the combination of FLNS and non-line-narrowing (NLN) fluorescence 
spectroscopy can provide adduct conformational information [23-25], i.e., whether the 
adduct is external, base-stacked, or intercalated. This methodology has recently been 
used to characterize DB[a,/]P diol epoxide (DB[a,/]PDE) derived DNA adducts and 
conformation dependent DNA repair [16]. These studies were performed using 
polynucleotides and calf thymus DNA reacted in vitro with DB[a,/]PDE and native DNA 
from mouse skin epidermis exposed to DB[a,/]P. It was shown that DB[a,/]PDE-DNA 
adducts possess stereochemical^ different structures and can adopt different 
conformations [16]. The results indicated a need for spectral characterization of all 
DB[a,/]PDE derived deoxyadenosine (dA) adduct standards at the nucleoside level. 
Fluorescence and computational studies have shown that trans-syn-DB [a, Z]P-
tetrol [26] and the depurinating adduct trans-syn~DB[a, /]PDE-14-N7Ade [24] possess 
two distinct fluorescence (0,0)-bands having different excited-state vibrational 
frequencies. Molecular dynamics simulations (in vacuo) identified two conformers for 
the DB[a,/]P-tetrols and trans-syn-DB[a,I\?DE-14-N7Ade. The aromatic portion of 
DB[a,/]P was severely distorted, and half-chair or half-boat structures for the 
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cyclohexenyl ring were observed [24,26]. An example, relevant to the results of this 
paper, is shown in Fig. A-l. Two unique structures (conformers I and II) are shown for 
trans-syn-X)Q[a,/]PDE-14-N7Ade. In the open-type adduct structure (frame A), the 
cyclohexenyl ring adopts a half-boat structure where no significant interaction between 
the adenine (Ade) and the aromatic system is possible. In the folded-type conformation 
II (frame B), Ade is in a pseudoequatorial position and the cyclohexenyl ring adopts a 
half-chair structure. Similar conformations were observed for trans-syn-DB[a, /]P-tetro 1 
[26]. The calculated and observed fluorescence origin bands established for various 
conformations of the trans-syn-, cis-syn-, trans-anti-, and m-aw//-DB[a,/]P-tetrols, as 
well as the calculated dihedral angles and the estimated *H NMR coupling constants for 
the proton pairs of the cyclohexenyl ring, are summarized in Table A-l. For 
stereo isomeric DB[o,/]P-tetrols, the agreement between the measured and theoretically 
estimated NMR coupling constants suggests that the results shown in Table 1 may be 
useful for interpretation of the spectroscopic data obtained for DB[a,/]PDE-dA adducts. 
In this work, DB[a,/]PDE-dA adducts, for which eight stereochemical 
configurations are shown in Fig. A-2, were studied by low-temperature fluorescence 
spectroscopy and molecular modeling. The NLN and FLN spectra of trans-anti, cis-anti, 
trans-cis, and cis-syn- DB[a,/]PDE-14-N6dA adducts presented below provide the 
necessary spectral information for investigating the nature of DB[a,/]PDE-DNA adducts 
formed at low levels in in vitro and in vivo studies. The structural characterization of 









Figure A-1. Optimized 0 K ground state structures of trans-syn-DB[a,/]PDE-14-N7Ade 
obtained after simulated annealing. Conformers I and II are shown in frames A and B, 
respectively. The insets show the conformation of the cyclohexenyl ring (half-boat vs. 
half-chair); R = adenine. Hydrogens and double bonds are omitted for clarity. Results 
from Ref. 24. 
Table A-l. Calculated and observed (0,0) transition energies, dihedral angles a and p with the estimated 
coupling constants for the (i j) proton pairs, and structure assignment for various conformations of syn- and 
«/zZ/-DB[fl,/]P-tetrols. Data from reference 26. 
DB|a,/JP- Conf. •^calc -^obs" ab Pb Structure Coupling 
tclrols (0,0) (0,0) (nm) (deg) (deg) assignment*1 constants® 
(nm) 
trcms-syn- I* 381.4 382.2 (EtOH), 25 8 half-boat, pseudoaxial vL/S/S 
382.7 (g/w) 
II 384.0 387.0 (g/w) -26 64 half-chair, L/vL/vL 
pseudoequatorial 
cis-syn- I* 382.2 — -24 62 half-chair, pseudoaxial L/vL/S 
II 384.5 385.2 (EtOH), 26 -60 half-chair, S/S/S 
385.5 (g/w) pseudoequatorial 
trans-anti- I* 383.2 383.6 (EtOH) -24 60 half-chair, pseudoaxial L/S/S 
II 384.4 385.4 (g/w) 27 -63 half-chair, S/S/vL 
pseudoequatorial 
cis-anti- I 382.0 382.8' (EtOH), 24 -59 half-chair, pseudoaxial S/S/S 
383.2 (g/w) 
I* 382.8 24 -25 flattened, pseudoaxial M/M/S 
II 384.3 -24 63 half-chair, L/S/S 
pseudoequatorial 
* The conformations denoted by an asterisk were the most consistent with the room-temperature *H NMR data. 
a) Spectroscopically-observed (0,0) transition energies in ethanol (EtOH) or glycerol/water (g/w) at 77 K. 
b) a describes the deviation from planarity in the fjord region and p describes the conformation of the cyclohexenyl ring; see Fig. A-l. 
c) The observed fluorescence (0,0)-bands may correspond to either the I or the I' conformation. 
d) Conformation of the cyclohexenyl ring and orientation of the hydroxyl group at the C14 position. 
e) Estimated coupling constants for the (11,12), (12,13) and (13,14) proton pairs; L = large, vL s very large, M = medium, 
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Figure A-2. Molecular structures of the eight DB[a,/]PDE-l4-N6dA adducts 
investigated:A) (+l-)-trans~syn-DR[a,Z]PDE-14-N6dA; B) (+/-)-c/jr-j>w-DB[a,/]PDE-14-
N6dA; C): (+/-)-/r<my-anti-DB[a,/]PDE-14-N6dA; and D): (+/-)-c/5-anti-DB[a,Z] PDE-
14-N6dA. The dihedral angles a, P, and y will be used to describe the deviation from 
planarity in the fjord region, the conformation of the cyclohexenyl ring, and the 
orientation of the dA moiety, respectively. dR corresponds to deoxyribose. 
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spectrometry is presented elsewhere.2 
A.3. Materials and Methods 
A.3.1. Caution: Anti-and syn-DB[a,I]P diolepoxides are extremely 
hazardous chemicals and should be handled carefully in accordance with NIH 
guidelines. 
A.3.2. Sample Preparation 
The DB[a,/]PDE derived adducts trans-anti-, cis-anti-, trans-syn-, and cis-syn-
DB [o, /]PDE-14-N6dA were synthesized by the reaction of anti- and syn-DB[a,/]PDE 
with dA. The (+/-)-a«//-DB[a,/]PDE was reacted with dA in dimethylformamide at 
100°C for 30 minutes to give four anti-DB[a, /]PDE-14-N6dA adducts. The (+/-)-syn-
DB[a,/]PDE was reacted with dA under the same conditions, to yield the four syn-
DB[a,/]PDE-14-N6dA adducts. For details on the synthesis and structural 
characterization, see the paper by K.-M. Li et al.2 
A.3.3. Adduct Purity. 
The purity of -dA standards separated by HPLC was checked by capillary 
electrophoresis (CE), which possesses higher separation power (i.e. higher efficiency) 
than HPLC. A mixture of 85% of A (40 mM dioctylsulfosuccinate and 8 mM sodium 
borate in 30% (by volume) acetonitrile - 70% water; pH= 9) and 15% of B (50mM Brij 
S)) was used as the CE buffer. These conditions allowed for separation of all eight 
" K.-M. Li, E.L.Cavalieri, E.G. Rogan, M. George, M.L. Gross, and A. Seidel, Structure elucidation of the 
adducts formed by dibenzo[a,l]pyrene diol epoxides with deoxyadenosine. Chem. Res.ToxicoL, 
accompanying paper. 
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diastereomers.3 Figure A-3 shows room-temperature absorbance electropherograms of 
the HPLC separated (-)-trans-anti- (a), (-)-cis-anti- (b), (+)-trans-syn- (c), and (+)-ci's-
jyzz-DB[a,Z]PDE-14-N6dA (d). The results establish that the purity levels are very high 
and, thus, one can be confident that the library of NLN and FLN spectra obtained is 
reliable. 
A.3.4. Low-Temperature Fluorescence Spectroscopy 
NLN fluorescence spectra at T = 77 K and FLN spectra (Si«-So excitation) at T = 
4.2 K were obtained using a Lambda Physik FL-2002 dye laser pumped by a Lambda 
Physik Lextra 100 XeCl excimer laser as the excitation source. For FLN spectroscopy 
several excitation wavelengths were used, each of which reveals a portion of the Si 
excited-state vibrational frequencies of the analyte (only selected spectra are presented). 
NLN spectra were obtained using non-selective excitation at 308 nm from the excimer 
laser. Samples were cooled in a glass cryostat with quartz optical windows. 
Fluorescence was dispersed by a McPherson 2061 1-m focal-length monochromator and 
detected by a Princeton Instruments IRY 1024/G/B intensified photodiode array. For 
time-resolved spectroscopy, a Princeton Instruments FG-100 pulse generator was 
employed; different detector delay times (0-60 ns) with a gate width of 200 ns were used. 
Resolution for FLN and NLN spectra was 0.03 nm and 0.8-nm, respectively. Two 
solvent matrices of different polarity were used: ethanol and a mixture of glycerol/water 
(50/50 v/v). Ethanol was spectrophotometry grade from Aldrich. Ultra pure grade 
glycerol was purchased from Spectrum Chemical (Gardena, CA). Samples (ca. 20 pL) 
3 K. P. Roberts, C-H. Lin, R. Jankowiak, and G. J. Small "On-line Identification of Diastereomeric 
Dibenzo[a,/]pyrene Diolepoxide-Derived Deoxyadenosine Adducts by Capillary Electrophoresis -















Figure A-3. Room-temperature absorbance electropherograms acquired during CE-
separation of the HPLC preseparated DB[o./]PDE-derived adduct standards: a) (+)-trans-
jyzi-DB[a,/]PDE-N6dA; b) (+)-cw-jyn-DB[a,/]PDE-N6dA; c) (-)-trans-anti-
DB[o,/]PDE-N6dA; and d) (-)-cis-anti-DB[a, Z]PDE-N6dA. The asterisk marks an 
impurity in the trans-anti-dA adduct. 
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were transferred to quartz tubes (2-mm i.d.) and sealed with a rubber septum. Adduct 
concentrations were in the -lO"6 M range. 
A.3.5. Molecular Mechanics 
Conformational analyses were carried out utilizing methods of molecular 
mechanics (MM), wherein energy calculations were performed with HyperChem's 
molecular modeling program (Release 5.1 for Windows™ Hypercube Inc.). 
HyperChem's force field (MM+) developed for organic molecules [27,28] was employed 
utilizing default parameters. As starting structures for the frans-anfi-DB[a,/]PDE-14-
N6dA adduct, different model-built configurations in which the saturated ring was either 
in a half-chair or half-boat conformation were used. The Polak-Ribiere algorithm (in 
vacuo) was used for molecular mechanics optimization; the structures were refined until 
the r.m.s. gradient was less than 0.001 kcal/mol. Electrostatic contributions were 
evaluated by defining a set of bond dipole moments for polar bonds. 
A.3.6. Molecular Dynamics (MD) 
To calculate thermodynamically favored conformations of the trans-ant i-
DB[a,/]PDE-14-N6dA adduct, separated from MM structures by energy barriers, 
quenched dynamics (simulated annealing) was used to explore the conformational space. 
No constraints were used during high-temperature searches of the conformational space. 
The starting half-chair and half-boat structures were minimized and then subjected to 50 
ps of molecular dynamics at various temperatures between 300 and 400 K. Starting and 
final temperatures in a dynamic run were set to OK, and the heating and cooling times 
were set to 5 ps; the step size was 0.0005 ps. At various time points during the 
simulation approximately 30 randomly selected structures were also annealed to 0 K and 
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optimized. These optimized structures were subsequently used as starting points for 
further calculations. The two dihedral angles a and P, which define the distortion in the 
fjord region and the conformation of the cyclohexenyl ring, Figure A-2, were used as 
variables during exploration of the conformational space. All simulations were 
performed in vacuo. 
A.4. Results and Discussion 
DB[cr,/]PDE derived -dA adducts, which were isolated from reaction mixtures in 
which both the racemic mixture and the optically pure syn- and anh'-DB[a,/]PDE were 
reacted with Ade, were studied. The NLN and FLN spectra obtained for adducts formed 
with the racemic mixtures of the respective diol epoxides gave four pairs of identical 
spectra (not shown) with the pairs corresponding to (+)- and (-)- enantiomers of trans-
syn-, cis-syn-, trans-anti-, and cis-anti-DB[a,/]PDE-14-N6dA adducts. These identical 
fluorescence spectra for (+)- and (-)- enantiomers, for a given adduct, was expected since 
we have previously reported for benzo[a]pyrene diol epoxide derived adducts that the 
(+)- and (-)-trans or (+)- and (-)-cis nucleoside enantiomers cannot be distinguished 
from one another by fluorescence methods [23]. True (+)- and (-)-enatiomers can not be 
distinguished since they are related by reflection (mirror) symmetry. Apparently, in the 
case of these DB[a,/]PDE-dA nucleotide adducts, the influence of the sugar moiety on 
the fluorescence characteristics is negligible. It is worthy to note that, due to the 
deoxyribose ring, these (+)- and (-)-dA adducts are not true enantiomers, but rather 
diastereomers.2 In what follows, detailed characterization of -dA adducts obtained with 
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the optically pure (-)-azz//-DB [a, /]PDE and (+)-jyn-DB [o, /]PDE enantiomers will be 
discussed for both trans- and cis- opening dA adducts. Identical data for (+)-anti-
DB[a,/]PDE and (-)-syn-DB[o,/]PDE enantiomers were also obtained (not shown). 
NLN spectra of trans-syn-, cis-syn-, trans-anti-, and cis-anti-DB[a, /]PDE-14-
N6dA adducts are shown in frames A-D of Fig. A-4, respectively. The major differences 
between the spectra in Fig. A-4 are revealed by the spectral position of the (0,0)-bands, 
the intensity distribution of the vibronic bands, and the relative distribution of adduct 
conformations. The origin bands labeled as (0,0)i or (0,0)n indicate that they belong to 
different molecular conformations, vide infra. As was the case for trans-anti- and trans-
j>?7-DB[a,/]P-tetrol isomers (see Table A-l), the NLN spectra of the -dA adducts are also 
solvent dependent. As a result, each of these adducts may exist in a conformation having 
its origin band at 382-385 nm (labeled as conformation I) and/or in a conformation 
having its origin band at ~388-390 nm (denoted as conformation II) with the ratio of I/II 
being solvent dependent. Additionally, variations in the vibronic intensity distribution 
and the So vibrational frequencies (Fig. A-4) are not surprising given that the parent 
fluorophore B[e]P has Czv symmetry, and the out-of-plane deformation, as well as 
conformation of the cyclohexenyl ring should depend on adduct stereochemistry as 
observed in the case of the stereoisomers DB[a,/]P-tetrols [26]. 
A.4.1. sy«-DB[o,/]PDE-dA Adducts. 
The NLN spectra of the (+)-fraw-fy»-DB[a,/]PDE-dA adduct, in ethanol (a) and 
glycerol/water (b) glass, are shown in Fig. A-4A. The spectra brought to light two 
fluorescence (0,0)-bands at 382.0 nm and 389.0 nm with relative intensity distributions 
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Figure A-4. NLN fluorescence spectra obtained for (+)-/ronî-jyn-DB[a,/]PDE-N6dA 
(Frame A), (+)-cis-syn- DB[a,/]PDE-N6dA (Frame B), (->/ra«s-an/j'-DB[a(/]PDE-N6dA 
(Frame C), and (-)-cis-anti- DB[a,/]PDE-N6dA (Frame D) adducts in ethanol (spectra a, 
c,e and g) and glycerol/water (spectra b,d,f and h). T = 77 K, XeX = 308 nm, delay time 
= 20 ns, and gate width = 200 ns. The numbers correspond to the ground-state (So) 
vibrational frequencies. 


















(+)-trans-syn- 382.0 Ie 382.0 I Pos/ ~0 Half-boat, pseudoaxial 
389.0 II 389.0 II Neg. Pos. II Half-chair, pseudoequatorial 
(+)-cis-syn- 383.6 I 384.0 I Neg. Pos. I Half-chair, pseudoaxial 
388.0 II 388.0 II Pos. Neg. Half-chair, pseudoequatorial 
(-)-trans-anti- 383.0° I' I' 28.5 -63.8 Half-chair, pseudoaxial 
(y = -158.4°) 
388.1 II' 388.3 II 30.9 59.0 II' Half-chair, pseudoequatorial 
(y = -61.0°) 
(-)-cis-anti- 385.0 I 385.0e I Pos. Neg. Half-chair, pseudoaxial 
389.0 II 389.0 II Neg. Pos. II Half-chair, pseudoequatorial 
a) The bold Roman numerals indicate the major conformations observed by low-temperature fluorescence. 
b) Conformation of the cyclohexenyl (non-aromatic benzylic) ring and the orientation for the dA moiety; a, p, and y are defined in Fig A-l. 
c) Pos., neg. = positive, negative. 
d) Minor conformation at the nucleoside level, but major conformation in single-stranded DNA [16] and in CE buffer solution.3 
In double stranded DNA this adduct adopts an intercalated Conf. 11 [16] (see text for details) 
e) Very weak, so cis-anti- DB[a,/]PDE- 14-N6dA in glycerol/water glass exists mostly in conformer II (see Figs. A-4D and A-10). 
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DB[d,/]P-tetrols (see Table A-l) and frans-syn-DB[a,/]PDE-14-N7Ade adducts [24] 
suggests that the main conformation of this adduct, with a characteristic origin band at 
382.0 nm, has an open-like structure (conformer I) with the cyclohexenyl ring in a half-
boat conformation. In the open-type structure, no strong interaction between dA and the 
aromatic system is possible. This is the dominant conformation observed in the ethanol 
matrix. In contrast, two distinct origin bands are observed in the glycerol/water matrix, 
which are assigned to conformer I ((0,0)-band at 382.0 nm) and conformer II, 
respectively. The latter conformer has its origin band at 389.0 nm and an intense 
Herzberg-Teller origin band [29-31] at ~760 cm Based on the results for the DB[a,/]P-
tetrois (see Table A-l) and conformer II of trans-syn-DB[a,/]PDE-14-N7Ade [24], 
conformation II of trans-syn-DB[a,/]PDE-N6dA can be assigned as a half-chair with dA 
partially stacked over the distal ring in a folded-type configuration. This conformation is 
characterized by significant %-% interaction between dA and the DB[a,/]P moiety, 
resulting in the red-shifted origin band. The NMR coupling constants obtained for the 
trans-syn-DB [a, /]PDE-dA adduct (Ju.i2= ~7 Hz, Ju.13 = 9.0 Hz, J13.14 = 8.0 Hz)2 are 
consistent with the above half-chair assignment predicted by dynamical simulation for 
trans-syn-DB[a, Z]P-tetrol, for which the estimated coupling constants of the (11,12), 
(12,13) and (13,14) proton pairs were large, very large and very large, respectively. We 
conclude therefore, that Zrcrm-syn-DB[a,/]PDE-N6dA, as observed in room-temperature 
NMR spectra (in MezSO solvent)2 exists in the folded-type conformation II. 
The existence of the above-discussed conformers is confirmed by FLN spectra. 
Multiplet origin structures for the trans-syn-ÙB[a, /]PDE-14-N6dA adduct in ethanol 
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Figure A-5. FLN spectra for (+)-frans-syn-DB[a, /]PDE-N6dA adducts in ethanol (spectra 
a and c) and 50/50 glycerol/water glass (spectra b and d) obtained for excitation 
wavelengths of 376.0 nm (Frame A) and 370.0 nm (Frame B), respectively. T = 4.2 K. 
The FLN praks are labeled with their excited-state vibrational frequencies, in cm"1. The 
spectral range shown covers the fluorescence origin bands of conformations I and II (see 
text). 
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Frames A and B, which reveal different regions of the vibronic spectrum, show FLN 
spectra obtained for two different excitation wavelengths, 376.0 nm and 370.0 nm, 
respectively. The FLN bands (zero-phonon lines (ZPL)) are labeled with their S, 
vibrational frequencies in cm"1. The vibrational frequencies of conformer I ((0,0), ~ 382 
nm) are the same in both glasses, with minor differences in the intensity distribution due 
to larger inhomogeneous broadening commonly observed in a glycerol/water glass 
[24,26], However, comparison of the ZPL in spectra c and b of Fig. A-5 reveals 
significant differences in the vibrational frequencies between conformer I and II. For 
example, the excited state mode frequencies at 766, 794, 863 and 924 cm"1 are typical for 
conformer I, while modes at 785, 862,932, and 961 cm"1 are observed for conformer II. 
These results suggest that the molecular conformations of conformer I and II are 
different. The same conclusion was reached based on results presented in Fig. A-4A and 
calculations performed for trans-syn-DB[a,/]P-tetro 1 [26], which indicate that the major 
conformation (conformer I) of the trans-syn-dA adduct has the cyclohexenyl ring in a 
half-boat structure. However, at room temperature the major conformation observed, as 
shown by *H NMR spectroscopy,2 is conformation II with a half-chair structure for the 
cyclohexenyl ring, and a folded-type structure with dA in a pseudoequatorial position. 
The latter is consistent with the large experimentally observed red-shift (~ 470 cm"1) of 
the (0,0)n band. 
Frame B of Fig. A-4 shows NLN spectra of the (+)-c/j-syn-DB[a, /]PDE-dA 
adduct in ethanol (curve c) and glycerol/water (curve d), respectively. In ethanol the 
(0,0) band is located at 383.6 nm, while in glycerol/water it is at 384 nm. The small 
spectral shift of 0.4 nm is due to the solvent effect. However, a small contribution from 
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the red-shifted conformer II, with its origin band at ~388 nm, is also revealed in both 
solvents. Unlike conformer I of trans-syn-DB[a, /]PDE-dA in ethanol, both 
conformations of the crs-isomer have a weak (0,0) band and very intense Herzberg-Teller 
origin band at -760 cm"1. The significant intensity of this band is owing to electronic 
vibrational coupling between the Si and higher energy dipole-allowed states, and is a 
consequence of the Si«-So absorption transition being only weakly allowed [31]. 
For cfj-jyM-DB[a, /]P-tetrol, only conformer I [26] was observed experimentally. 
However, modeling studies suggested that in vacuo c/s-syw-DBfa/JP-tetrol may exist in 
two different half-chair conformations [26]. Thus, based on Ref [26] and Table A-l, the 
minor conformation of cis-syn-dA (conformer II having its (0,0)-band at 388 nm) is 
tentatively assigned as a half-chair structure for the cyclohexenyl ring (negative (3 value) 
with dA in a folded-type geometry. The main conformation (conformer I with its (0,0)-
band at 384 nm) is assigned as a different half-chair (with a positive p value) and dA in 
an open-type configuration. The latter assignment is in good agreement with the *H 
NMR coupling constants for the proton pairs of the cyclohexenyl ring with J11.12, J12.13, 
J13, h being ~7 Hz (large), 7.5 Hz (large), and ~3 Hz (small), respectively.2 
In Fig. A-6, FLN spectra for the cis-syn-dA adduct, obtained for 378.0 nm 
excitation, are presented. Spectra a and b were obtained in ethanol and glycerol/water 
glasses, respectively. Again, comparison of these spectra shows no differences in 
vibrational frequencies for conformer I (within the (0,0)i spectral range), proving that this 
conformation is the same in both glasses. The higher relative intensities of the 270 and 
428 cm"1 modes in glycerol/water glass are, as in the case of the trans-syn-isomer, due to 
larger inhomogeneous broadening observed in glycerol/water glass. However, in 
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Figure A-6. FLN spectra for (+)-cz>-jyn-DB[a, /]PDE-N6dA adducts in ethanol (spectrum 
a) and 50/50 glycerol/water glass (spectrum b) obtained for an excitation wavelength of 
378.0 nm. Delay time 40 ns, T = 4.2 K. The (0,0)j and (0,0)» indicate the origin bands of 
conformation I and II, respectively. The FLN peaks are labeled with their excited-state 
vibrational frequencies, in cm"1. 
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glycerol/water, a relatively large contribution from adduct conformation II, having its 
origin band red-shifted to ~ 389 nm, is also observed. This is in agreement with data 
presented in Fig. A-4B (spectrum d). 
A.4.2. anti-DB[a,l]PDE-dA Adducts. 
Frames C and D of Fig. A-4 show NLN fluorescence spectra for trans-anti- and 
cis-anti-DB [a, /]PDE-dA adducts. Spectra e,g and f,h were obtained in ethanol and 
glycerol/water glasses, respectively. In contrast to the jy«-DB[a,/]PDE derived adducts, 
the red-shifted conformation is clearly observed for both trans-anti- and cis-anti-dA 
adducts. Fig. A-4C shows that the major conformer for trans-anti-DB[a, /]PDE-dA, in 
both solvents, has its origin band at ~ 389 nm. Also, in this case, the Herzberg-Teller 
origin band at -770 cm"1 is the most intense. The coupling constants previously 
calculated for conformer I (with Jn.ia = large, Ji2,i3 = small, and Ju.w = small) and 
conformer II (with J| 1,12 = small, J12.13 = small, and Ju.h = large) of trans-anti-DB[a,/]P-
tetrol [26] cannot explain the proton NMR coupling constants measured for the (+)-trans-
anti-dA adduct, which are Jn,i2= 8.0 Hz (large), J12.13 = 6.0 Hz (medium), and Ju.u = 
5.0 Hz (medium).2 The J12.13 and Ji3,u coupling constants for the (-)-trans-anti-dA 
adduct were not well resolved in Me2SO, and thus can not be directly compared with 
those of (+)-trans-anti-dA. Nonetheless, we emphasize that circular dichroism, NLN, 
and FLN spectra for (+)- and (-)- diastereomers were identical (data not shown), proving 
that the (+)- and (-)-trans-anti-DB[a,Z]PDE-14-N7Ade adducts do exist in the same 
conformation. 
To interpret the above data on trans-anti-DB [a, /]PDE-14-N7Ade adducts, a 
theoretical investigation was initiated using MM and MD simulations. The minimum 
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energy of the major conformation observed in MD simulations was 33.4 kcal/mol. Its 
structure is shown in Fig. A-7, which indicates that this adduct exists in a folded-type 
conformation. The dihedral angles a and p are both positive, with values of 30.9° and 59 
°, respectively. Angle a, defined as (Cl4a-Cl4b-Cl4c-Cl), describes a propeller-like 
distortion of the DB[a,/]P moiety that relieves the strain of the sterically hindered fjord 
region of the DB[a,/]P residue by minimizing the steric repulsion between the HI and 
H14 protons. Similar values of a were observed for trans-syn-D&[a,[\WE-14-N7Ade 
[24] and benzo[c]phenanthrene diol epoxide adducts [32]. On the other hand, the a and (3 
values for frans-an/z'-DB[a,/]P-tetrol, as shown in Table A-l, are (-24°, 60°) and (27°, 
-63°) for conformers I and II, respectively [26]. The torsion angle y (C6-N-Cl4-Cl4a), 
which defines the relative orientation of the dA moiety, is equal to -61°. The half-chair 
structure of the cyclohexenyl ring, with dA at C14 in a semiaxial position, allows 
formation of a folded-type configuration with strong %-% interaction between dA and the 
distal ring of DB[a,/]P (in the fjord region). This interaction is responsible for the 
spectroscopically observed red-shift of the (0,0) band to ~389 nm. The calculated 
coupling constants for the proton pairs Jn.ia, Ji2,i3, and Ji3.i4are large, medium, and 
medium, consistent with the lH NMR data.2 Thus the major conformation of the trans-
a«r/-DB[a,/]PDE-dA adduct, due to specific steric hindrance created by the fjord region 
of DB[a,/]P, exists in a conformation with positive a and p values, and is referred to as 
conformer II' (Table A-2). 
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Figure A-7. Optimized 0 K ground-state structure of the trans-anti-DB[a, /]PDE-N6dA 
adduct (conformation II') obtained after simulated annealing and subsequent geometry 
optimization. 
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Another unique conformation of trans-anti-dA (with similar local energy 
minimum of -34 kcal/mol) was also observed in the simulations. In this conformation, 
the (a, P) values are (28°, -63.7°) with the dA moiety in a pseudoaxial position, thus 
leading to the open-type structure with a large y value of 158.4°. Consequently, no 
significant interaction between dA and the aromatic system is possible. We associate this 
structure with the experimentally observed minor conformer (I') having its origin band at 
383.0 nm. Although this conformer is hardly observed in ethanol (see Fig. A-4C), it is 
preferentially formed in a micellar CE buffer matrix.3 The FLN spectra obtained for the 
trans-anti- dA-isomer are shown in Fig. A-8; frames A and B were obtained for two 
different excitation wavelengths, 374.0 nm and 378.0 nm, respectively. Comparison of 
spectra a,c (ethanol) with spectra b,d (glycerol/water) indicates that the major, red-
shifted, conformer II' is the same in both glasses. The weak modes at 422,549,627 cm"1 
(spectrum a) correspond to the minor conformer I' with its origin band at 383.0 nm. 
The NLN spectra for the cis-anti-DB[a,/]PDE-dA adduct (Fig. A-4D), in contrast 
to czj-awz'-DB [a, f|P-tetrol [26], imply that two conformers may exist in ethanol, while 
only one conformer is observed in the glycerol/water glass. The origin bands of these 
conformers are at 385.4 nm and 389.8 nm, respectively. Room temperature NMR data 
obtained in MezSO revealed the presence of only one conformation with J| 1,12 = large, 
J 12,13 = small, and Ji3,w (not determined). These coupling constants, based on the 
calculations for cz's-anfz-DB[a, /]P-tetrol [26] and preliminary data for the cis-anti-
DB[a,/]PDE-dA adduct (data not shown), are consistent with conformation II in which 
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Figure A-8. FLN spectra for {-)-trans-anti-DB[a,/]PDE-N6dA adducts in ethanol 
(spectra a and c) and 50/50 glycerol/water glass (spectra b and d) obtained for excitation 
wavelengths of 374.0 nm (Frame A) and 378.0 nm (Frame B), respectively. T = 4.2 K. 
The FLN peaks are labeled with their excited-state vibrational frequencies, in cm"1. The 
spectral range shown covers the fluorescence origin bands of conformations I' and II'. 
The peaks at 270, 375,422,549, and 627 cm"1 correspond to the minor conformation I' 
(see text for details). 
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angle p. The blue-shifted conformation ((0,0) = 385.0 ran) most probably has a negative 
value of p with dA in an open-type configuration. 
Time-resolved spectroscopy revealed the cis-anti-dA adducts in conformation I 
possess a different fluorescence lifetime compared to adducts in conformation II, so the 
fraction of adducts in conformation I can be resolved. The spectrum obtained as the 
difference between two delay times (60 and 20 ns) of the observation window is shown in 
Fig. A-9. This temporal difference spectrum reveals that the adducts in conformation I 
have a longer fluorescence lifetime. As a result, only the origin band at 385.0 ran and its 
corresponding vibronic progression is exposed. This is in contrast to spectrum g of Fig. 
A-4D, where both conformers and their vibronic modes are observed. 
The FLN spectra in Fig. A-10 for the cis-anti-isomer also suggest the presence of 
two unique conformations, consistent with the data shown in Fig. A-4D. Comparison of 
the vibrational frequencies (-850-1100 cm"1) in spectra b of Figs. A-8A and A-10 showed 
that the red-shifted conformers of the trans-anti- and cis-anti-dA adducts have different 
vibrational frequencies (e.g., 926 and 966 cm"1 versus 929 and 960 cm'1, respectively). 
This supports our earlier assignment that conformer II' of the trans-anti- and conformer II 
of cis-anti-DB[a,[\?DE-H6dA isomers are clearly not the same. 
A.4.3. Comparison of trans-syn- and cis-syn- vs trans-anti' and cis-
a/i/i-DBla./JPDE-N6dA adducts. 
Fig. A-l 1 shows four FLN spectra (in glycerol/water glass) obtained under 
identical conditions for trans-syn- (a), cis-syn- (b), trans-anti- (c), and cis-anti-
DB[a,/]PDE-N6dA (d) diastereomers, respectively. These data show that the syn-type 
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Figure A-9. NLN fluorescence spectrum revealing the pure contribution from conformer 
I of the (-)-cis-anti-DB[a, Z]PDE-N6dA adducts. The spectrum was obtained as a 
difference between 60 ns and 20 ns delay time of the observation window; Xe* =308 nm, 
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Figure A-10. FLN spectra for (—)-c/5-aw//-DB[a,/]PDE-N6dA adducts in ethanol 
(spectrum a) and 50/50 glycerol/water glass (spectrum b) obtained at excitation 
wavelength of 374.0 nm. Delay time 40 ns, T = 4.2 K. In ethanol glass the major 
conformation is I, while in glycerol/water, conformation II predominates. The FLN 
peaks are labeled with their excited-state vibrational frequencies, in cm"1. 
171 






384 386 388 390 
Wavelength (nm) 
Figure A-11. FLN spectra of trans-syn- (curve a), cis-syn- (curve b), trans-anti- (curve 
c), and cz^-azz//-DB[a,/]PDE-N6dA (curve d) adducts in a glycerol/water glass. T = 4.2 K. 
Xex = 376 nm. ZPL are labeled with their excited-state vibrational frequencies in cm"1. 
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syn adducts, while strong lines at 428,472, 506, and 555 cm"1 are characteristic for the 
cis-syn-dA isomers. A different pattern of zero-phonon lines is observed in frame B for 
trans- and cis-anti-dA adducts, spectra c and d, respectively. Here the characteristic 
modes are 740, 770, 800, and 838 cm"1 for trans- and 745, 796, 854, 929, and 960 cm"1 
for cis-anti-dA. Differences were also observed in other frequency regions (data not 
shown). With an experimental uncertainty of ±3 cm"1, the observed variations are 
considered to be significant. These results show that trans- and cis- isomers of the syn-
and am/-DB[ti,/]PDE derived dA adducts are readily distinguished by FLN spectroscopy. 
A.5. Conclusions 
We have demonstrated, using low-temperature fluorescence spectroscopy and 
computational chemistry, that not only the major but also the minor DB[a,/]PDE derived 
dA adduct conformations can be characterized. Conformational data, including the 
results from molecular modeling and solvent dependent studies performed for the 
diastereomeric DB[a,/]PDE-N6dA adducts, provided insight on possible conformations of 
the cyclohexenyl ring and the orientation of the deoxyadenosine moiety. It was shown 
that both open-type (I/I') and folded-type structures (II/IF) could be formed. Comparison 
of the fluorescence origin bands (Table A-2) reveals that in a glycerol/water glass trans-
syn- and cis-syn- isomers adopt mostly conformation I, while trans-anti- and cis-anti-
isomers exist mostly in conformation II' and II, respectively. The major low-temperature 
conformations of cis-syn- (I), trans-anti- (II') and cis-anti-dA (II) observed by 
fluorescence are compatible with the *H NMR data. However, for trans-syn-
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DB[ti,/]PDE-N6dA the 'H NMR data shows only conformer II, while the low-temperature 
fluorescence results shows a mixture of conformers I (major) and II (minor). 
The major conformers observed for trans-anti-dA (IT) and cis-anti-dA (II) are 
assigned as folded-type configurations with the same structure for the cyclohexenyl ring 
(positive P), opposite signs of a, and dA in pseudoequatorial position partially stacked 
over the distal ring (see Table A-2). The stacking leads to the experimentally observed 
red-shift of the fluorescence origin bands. In contrast, the minor conformations of the 
above two isomers (I'and I) are characterized by a different half-chair (negative P) with 
the dA moiety in a pseudoaxial position. Both minor conformers appear to have similar 
deviation from planarity in the fjord-region (positive a), as shown in Table A-2. In 
contrast to the trans-anti- and cis-anfi-DB[o,/]PDE-N6dA adducts, where the major 
conformations have a half-chair structure in the cyclohexenyl ring, conformers I and II of 
irans-syn-dA feature half-boat and half-chair structures, respectively, with different 
orientations of the dA moiety. The cis-syn-dA adduct with the half-chair cyclohexenyl 
ring in conformers I (open) and II (folded), and (a, p) being (positive, negative) and 
(negative, positive), respectively, are in agreement with the c/s-jyn-DB[a(/]P-tetrol 
calculations [26]. The different vibrational patterns in the FLN spectra can provide a 
means of distinguishing the trans- and cis- isomers for both syn- and owz'-DB[a,Z]PDE-
14-N6dA adducts. It is anticipated that these high resolution FLN spectra will prove 
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useful for future identification of DB[a, /]PDE-DNA adducts (at the dAMP level) formed 
in biological systems.4 
These fluorescence results establish that a«//-DB[a,/]PDE derived dA adducts, the 
major adducts formed in mouse skin and calf-thymus DNA [16], preferentially adopt 
conformation II (or II') with origin bands at ~388-390 nm. The large red-shift of the 
(0,0)-band is in agreement with modeling studies, which indicate that these conformers 
exist in a folded-type geometry with significant tc-tc interactions. This suggests that 
molecular conformations of -dA adducts may be important for understanding the 
preference of the bound metabolite towards external, base-stacked and intercalated 
conformations, which were recently observed in DNA [16,25]. Specifically, it was 
shown that in mouse skin the majority of aw/z-DB[a,/]PDE-derived DNA adducts adopt 
intercalated conformations, which in turn may influence their recognition by repair 
enzymes [25,33]. The analysis of mouse skin DNA exposed to DB[a,/]P, which showed 
that external adducts are repaired more efficiently than intercalated adducts [16], 
accentuates the importance of adduct conformation. The conformational data presented 
in this manuscript suggest the majority of anfi-DB[a,/]PDE-14-N6dA adducts, due to a 
folded-type configuration, may be easily accommodated by the double helix of DNA. 
Moreover, the fact that the anti- dA adducts assume a folded-type configuration is 
consistent with the significant red-shift of the fluorescence origin band of intercalated 
an/i'-DB[a,/]PDE-dA adducts observed for intact DNA [16]. Therefore, we conclude that 
the large shift (to ~ 398 nm) of the fluorescence origin bands of DNA adducts observed 
* P. Devanesan, F. Ariese, R. Jankowiak, G. J. Small, E. G. Rogan and E. Cavalieri, A novel method for the 
isolation and identification of stable DNA adducts formed by dibenzo[o,/]pyrene and dibenzo[o,Z]pyrene 
11,12-dihydrodiol-13,14,-epoxides in vitro. Chem. Res. Toxicol., accompanying paper. 
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in Réf. 16 are caused by type II (or II') conformers, which allow intercalation and, as a 
result, strong n-n interactions between the adduct and the DNA bases. In addition, it was 
shown here that the cis-anh'-DB[a,/]PDE-14-N6dA adduct forms an open-type structure 
(I), implying that this adduct adopts an external conformation with intact DNA, 
consistent with our earlier findings [16]. Hence, it is entirely possible that the diverse 
structural conformations formed by DB[a,Z]PDE-derived DNA adducts are responsible 
for the high carcinogenic potency of DB[a,/]P. 
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APPENDIX B. PRELIMINARY INVESTIGATION OF 4-
HDROXYTAMOXIFEN AND a-ACETOXYTAMOXIFEN DNA ADDUCTS 
WITH LOW-TEMPERATURE FLUORESCENCE SPECTROSCOPY 
B.l. Introduction 
The anti-estrogen drug tamoxifen (TAM) is being used in the treatment of women 
with breast cancer and has demonstrated potential as a chemopreventive agent to breast 
cancer [1,2]. However, its use as a chemopreventive agent has shown an increase in 
endometrial cancers, and studies with rats showed that TAM is a genotoxic liver 
carcinogen [2]. Metabolic activation and the subsequent DNA damage from TAM are 
not clearly understood. This is primarily because characterization of DNA damage at the 
real-world level has mainly been accomplished with the highly sensitive technique of 32P-
postlabeling [1,2], which can provide inconclusive results due to the amount of time 
needed to perform the analysis, leading to post-digestion degradation of TAM-DNA 
adducts. Therefore, to better elucidate the genotoxic mechanism of TAM, we will utilize 
low-temperature laser-induced fluorescence and fluorescence line-narrowing 
spectroscopy (FLNS) to identify/characterize intact DNA adducts produced with various 
activated forms of tamoxifen. Following the analysis of intact TAM-DNA adducts, DNA 
will be digested to the nucleoside level for analysis by capillary electrophoresis (CE) 
combined with on-line FLNS to identity the individual adducts and determine their 
relative abundance. In this preliminary report, two metabolic forms of TAM (4-
hydroxytamoxifen [3] and a-acetoxytamoxifen [4]) are reacted with DNA to determine 
the nature of their DNA adduction. 
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TAM on its own produces very weak and broad fluorescence at room 
temperature. However, by photocyclizing TAM with UV light [5], as shown in Figure B-
1, a rigid phenanthrene structure is formed which provides highly characteristic spectra at 
77 K (308 nm excitation wavelength). By this method various TAM-DNA adduct 
isomers can be spectroscopically characterized and identified in intact DNA and, after 
digestion, at the nucleoside level. Below are the preliminary results of such analyses, 
beginning with DNA adducts formed with 4-hydroxytamoxifen using various activation 
systems. 
B.2. Results and Discussion 
B.2.1. 4-Hydroxytamoxifen 
Shown in Figure B-2A are the fluorescence results (T = 77 K, XcX = 308 nm) of 
activating the reaction of calf-thymus DNA and 4-hydroxytamoxifen with MnOi as a 
chemical oxidizing agent, before (spectrum a) and after photocyclization (spectrum b) 
with a 15 watt Hg-lamp for 15 minutes at a distance of 5 cm. The DNA samples were 
dissolved (lmg/mL) in SSC buffer. As can be clearly seen, before cyclization the 
spectrum is broad and featureless, centered at ~ 413 nm. However, after 15 minutes of 
cyclization a highly characteristic spectrum can be obtained (b) with an origin band at 
361.5 nm. Similarly, shown in Figure B-2B are the before and after photocyclization 
results of activating the reaction of calf-thymus (CT) DNA and 4-hydroxytamoxifen with 
horseradish peroxidase (HRP) and H2O2. Again, before cyclization the 77 K. fluorescence 
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Figure B-2. Fluorescence spectra for DNA reacted with 4-hydroxytamoxifen using 
MnOi (Frame A) and HRP/H2O2 (Frame B) activation systems before photocyclization 
(spectrum a in each frame) and after cyclization (spectrum b in each frame). T = 77 K, XcX 
= 308 nm. 
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photocyclization a more characteristic spectrum is revealed, with its origin band at 364.5 
nm. 
It has been suggested by 32P-postlabeling that rat liver and human liver 
microsomes (with various cofactors) produce similar adducts with CT-DNA [3]. The 
first test of this assertion by low-temperature fluorescence detection of intact DNA is 
shown in Figure B-3A. Using the procedure described above, spectrum a is before 
photocyclization and spectrum b is after photocyclization of 4-hydroxytamoxifen 
activated with human liver microsomes and cumene hydroperoxide as a cofactor. Similar 
to the two activation systems described above, the spectrum before cyclization is broad 
and featureless, with a maximum near 415 nm. However, in contrast to the systems 
described above, after photocyclization (spectrum b) the blue-shifted spectrum remains 
broad, centered at ~ 374 nm. This suggests strong interaction/coupling of the activated 
tamoxifen with DNA, possibly an internal type adduct. 
Frame B of Fig. B-3 shows the fluorescence results from activation of 4-
hydroxytamoxifen with human liver microsomes and NADPH as a cofactor. Oddly, 
before photocyclization (spectrum a), after 15 minutes of photocyclization (spectrum b), 
and after 35 minutes of photocyclization (spectrum c), results in very similar spectra 
(centered at-415 nm), where no blue-shift of the spectra occurs after exposure to the UV 
lamp. This could possibly be the result of a cross-linked type of adduct, where the TAM 
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Figure B-3. Fluorescence spectra for DNA reacted with 4-hydroxytamoxifen using 
human liver microsomes/cumene hydroperoxide (Frame A) and human liver microsomes/ 
NADPH (Frame B) activation systems before photocyclization (spectrum a in each 
frame) and after cyclization (spectrum b in each frame). T = 77 K, A*x = 308 nm. 
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These results indicate that in all four activation systems, at least four different 
types of products are formed. Activation of 4-hydroxytamoxifen with MnO% shows 
sharp, structured spectra, indicating that in this case, the adduct if of the external type, 
where electron-phonon coupling is weak. Similarly, activation of 4-hydroxytamoxifen 
with human liver microsomes and NADPH indicate that adducts are also of the external 
type, yet different from those formed with MnCh, due to the shift in the fluorescence 
origin band. The possibility of more than one type of adduct being formed can also be 
considered, which would explain spectra being more broad than that of MnOa activation, 
but could also be due to adducts with larger electron-phonon coupling with DNA. 
Moreover, there could also be residual, unreacted 4-hydroxytamoxifen that is intercalated 
(physically bound) in the DNA and not completely removed during washing procedures, 
or the formation of internal type adducts, i.e., adducts covalently bound within the DNA 
helix. Lastly, the shift in the fluorescence origin band indicates that the adduct is not 
identical to that formed with MnCh. In the case of activating 4-hydroxytamoxifen with 
human liver microsomes and cumene hydroperoxide (Figure B-3A) the results indicate 
that an internal type of adduct may be formed, or simple intercalation. However, in the 
latter case, the signal was much stronger than that observed for the control, where 
intercalation was observed (data not shown). In regard to activation of 4-
hydroxytamoxifen with human liver microsomes and NADPH (Figure B-3B), the 
adduction appears to be of an internal type, yet different than that for the system previous 
system of human liver microsomes and NADPH. Similar results were previously shown 
by Bodell et al. [3], where it was reported by 32P-postlabelling that some adducts formed 
with NADPH are different from those formed with cumeme hydroperoxide. 
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These results also indicate that low-temperature fluorescence spectroscopy can be 
useful in characterizing different types of adducts formed with 4-hydroxytamoxifen. 
However, studies that are more conclusive should include higher resolution spectroscopy 
(i.e., FLNS) on the intact DNA samples, followed by digestion of the DNA to the 
nucleoside level. Once digested, FLNS can be used on-line with capillary electrophoresis 
and HPLC to separate the adducts, determining not only their identity (when compared to 
synthetic standards) but also their relative abundance. 
B.2.2. a-Acetoxytamoxifen 
Osborne et al., [4] have also reported the detection of covalent DNA-TAM 
adducts in the liver of rats treated with tamoxifen [4]. It was suggested that tamoxifen is 
most likely metabolized to a-acetoxytamoxifen, which binds to DNA. The major 
adducts found in rat liver tissue were isolated and purified by and characterized by 
HPLC, MS, and NMR. They are the E and Z form of 4-{-[2-
(dimethylamino)ethoxy]phenyl} -3,4-diphenyl-2-(9p-deoxyribofuranosy l-6-oxopurin-2-
ylamino)-3-butene, also known as TGI and TG2, respectively [4]. In what follows, all 
samples were photocyclized as described above, and fluorescence spectra were taken at 
77 K with an excitation wavelength of 308 nm and in an ethanol solvent. The 
fluorescence spectra of TGI had its before cyclization maximum at ~ 413 nm, and TG2 at 
~ 410 nm (data not shown). After cyclization, the fluorescence origin band of TG1 and 
TG2 were both at ~ 357.5 nm, as shown in Figure B-4. Since these two adducts are E/Z 
isomers, it is possible that they photocyclize to the same species. Moreover, the spectrum 














350 400 450 
Wavelength (nm) 
Figure B-4. Fluorescence spectra for TGI and TG2 after 15 minutes of photocyclization; 
T = 77 K, Xex = 308 nm, in ethanol (see text for details). 
189 
shoulder at 351.4 nm. This could possibly be the cyclized Z form of the adduct, however, 
off-line FLNS and on-line HPLC-/CE-FLNS should be used to confirm or deny this, so 
that a pure reference spectrum can be generated for these standards to determine if a-
acetoxytamoxifen adducts are formed with calf-thymus DNA. 
Shown in Figure B-5 are the 77 K fluorescence results of photocyclization (as 
described above) of intact calf-thymus DNA with different adduction level of a-
acetoxytamoxifen (as established by 32P-postlabeling), X«x = 308 nm. As can be seen, in 
going from high to low adduction levels (spectra a-e), the resultant spectra become 
broader and shift to the red (see figure caption). Spectrum a is the result of the highest 
adduction level in this study, 1 adduct in 400 base-pairs. This spectrum shows a 
characteristic phenanthrene type spectrum with a fluorescence origin band at 361.5 nm. 
The sharp fluorescence from the phenanthrene moiety becomes lost by spectrum d, which 
is an adduction level of 200 adducts in 106 base pairs. This suggests that at high 
adduction at least two types of adducts may be formed, one external and the other 
internal, whereas, at low levels, only one internal adduct is formed. To better 
characterize the types of adducts formed from a-acetoxytamoxifen with DNA, the DNA 
was digested to the nucleoside level for further low-temperature analysis. 
Shown in Figure B-6 are the results of photocyclized DNA digests that were 
purified by HPLC. Spectra a and b correspond to the HPLC fraction for TGI and TG2, 
(as established from rat liver DNA digests described above), digested from DNA with 
1200 adducts per 106 base pairs. Spectrum c corresponds to digest that should contain 
both TGI and TG2, from DNA adducted at a level of 5 adducts in 106 base-pairs. As 
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Figure B-5. Fluorescence spectra for various adduction levels of a-acetoxytamoxifen 
with DNA: (a) 1 adduct in 400 base-pairs, i.e., 1:400, (b) 1200:106, (c) 200:106, (d) 
19:10*, (e) no adducts—physical intercalation only. Each was photocyclized for 15 
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Figure B-6. Fluorescence spectra of photocyclized DNA digests that were purified by 
HPLC and photocyclized for 15 minutes. Spectra a and b correspond to fraction that 
contain TGI and TG2, respectively. Spectrum c corresponds to a fraction containing 
both TGI and TG2: T = 77 K, XeX = 308 nm, in ethanol. 
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shown in the spectra a and b, the fluorescence origin band is at 358.1 nm, with an 
unknown contaminant peak at 343 nm. On the other hand, spectrum c shows a more 
complex fluorescence spectrum with an origin band at ~ 362 nm. These results indicate 
that to be certain if the adducts formed in rats treated with tamoxifen are the same as 
those formed when reacting calf-thymus DNA with a-acetoxytamoxifen, that samples 
will require on-line FLNS detection. This is due to the large amount of impurities from 
incomplete fractionation by HPLC and the inherent low-resolution of 77 K, 308 nm 
excitation. 
B.3. Conclusion and Future Prospects 
By combining, results from off-line low-temperature fluorescence spectroscopy of 
intact TAM-DNA adducts with results from 32P-postlabeling and HPLC-/CE-FLNS of 
DNA digested to the nucleoside level, more definitive identification/characterization and 
quantification of these adducts can be accomplished. Fluorescence results from intact 
DNA adducts may offer insight into the recognition and repair of these types of adducts. 
On the other hand, analysis at the nucleoside level will not only allow for more thorough 
identification and characterization, but will also provide the ability to determine the 
relative abundance of the various TAM-DNA adducts formed. It is anticipated that by 
utilizing these techniques in a complementary fashion to study the products formed by 
the two common activated forms of the anti-estrogen drug tamoxifen described above, a 
further understanding of the genotoxic nature of this drug and its viability as a 
chemopreventive agent to breast cancer can be realized. 
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APPENDIX C. PRELIMINARY INVESTIGATION OF AN INTACT NON 
COVALENT PHOTOSYNTHETIC MEMBRANE PROTEIN (CP43) 
COMPLEX BY CAPILLARY ELECTROPHOREIS AND NON-LINE 
NARROWING FLUORESCENCE SPECTROSCOPY 
C.l. Introduction 
Photosystem II (PSII) is a large membrane protein complex found in green plants, 
algae, and cyanobacteria, and is made up of at least 25 smaller protein subunits [1]. 
CP43 (M.W. 43 kDa) is one such subunit containing non-covalently bound chlorophyll 
and serves as an antenna for tunneling solar energy captured by peripheral antenna 
subunits to the reaction center, where the photochemical reactions take place [2], To 
study these mechanistic processes, as they would occur in nature, the 3-dimensional 
structure of the protein needs to remain in its native state. A common procedure for 
studying these processes is to fractionate the particular subunits of PSII via 
chromatography and/or electrophoresis, followed by off-line spectroscopic 
characterization [3-5]. However, these proteins often denature (to varying degrees) under 
even the most careful experimental conditions, which can lead to the release of 
chlorophyll molecules and/or reorientation of the chlorophyll's local environment. This, 
along with possible aggregation of the monomeric subunit, can alter the spectral 
(absorbance/fluorescence) properties of CP43, leading to many contributing factors 
(additional spectral bands) in the off-line spectral analyses. Consequently, interpretation 
of the relative contributions is the subject of much debate due to the subjective nature of 
deconvolving spectroscopic data [4,5]. In what follows, a fractionated CP43 sample is 
analyzed by capillary electrophoresis (CE) with on-line low temperature laser-induced 
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fluorescence spectroscopy, under non-line-narrowing (NLN) conditions, i.e., 4.2 K, Xc* = 
351.1 nm. Any denaturation that occurs during sample handling or contamination of 
other subunits from incomplete fractionation can be electrophoretically displaced from 
the native, intact CP43 zone, which can then be frozen to 4.2 K. in mid-separation for 
spectroscopic characterization. The CE-buffer (see below) was chosen to keep the 
proteins in their native state and minimize aggregation [4]. Although these results are 
preliminary, and more studies of on-line fluorescence line-narrowing detection should be 
done, this is a promising approach of studying subunits of PSII in their most native form. 
C.2. Experimental 
The same experimental setup for room- and low-temperature CE-LIF as that 
described in Chapter 4 was used. The difference being that in this case there was no 
FLNS, only NLN spectra were obtained to determine if there is denaturation. The sample 
buffer was 20 mM BisTris, 20 mM NaCl, 0.1% (w/v) n-dodecyl-P,D-maltoside, 10% 
glycerol (w/v), pH 8.0. This buffer, excluding the percentage of glycerol (used for glass 
formation), has been reported to be suitable for CP43 [4], The excitation wavelength was 
351.1 nm. The operating voltage for the CE was 20 kV, which resulted in a ~ 20 pA 
current; 75 pm i.d. x 365 (im o.d., UV-transparent capillary (Polymicro Tech., Phoenix, 
AZ). Low-temperature experiments were obtained at 4.2 K, with a resolution of 0.8 nm. 
C.3. Results and Discussion 
Shown in Figure C-lais the CE-separation of a HPLC-fractionated CP43 sample. 
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Figure C-1. CE electropherograms of (a) CP43 after immediately thawing from -70°C, 
(b) after 4 hours at room-temperature in the dark, (c) after refreezing for 1-month at -
70°C. CE conditions: 20 mM BisTris, 20 mM NaCl, 0.1% (w/v) n-dodecyl-(5,D-
maltoside, 10% glycerol (w/v), pH 8.0; 20 kV (~ 20 fiA); 75 jim i.d. x 365 pm o.d. 
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~ 13 minutes (peak 1) and ~ 14.5 minutes (peak 2). By monitoring room temperature 
fluorescence at an excitation wavelength of 351.1 nm, peak 1 revealed fluorescence near 
-675 nm, while that for peak 2 was ~ 681 nm (data not shown). This indicated that peak 
1 could possibly be denaturation of peak 2. Moreover, it was shown in a previous study 
of a similar core antenna subunit system (CP47) that denaturation can be revealed with 
the aid of ion-exchange chromatography [5]. The other peaks are possibly aggregated 
dimers or other multimers since there fluorescence at room temperature was red-shifted 
beyond what has been reported for monomelic CP43 [6]. 
To further characterize and identify peaks 1 and 2 in electropherogram a of Fig. 
C-l, the separation was repeated and this time the first two peaks were frozen in mid-
separation to 4.2 K. The resulting non-line-narrowed fluorescence (XeX - 351.1 nm) for 
each is shown in Figure C-2. The spectrum corresponding to peak 1 revealed a broad 
fluorescence (fwhm ~ 20 nm) centered at 674 nm (spectrum a), possibly denatured CP43, 
while the spectrum corresponding to peak 2 in the electropherogram was only ~ 6 nm at 
fwhm, centered at 683.3 nm. The latter is indicative of intact CP43 at 4.2 K [4,5]. 
Further evidence that the first peak in the electropherogram was the result of 
protein denaturation was accomplished by leaving the sample at room temperature in the 
dark for ~ 4 hours. The result of the CE separation is for this sample is shown in Figure 
C-lb. As shown, the large peak with CP43-type fluorescence (peak 2 in the 
electropherogram) has significantly decreased, while peak 1 in the electropherogram has 
increased. This suggests that peak 1, with its broad 4.2 K. fluorescence centered at 674 
nm, could be the partial denaturation product of peak 2. 
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Figure C-2. On-line NLN fluorescence spectra of peaks 1 (spectrum a) and 2 (spectrum 
b) in the electropherogram of Figure C-l. T = 4.2 K, X» = 351.1 nm. The fluorescence 
maximum of spectra a and b are 674 and 683.3 nm, respectively. 
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After leaving the sample in a freezer at -70°C for one month and then re-thawing, 
another CE-separation was performed, shown in Figure C-lc. In this figure, it is clear 
that the majority of all peaks have disappeared, likely denaturing into peak 2 under 
ambient conditions and from thawing and refreezing. 
C.4. Conclusion and Future Prospects 
Although the above buffer is likely better than previous buffer systems (e.g., 
Triton X) to maintain CP43 in its native state, the results indicate that CP43 can readily 
denatured under these conditions, with possible aggregation. However, with CE coupled 
on-line to high-resolution fluorescence detection (FLNS), future studies can be performed 
on the on-line purified analyte zone corresponding to native CP43. Furthermore, studies 
NLN and FLN studies should also be conducted on the remaining peaks in the 
electropherogram to assess their exact nature, i.e., dimer, trimer, etc. 
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